data_2do3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2do3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -114.45 159.55 20.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.1 146.54 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 89.0 -17.57 50.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -92.19 152.32 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 43.9 t-80 -92.98 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.454 HG22 ' CG1' ' A' ' 492' ' ' ILE . 1.7 m -135.74 151.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 480' ' ' VAL . 30.2 tttm -114.69 159.73 20.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.401 ' N ' ' CG ' ' A' ' 479' ' ' LYS . 41.8 t -106.23 111.06 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . 0.424 ' CG2' ' OE1' ' A' ' 519' ' ' GLN . 28.5 pt -92.99 -30.39 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.0 -179.32 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.35 -167.04 23.37 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.41 4.23 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -129.19 25.61 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.51 112.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.39 24.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.494 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.53 153.03 25.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 32.6 p -137.5 164.06 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . 177.78 -173.93 46.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.5 162.51 12.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.454 ' CG1' HG22 ' A' ' 478' ' ' VAL . 56.2 mt -93.46 114.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.3 m -104.88 -28.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -146.44 142.37 28.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.54 142.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.71 159.47 41.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.58 -18.63 65.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.85 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 512' ' ' LYS . 1.4 p90 -135.2 179.71 6.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.94 129.1 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.5 mm -94.56 118.81 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -116.62 137.02 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -82.87 121.5 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 4.9 t -78.46 151.91 32.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.79 -12.79 17.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.6 mt -90.7 -54.94 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 23.6 p -85.39 -11.91 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.4 mtm 58.28 37.87 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -132.53 -178.01 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 510' ' ' GLU . 31.9 mp0 -102.28 117.9 35.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.24 135.26 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 499' ' ' PHE . 66.5 tttt -107.91 111.7 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.72 161.22 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' A' ' 499' ' ' PHE . 72.8 mt -82.41 151.48 65.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -5.17 15.53 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -86.75 -12.98 46.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -115.63 9.13 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.13 167.98 10.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . 0.424 ' OE1' ' CG2' ' A' ' 481' ' ' ILE . 13.4 pt20 -158.45 130.03 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.444 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 8.7 m-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.29 159.16 29.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -60.34 121.15 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 116.5 -11.43 16.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.83 150.85 21.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -85.1 131.5 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.85 154.45 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.42 157.62 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.69 125.44 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -108.54 -31.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.18 170.92 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.12 -153.8 17.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -89.94 -22.1 22.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.32 39.41 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 123.98 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 97.6 22.19 17.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 489' ' ' THR . 9.6 t70 -118.66 170.93 8.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' THR . . . . . 0.471 ' N ' ' OD1' ' A' ' 488' ' ' ASP . 40.8 p -149.34 157.12 43.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.73 -179.76 48.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.26 154.01 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.51 110.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.78 -34.6 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -143.37 120.76 11.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.5 117.21 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -103.96 161.42 13.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.97 -28.2 69.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -88.43 -66.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.531 ' CD1' ' HG3' ' A' ' 512' ' ' LYS . 1.2 p90 -123.36 179.62 4.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.69 129.81 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.139 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 512' ' ' LYS . 3.0 mm -97.95 111.14 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -111.66 137.25 49.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -81.7 138.7 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 18.1 t -91.43 147.31 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.18 -18.72 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.26 -54.32 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 42.8 p -81.74 -13.94 57.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.0 mtm 52.8 47.54 24.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -138.76 171.87 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -99.8 109.88 22.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.74 132.74 43.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.531 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 2.4 ttpm? -97.74 117.85 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.75 140.65 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 48.7 mt -64.55 152.1 90.27 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 2.78 3.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -98.98 -4.36 32.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -121.78 17.93 11.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 41.4 mt -123.31 163.13 21.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -153.61 127.12 8.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 9.9 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.925 0.393 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -109.81 146.46 34.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.4 ttp -42.26 133.66 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 106.91 -41.16 2.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.439 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.45 159.97 32.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -98.99 144.11 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 502' ' ' LEU . 26.5 m -139.39 146.8 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -117.56 152.65 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.14 131.81 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.82 -19.55 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.13 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.27 -176.92 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 90.94 -166.31 31.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.426 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -80.46 -6.04 57.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -122.96 44.05 2.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -71.89 112.3 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.32 7.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.05 168.45 9.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 33.4 p -151.55 151.14 31.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -174.54 178.42 46.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.64 158.71 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 36.1 mt -86.07 115.98 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.22 -24.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -150.41 133.75 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.78 130.8 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -125.52 155.97 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.96 -16.67 32.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -97.81 -61.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.549 ' CZ ' ' HD2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -138.61 164.97 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.25 123.97 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.1 mm -89.65 117.9 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . 0.432 HD12 ' CG2' ' A' ' 478' ' ' VAL . 2.6 pt? -114.12 143.33 44.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -83.85 131.6 34.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.5 t -101.3 141.7 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.74 -24.76 19.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.89 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 30.6 mt -71.27 -52.86 16.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 62.8 p -91.29 -17.65 25.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 9.5 mtt 63.96 40.61 7.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -143.7 171.87 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -92.49 126.71 37.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 58.2 mt -111.2 133.46 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.549 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 0.8 OUTLIER -99.73 114.66 27.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.58 146.03 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.62 151.31 94.86 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -1.96 9.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.382 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -91.45 -14.31 30.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.91 2.42 19.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.66 153.66 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -141.65 131.3 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -118.76 170.14 9.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.0 ttp -53.85 140.16 31.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 91.77 -23.1 27.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -85.91 149.1 25.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -98.03 131.79 44.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 22.3 m -125.56 170.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -134.79 144.82 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 18.3 t -90.57 122.15 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.0 pt -106.31 -23.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -140.71 178.39 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.63 -152.14 20.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -88.35 -25.36 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -103.75 40.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.42 111.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.34 -9.18 26.6 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -93.3 145.03 24.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.7 p -130.4 159.85 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.24 174.81 47.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.12 166.41 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 22.9 mt -99.97 107.76 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.81 -27.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -154.67 148.76 25.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.94 144.84 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.63 142.36 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -47.63 -22.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -93.43 -59.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.428 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 171.36 14.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 53.9 t -114.73 128.79 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.77 107.28 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -106.17 136.88 45.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -85.54 132.37 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -87.41 152.49 22.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -101.15 -18.5 16.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.69 -53.95 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 72.1 p -82.01 -12.64 58.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.082 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.4 mtp 54.33 28.19 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -122.1 174.28 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.22 121.23 32.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.22 137.72 44.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.428 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.8 tmtt? -116.62 124.08 48.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 17.8 t -151.99 150.94 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.85 152.52 96.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.583 0.706 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.08 11.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -86.45 -21.74 26.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -108.2 20.31 18.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 67.3 mt -126.29 156.57 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -153.85 127.83 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.539 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 1.5 m-30 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -134.99 153.42 52.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 ttt -52.06 127.48 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 111.38 -10.89 28.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.21 164.27 11.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -103.44 137.9 40.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.58 168.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.15 147.15 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.1 104.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.4 pt -86.68 -27.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -137.8 171.99 13.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 106.85 -162.14 13.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -89.95 -0.03 57.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -120.36 15.35 12.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -39.67 121.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.68 53.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.24 131.49 55.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.3 p -123.81 163.18 21.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 178.91 -174.7 46.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -97.98 158.76 15.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.73 114.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.5 -33.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -140.32 140.21 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.63 124.93 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.0 155.81 30.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -59.77 -17.26 33.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.36 -61.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.557 ' CD2' ' HE3' ' A' ' 512' ' ' LYS . 1.2 p90 -134.91 168.0 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.16 123.94 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.49 117.36 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -112.42 139.42 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -82.12 126.23 31.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 47.2 t -86.53 153.8 21.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -105.32 -28.98 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.55 -50.15 19.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.0 p -93.94 -13.55 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 79.1 mtp 59.49 30.27 19.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -123.46 158.98 30.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -84.26 112.29 20.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 26.2 mt -93.25 140.35 29.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.557 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 28.3 tttt -109.55 123.06 48.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 19.2 t -154.34 157.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 66.9 mt -73.65 152.12 89.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.64 8.84 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -89.91 -30.66 17.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.29 6.69 45.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.53 156.08 23.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -143.1 129.31 19.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 11.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -120.16 156.41 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.62 126.05 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.78 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -72.09 158.21 36.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -98.13 130.9 44.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.424 ' CG1' HD13 ' A' ' 492' ' ' ILE . 22.6 m -126.34 161.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -129.63 148.18 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.13 116.76 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.46 -21.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.93 179.12 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.69 -149.46 19.23 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -89.92 -28.89 18.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -103.09 41.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -56.83 108.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.2 -17.3 19.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -75.15 141.77 43.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -128.78 151.17 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.47 39.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.21 158.78 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.424 HD13 ' CG1' ' A' ' 478' ' ' VAL . 45.7 mt -88.72 111.34 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 14.0 m -100.4 -28.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.06 142.43 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.8 146.88 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -139.79 140.83 36.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.15 -22.33 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -90.03 -62.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.546 ' CD2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -136.98 169.92 16.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 39.6 t -115.91 127.62 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.3 mm -95.23 121.68 46.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -118.74 138.04 52.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -82.39 126.3 32.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 8.1 t -81.23 151.96 27.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -96.62 -18.87 19.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.83 -53.07 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 54.3 p -81.56 -0.8 43.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.444 ' C ' ' O ' ' A' ' 507' ' ' THR . 20.8 mtp 35.14 50.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 507' ' ' THR . 29.7 m-70 -145.67 170.23 16.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.1 118.43 28.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.69 137.17 42.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.546 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 25.8 tttt -111.63 114.98 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.75 141.69 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.28 152.13 64.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 1.86 4.04 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.33 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -93.71 -10.8 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.41 21.35 13.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.546 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.3 mt -128.79 166.98 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 138.47 13.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.926 0.393 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -118.73 155.84 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' MET . . . . . 0.443 ' HA ' ' CG2' ' A' ' 492' ' ' ILE . 0.3 OUTLIER -56.74 136.75 55.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . 0.432 ' N ' ' SD ' ' A' ' 474' ' ' MET . . . 101.01 -11.13 58.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.556 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.7 154.38 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -97.21 133.26 42.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 4.3 m -128.61 159.0 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -125.52 141.84 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 488' ' ' ASP . 15.4 t -82.92 128.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.6 pt -111.92 -23.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.62 172.37 12.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.26 -152.31 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -88.89 -26.58 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.813 0.339 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -102.94 38.17 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.37 106.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.33 -18.22 11.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 480' ' ' VAL . 3.1 t70 -77.39 146.1 36.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 65.5 p -134.07 153.2 51.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.31 -178.08 41.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -99.69 154.91 17.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 474' ' ' MET . 72.2 mt -86.57 122.43 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.4 m -112.72 -34.63 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -143.37 121.99 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.39 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -124.97 153.35 42.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.13 -28.22 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -84.63 -61.35 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.412 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -138.87 174.31 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.35 136.47 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 9.9 mm -105.78 108.88 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -107.85 141.94 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -84.35 124.22 31.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 12.2 t -76.14 154.81 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.97 -26.24 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.53 -57.89 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 508' ' ' MET . 77.1 p -79.99 3.76 19.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 507' ' ' THR . 45.7 mtt 35.08 49.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -139.71 177.75 7.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.99 121.82 38.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 27.5 mt -103.95 141.02 36.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.412 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.2 tmtt? -118.24 121.28 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . 0.406 HG21 ' C ' ' A' ' 512' ' ' LYS . 13.0 t -154.56 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 69.0 mt -62.63 150.25 86.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -1.14 7.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.289 . . . . 0.0 112.356 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.35 -10.67 45.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.1 11.88 15.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 22.4 mt -120.07 158.21 27.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -148.95 140.53 23.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.7 m-30 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -121.09 154.01 36.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 27.8 ttp -49.89 133.77 21.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.52 -38.76 3.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.02 154.2 38.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -97.19 143.91 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 25.1 m -139.08 177.65 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 19.0 ttpt -142.88 156.6 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 40.3 t -99.59 109.2 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.3 pt -89.56 -23.94 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.56 170.96 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.24 -156.45 17.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -85.06 -27.15 26.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -99.13 28.34 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.74 119.78 5.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 98.01 16.66 32.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -117.06 138.74 51.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.8 p -118.65 157.72 26.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.6 171.74 44.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.61 164.88 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.9 108.51 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.02 -37.47 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -140.68 153.3 45.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.95 127.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 498' ' ' ASN . 2.4 mp0 -122.92 140.55 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -44.16 -23.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 496' ' ' GLU . 5.4 m-80 -88.67 -68.9 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.504 ' CG ' ' HE3' ' A' ' 512' ' ' LYS . 0.8 OUTLIER -130.74 171.26 13.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.24 137.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.0 mm -104.61 106.29 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -103.49 136.35 43.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -80.7 129.35 34.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.9 t -84.99 148.61 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -98.08 -14.01 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.87 -51.38 4.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 67.4 p -83.16 -4.34 58.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 4.7 mtt 45.87 34.86 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.05 176.42 8.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -94.73 117.53 30.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.86 135.14 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.504 ' HE3' ' CG ' ' A' ' 499' ' ' PHE . 3.0 tmtt? -107.74 131.03 54.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . 0.411 HG23 ' C ' ' A' ' 512' ' ' LYS . 6.7 t -156.89 149.57 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 52.0 mt -68.7 152.0 96.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 1.37 4.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.679 2.253 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -92.25 -27.67 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -106.76 40.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 57.1 mt -143.29 162.99 34.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -152.12 137.71 17.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.6 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.934 0.397 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 492' ' ' ILE . 9.2 ptmm? -112.7 159.84 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.6 ttt -59.84 126.18 26.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.03 -37.49 3.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -75.29 160.09 30.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -100.0 130.47 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.56 153.0 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.97 138.3 54.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.6 t -91.4 121.79 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.152 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 44.9 pt -106.15 -23.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.24 172.4 12.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 103.09 -156.81 18.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.497 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -83.23 -20.04 35.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -112.87 43.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -61.29 138.84 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.78 -16.06 22.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.39 149.18 25.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 4.8 p -140.97 159.15 42.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -172.51 -169.72 35.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.99 160.17 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.468 ' CD1' ' O ' ' A' ' 473' ' ' LYS . 24.0 mt -91.67 112.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.114 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.35 -31.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -153.4 131.81 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.24 151.66 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.7 157.57 46.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.61 -17.31 46.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.95 -66.48 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.516 ' CG ' ' HD3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -127.42 174.79 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.85 127.57 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 108.57 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -109.97 141.65 42.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -86.5 135.28 33.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.7 t -91.71 142.9 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.45 -5.4 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 44.5 mt -90.81 -73.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.2 p -82.35 7.57 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.8 mmm 44.13 30.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -111.63 159.24 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -82.78 117.67 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.38 153.7 19.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.516 ' HD3' ' CG ' ' A' ' 499' ' ' PHE . 6.1 tmmm? -123.77 124.52 42.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.0 143.65 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.123 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.57 156.01 92.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.959 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -0.34 6.79 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.713 2.276 . . . . 0.0 112.319 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -97.25 -15.52 20.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -115.8 34.51 4.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.564 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.9 mt -134.26 157.52 46.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -145.44 129.17 17.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.3 m-30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.906 0.384 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.83 -178.17 3.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.4 ttt -74.18 156.73 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 76.53 -9.63 21.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -93.51 148.39 22.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -95.8 113.51 25.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.829 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 10.8 m -106.36 161.39 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -121.78 141.55 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 19.4 t -89.49 116.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 482' ' ' ALA . 24.6 pt -100.55 -30.37 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . 0.458 ' N ' HG13 ' A' ' 481' ' ' ILE . . . -139.96 171.0 14.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.56 -157.17 15.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.533 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -87.92 -9.89 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.23 38.74 3.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -60.19 137.73 58.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.31 -20.22 27.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.61 160.19 21.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -143.57 165.43 27.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.82 -178.83 48.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.2 mt -99.37 160.98 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.455 HG22 ' CG1' ' A' ' 500' ' ' VAL . 6.1 mt -94.51 105.01 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.89 -28.11 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -153.34 141.98 20.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 496' ' ' GLU . 60.5 t -126.23 139.24 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 495' ' ' VAL . 7.2 mm-40 -126.46 146.53 50.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -49.11 -29.08 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -85.31 -60.25 2.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.49 178.06 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 492' ' ' ILE . 39.8 t -119.79 132.52 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.1 mm -97.09 110.94 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -112.72 137.55 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -84.25 135.62 34.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -91.36 142.3 27.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.66 -10.5 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.12 -48.49 4.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 9.0 p -92.96 -3.57 54.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 44.6 mmm 42.55 34.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -123.29 164.43 18.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -85.28 104.03 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt -87.91 143.26 27.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -114.89 113.37 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.29 139.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.89 153.69 71.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.584 0.707 . . . . 0.0 110.933 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 2.1 3.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.631 2.221 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -97.46 -4.65 37.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -118.27 1.27 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 472' ' ' PHE . 20.1 mt -113.98 152.84 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . 0.452 ' OE1' ' CG2' ' A' ' 481' ' ' ILE . 9.4 pt20 -143.97 132.28 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.8 m-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.932 0.396 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -136.34 153.53 51.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 19.4 ttp -51.26 125.58 14.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.52 -29.61 7.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -84.77 158.92 20.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -102.69 131.77 49.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.411 ' CG2' HD12 ' A' ' 502' ' ' LEU . 14.8 m -123.45 159.39 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -125.04 136.5 53.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.24 114.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 33.2 pt -97.97 -24.72 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.45 -179.42 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.93 -160.59 21.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -86.13 -7.76 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -119.15 35.83 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -57.66 138.6 55.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 84.02 -13.92 46.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -87.98 151.58 22.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 24.3 p -139.6 162.27 35.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.82 178.39 48.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.42 161.26 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -90.26 117.91 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -107.61 -31.65 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -149.18 137.79 21.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.53 138.34 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.407 ' OE2' ' CD1' ' A' ' 501' ' ' ILE . 11.8 mt-10 -126.42 148.82 49.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -54.63 -21.09 9.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . 0.412 ' HB3' ' CD2' ' A' ' 499' ' ' PHE . 4.2 t-20 -94.14 -53.7 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.454 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.2 p90 -142.36 172.0 13.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.75 125.34 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.079 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . 0.407 ' CD1' ' OE2' ' A' ' 496' ' ' GLU . 9.1 mm -90.85 119.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . 0.411 HD12 ' CG2' ' A' ' 478' ' ' VAL . 2.3 pt? -116.54 140.53 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -85.58 132.03 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 13.4 t -85.95 154.82 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.92 -26.29 14.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.1 mt -86.85 -54.25 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 38.7 p -80.16 -7.23 58.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.7 mtm 45.55 36.94 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 507' ' ' THR . 17.9 m-70 -135.67 163.58 29.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.21 125.73 32.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 42.9 mt -109.92 133.99 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.454 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 49.6 tttt -101.68 111.65 23.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.79 143.41 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.6 153.22 83.95 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.643 0.735 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -0.89 7.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -91.18 -11.2 39.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -112.21 1.94 16.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 44.0 mt -116.45 159.58 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -151.96 133.79 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 492' ' ' ILE . 97.2 mttt -121.0 149.33 42.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 13.7 ttp -42.47 140.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 96.05 -49.52 1.74 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.78 152.05 37.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -94.7 130.09 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.54 158.14 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.37 148.45 50.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.07 121.6 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -103.8 -23.64 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.39 -177.89 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.04 -152.5 19.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -89.9 -5.52 56.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -128.08 37.82 4.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.96 136.78 57.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.84 17.01 71.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.4 172.87 6.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 72.1 p -151.44 160.6 43.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 177.33 177.27 46.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.58 154.44 19.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 473' ' ' LYS . 39.7 mt -82.93 119.68 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.24 -26.34 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -160.56 120.83 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 11.5 t -109.57 146.42 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -132.31 150.96 52.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.52 -27.03 23.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -85.35 -59.64 2.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.485 ' CD1' ' HG3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -139.55 174.13 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 36.6 t -113.82 134.33 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.7 mm -103.79 111.42 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -114.51 138.99 49.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -79.74 132.08 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -90.02 152.06 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.21 -20.89 17.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.08 -49.44 6.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 508' ' ' MET . 76.9 p -89.3 2.72 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 507' ' ' THR . 14.0 mtp 36.3 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.94 171.74 12.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.56 117.22 28.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.03 127.33 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.485 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 18.3 ttpt -101.55 117.07 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.65 157.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.18 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 92.4 mt -77.42 153.88 81.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.615 0.721 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 0.86 5.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.257 . . . . 0.0 112.338 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -95.15 -12.41 26.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.75 13.04 16.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.529 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 92.9 mt -115.56 162.35 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . 0.411 ' HG2' ' C ' ' A' ' 518' ' ' LEU . 12.9 mm-40 -152.07 137.74 17.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.3 m-30 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.459 ' N ' HD12 ' A' ' 492' ' ' ILE . 44.2 pttt -123.48 141.17 52.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 473' ' ' LYS . 13.6 ttt -34.61 128.92 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 107.04 -49.58 0.86 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.79 154.03 31.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -94.93 137.49 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.02 156.29 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.159 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 480' ' ' VAL . 21.8 tttt -128.37 148.39 50.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.407 ' N ' ' HG3' ' A' ' 479' ' ' LYS . 36.1 t -95.27 111.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.8 pt -94.53 -25.09 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.71 178.21 7.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.96 -154.48 19.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -86.33 -28.62 23.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 485' ' ' PHE . 6.0 m-85 -100.55 34.5 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.05 137.27 46.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.9 -21.15 24.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.34 158.29 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 27.8 p -145.34 159.82 42.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.62 178.8 43.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -97.08 155.17 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 473' ' ' LYS . 24.5 mt -81.82 111.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.01 -25.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -155.83 150.22 25.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.9 137.8 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.87 140.59 49.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.66 -29.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -83.7 -64.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.47 173.61 11.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.2 t -114.41 140.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.8 mm -105.01 118.95 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -116.79 137.37 52.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -84.25 129.69 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.6 t -85.53 152.81 22.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.41 -21.41 17.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 68.0 mt -90.49 -52.89 4.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 22.8 p -82.41 -9.0 59.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.6 mtt 46.24 41.09 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -136.25 167.97 20.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.96 113.88 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.99 131.85 43.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -105.37 108.34 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 514' ' ' LEU . 39.8 t -133.76 154.08 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.409 ' N ' HG13 ' A' ' 513' ' ' VAL . 78.3 mt -71.82 155.26 92.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.33 15.93 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.232 . . . . 0.0 112.378 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.95 -26.99 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.57 18.33 16.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 48.8 mt -132.8 155.23 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -140.42 138.57 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.0 m-30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.912 0.387 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -120.64 144.57 48.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 9.0 mtm -45.86 143.09 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.79 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.31 160.58 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -104.66 133.01 50.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.05 159.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -120.23 149.94 41.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 25.5 t -95.12 123.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.128 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . 0.41 ' CG2' ' OE1' ' A' ' 519' ' ' GLN . 15.6 pt -103.54 -26.57 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.75 -175.65 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.74 -153.9 20.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -89.15 -3.89 58.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.36 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.65 33.47 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -56.95 108.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.13 -13.17 16.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.52 157.48 17.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -138.03 164.44 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.12 175.53 47.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 mt -92.2 165.58 13.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 46.8 mt -97.67 113.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 9.5 m -103.37 -33.4 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -148.62 148.55 30.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 15.9 t -133.46 140.93 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -129.52 145.9 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -48.46 -33.4 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.94 -60.48 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 -179.0 5.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.62 144.25 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.68 110.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -110.07 137.18 48.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -82.75 131.11 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 146.51 26.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -98.5 -22.43 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 66.6 mt -81.64 -59.57 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 56.4 p -84.04 -2.23 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 42.6 mtt 48.23 36.82 7.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.27 172.22 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -92.19 123.38 35.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 13.8 mt -104.5 135.24 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.6 tttt -113.4 112.18 23.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.63 162.2 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.34 152.15 85.74 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.611 0.72 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -2.0 9.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -89.07 -28.4 20.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.9 15.05 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 50.8 mt -125.33 169.07 12.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . 0.41 ' OE1' ' CG2' ' A' ' 481' ' ' ILE . 17.2 pt20 -163.52 134.23 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.931 0.396 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 474' ' ' MET . 58.9 mttm -117.63 137.82 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' MET . . . . . 0.418 ' C ' ' O ' ' A' ' 473' ' ' LYS . 28.4 ttm -36.81 133.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.95 -45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -67.31 155.45 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.879 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -94.78 124.97 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.27 162.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -135.0 149.33 50.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.02 124.81 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . 0.436 ' CG2' ' NE2' ' A' ' 519' ' ' GLN . 35.4 pt -103.29 -27.35 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.89 -177.16 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.94 -151.31 19.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -88.4 -24.08 23.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 39.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.28 119.67 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 103.08 -13.39 55.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.62 155.07 19.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 33.0 p -135.98 170.95 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 176.12 174.89 43.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.7 151.71 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.3 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 25.2 mt -80.77 106.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 m -97.45 -33.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -147.63 146.73 29.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.08 151.5 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -145.94 145.89 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -49.23 -30.43 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -82.27 -65.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.464 ' CE1' ' NZ ' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -133.87 171.25 14.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.4 t -113.98 134.38 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 20.5 mm -100.26 132.12 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.94 146.27 50.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -91.6 129.76 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -91.83 127.91 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.58 -18.31 61.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.4 -61.36 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 18.3 p -82.74 -5.03 58.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 36.7 mtm 47.3 39.93 9.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -136.14 170.85 15.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -87.54 114.99 24.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 38.1 mt -95.84 142.79 27.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.464 ' NZ ' ' CE1' ' A' ' 499' ' ' PHE . 5.8 tttp -112.58 118.31 34.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 11.5 t -148.12 143.11 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.152 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.77 155.1 90.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -1.18 8.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 22.0 ptt85 -93.22 -7.46 45.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.14 5.16 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 46.0 mt -112.75 159.41 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . 0.436 ' NE2' ' CG2' ' A' ' 481' ' ' ILE . 15.5 pt20 -152.88 131.02 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 9.1 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 4.8 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.949 0.404 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -115.98 148.31 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -45.16 137.67 4.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 97.95 -39.41 2.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.42 156.52 38.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 34.8 t-80 -97.68 129.85 44.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 492' ' ' ILE . 30.0 m -119.44 158.86 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -126.65 152.14 47.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 50.5 t -100.38 117.29 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.85 -23.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -141.86 -179.65 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.82 -159.05 21.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -81.63 -21.02 38.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . 0.555 ' CE2' HD22 ' A' ' 511' ' ' LEU . 26.8 m-85 -111.64 40.21 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.8 108.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.96 -24.53 8.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.75 155.14 41.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 61.0 p -143.43 148.39 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -165.25 -173.83 34.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.451 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.06 159.47 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.443 HD12 ' CG1' ' A' ' 478' ' ' VAL . 54.8 mt -87.06 124.97 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.93 -35.1 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -151.4 117.14 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.59 131.44 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.15 -20.83 66.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -95.62 -65.57 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -124.2 173.16 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.49 137.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 8.6 mm -106.73 120.5 58.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -119.03 140.19 50.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 508' ' ' MET . 83.4 t80 -78.95 129.55 34.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 24.0 t -83.33 138.43 33.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.44 2.31 55.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.01 -67.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 508' ' ' MET . 16.2 p -108.58 29.11 7.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 503' ' ' PHE . 0.4 OUTLIER 34.52 49.61 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -116.55 159.0 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -94.24 116.26 28.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.555 HD22 ' CE2' ' A' ' 485' ' ' PHE . 83.1 mt -99.29 138.76 35.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.553 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 6.5 tmtt? -114.9 110.32 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.45 145.1 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.25 152.9 77.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.34 30.57 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -19.48 53.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -112.32 21.18 16.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.568 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 25.8 mt -120.78 162.19 20.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -149.9 142.09 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -120.46 138.73 53.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' MET . . . . . 0.459 ' HA ' ' CG2' ' A' ' 492' ' ' ILE . 2.6 ttp -38.33 132.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 109.35 -34.74 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -79.92 163.16 24.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 9.7 t-80 -100.36 121.92 42.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.405 ' CG1' HD12 ' A' ' 492' ' ' ILE . 14.4 m -114.71 148.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -124.11 143.32 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -93.88 124.05 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.9 pt -107.13 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 517' ' ' ASP . . . -140.29 -176.94 4.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.58 -159.39 25.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.17 -10.55 54.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.55 32.08 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -56.39 125.11 20.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.03 64.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -99.82 129.96 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 67.1 p -124.78 146.63 49.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -168.7 -170.26 33.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.49 158.95 16.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 474' ' ' MET . 45.3 mt -89.29 121.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.37 -35.55 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -144.27 121.44 11.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.12 126.96 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.47 157.15 21.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.78 -36.82 77.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.63 -59.15 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.564 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.7 OUTLIER -136.56 176.7 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.01 140.03 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.6 mm -109.0 109.68 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.26 137.16 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 504' ' ' SER . 65.1 t80 -79.69 132.37 36.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 503' ' ' PHE . 1.4 t -84.9 149.0 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.76 -31.6 10.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.7 -44.63 18.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 2.7 p -90.34 -10.01 45.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 29.1 mtt 51.96 36.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -137.08 159.88 40.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -80.84 128.9 34.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 30.6 mt -116.47 135.06 54.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.564 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.4 tmtt? -103.63 129.12 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.47 161.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.07 154.02 72.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.607 0.717 . . . . 0.0 110.961 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 2.28 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -95.57 -25.64 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.816 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . 0.46 ' OD1' ' CB ' ' A' ' 482' ' ' ALA . 31.7 m-20 -105.0 22.69 14.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.546 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 72.1 mt -121.78 150.79 41.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -141.95 126.42 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 472' ' ' PHE . 1.6 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.932 0.396 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 474' ' ' MET . 41.4 mttp -120.9 139.67 52.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 473' ' ' LYS . 18.1 ttt -34.65 132.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 102.33 -40.7 2.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.83 157.28 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -101.94 136.76 41.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 492' ' ' ILE . 3.8 m -139.03 159.42 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 480' ' ' VAL . 3.1 ttpm? -123.19 159.36 28.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 488' ' ' ASP . 48.0 t -104.39 121.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 20.3 pt -101.73 -23.43 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.79 171.29 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.29 -166.03 15.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -76.52 -7.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.7 42.19 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -55.54 135.03 51.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 72.78 10.63 77.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . 0.478 ' O ' ' CG2' ' A' ' 480' ' ' VAL . 19.9 t0 -95.99 125.03 40.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 18.9 p -109.79 155.55 21.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . 0.408 ' CA ' HD12 ' A' ' 502' ' ' LEU . . . -177.23 174.62 47.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.76 153.08 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.429 ' CD1' HG13 ' A' ' 478' ' ' VAL . 14.5 mt -83.41 118.84 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.5 m -111.23 -31.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -146.16 141.02 27.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.39 128.67 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -124.75 148.45 48.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -52.22 -24.62 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -87.75 -61.73 1.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.562 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -140.09 169.11 18.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 62.6 t -114.24 134.77 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.28 119.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . 0.408 HD12 ' CA ' ' A' ' 490' ' ' GLY . 2.6 pt? -115.63 139.54 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.74 125.77 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 6.1 t -86.01 153.1 22.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.25 -32.37 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.24 -56.08 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 81.7 p -80.73 -8.41 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.4 mtt 49.56 31.07 3.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -130.02 172.4 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.6 124.24 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.1 133.7 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.562 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 16.5 tttm -103.0 114.96 29.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 514' ' ' LEU . 23.0 t -140.15 151.81 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.447 ' N ' HG13 ' A' ' 513' ' ' VAL . 66.4 mt -72.04 155.16 92.13 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.609 0.719 . . . . 0.0 110.86 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.24 4.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.334 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -34.05 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 22.34 7.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 23.9 mt -122.64 149.27 44.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -138.48 135.51 35.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . 0.421 HD22 ' CG1' ' A' ' 478' ' ' VAL . 9.8 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -111.79 153.75 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.9 ttt -52.41 138.25 27.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 99.8 -26.72 23.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.83 147.99 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 21.7 t-80 -92.54 144.32 25.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.67 166.61 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 480' ' ' VAL . 6.9 tptm -130.72 131.58 44.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 518' ' ' LEU . 24.8 t -80.88 108.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 -26.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -130.68 176.36 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.64 -164.06 25.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -84.68 -19.21 33.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 511' ' ' LEU . 31.2 m-85 -105.97 41.28 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.31 133.92 46.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.05 55.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.03 137.99 53.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 7.1 p -117.73 152.19 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . 0.43 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -176.19 176.84 47.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.56 165.54 12.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 71.5 mt -94.31 113.31 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.57 -33.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -142.14 150.06 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.5 128.87 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -126.35 143.61 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -48.89 -22.42 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.02 -57.87 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.547 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -142.7 169.75 17.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.36 133.43 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.9 mm -100.04 117.5 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -114.95 138.25 51.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.3 125.57 32.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 20.8 t -83.57 130.86 35.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.14 -11.7 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 92.9 mt -98.0 -57.24 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 508' ' ' MET . 73.3 p -84.05 2.02 41.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 507' ' ' THR . 35.6 mmm 36.64 49.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -140.86 166.36 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -91.98 115.18 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.464 HD23 ' CE2' ' A' ' 485' ' ' PHE . 60.1 mt -99.95 137.55 38.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.547 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.7 tttt -109.08 110.43 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 514' ' ' LEU . 5.6 t -136.4 150.76 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 513' ' ' VAL . 92.7 mt -70.86 154.54 94.21 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.586 0.707 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -2.24 9.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -95.4 -9.73 31.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.29 38.39 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.512 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 71.2 mt -143.5 155.5 44.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -140.27 132.34 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.1 m-30 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.61 155.15 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -52.52 134.86 34.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 98.38 -25.81 26.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.71 148.22 25.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -88.21 142.08 28.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' VAL . . . . . 0.459 ' CG2' HD11 ' A' ' 502' ' ' LEU . 10.9 m -136.94 157.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 1.9 ttmp? -121.91 147.8 45.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 48.1 t -97.88 99.13 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 22.4 pt -87.56 -18.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -134.94 170.98 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.74 -158.04 20.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -89.98 -16.96 28.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.84 39.26 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.54 109.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.89 -13.86 14.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.63 137.86 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -118.29 165.77 13.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.166 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.63 176.71 48.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.48 156.08 16.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.23 114.1 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.46 -33.89 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -142.61 144.04 32.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.15 120.63 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.28 149.86 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.79 -30.75 46.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -80.6 -59.37 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' PHE . . . . . 0.532 ' CD1' ' CG ' ' A' ' 512' ' ' LYS . 1.1 p90 -141.15 173.53 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.17 134.09 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 mm -99.66 121.83 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' LEU . . . . . 0.459 HD11 ' CG2' ' A' ' 478' ' ' VAL . 2.3 pt? -119.75 137.91 53.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -82.48 124.79 30.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 3.0 t -82.0 154.97 25.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -101.78 -9.34 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 35.9 mt -99.19 -55.19 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 81.1 p -84.87 4.05 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 507' ' ' THR . 3.4 mtt 35.1 54.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 507' ' ' THR . 53.9 m-70 -149.3 177.85 9.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -98.53 115.84 29.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 18.2 mt -104.55 139.89 38.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' LYS . . . . . 0.532 ' CG ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -108.12 118.11 35.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.35 146.72 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.4 153.24 95.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -1.61 8.78 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.54 -11.13 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.62 23.57 12.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 88.8 mt -131.69 153.09 50.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 520' ' ' LEU . 2.7 pp0? -145.39 127.94 16.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' LEU . . . . . 0.442 ' O ' ' NE2' ' A' ' 519' ' ' GLN . 13.1 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 11.1 t -98.09 173.1 7.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.0 m -59.98 132.12 52.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -173.84 -178.16 43.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 3.8 m -102.05 -51.9 3.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.836 0.351 . . . . 0.0 110.847 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 2.6 m -69.07 125.87 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 463' ' ' PHE . . . -117.97 163.51 12.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.79 81.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 110.836 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 461' ' ' GLY . 44.4 m-85 -123.4 74.95 52.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.626 0.727 . . . . 0.0 110.82 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -5.19 15.6 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.737 2.291 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -112.8 104.82 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -105.31 87.19 2.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -95.63 101.36 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.54 104.12 16.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -131.93 132.87 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.86 -40.63 76.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -47.17 109.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -50.21 110.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -114.45 159.55 20.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.1 146.54 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 89.0 -17.57 50.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -92.19 152.32 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 43.9 t-80 -92.98 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.454 HG22 ' CG1' ' A' ' 492' ' ' ILE . 1.7 m -135.74 151.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 480' ' ' VAL . 30.2 tttm -114.69 159.73 20.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.401 ' N ' ' CG ' ' A' ' 479' ' ' LYS . 41.8 t -106.23 111.06 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . 0.424 ' CG2' ' OE1' ' A' ' 519' ' ' GLN . 28.5 pt -92.99 -30.39 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.0 -179.32 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.35 -167.04 23.37 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.41 4.23 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -129.19 25.61 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.51 112.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.39 24.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.494 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.53 153.03 25.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 32.6 p -137.5 164.06 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . 177.78 -173.93 46.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.5 162.51 12.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.454 ' CG1' HG22 ' A' ' 478' ' ' VAL . 56.2 mt -93.46 114.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.3 m -104.88 -28.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -146.44 142.37 28.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.54 142.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.71 159.47 41.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.58 -18.63 65.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.85 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 512' ' ' LYS . 1.4 p90 -135.2 179.71 6.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.94 129.1 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.5 mm -94.56 118.81 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -116.62 137.02 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -82.87 121.5 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 4.9 t -78.46 151.91 32.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.79 -12.79 17.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.6 mt -90.7 -54.94 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 23.6 p -85.39 -11.91 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.4 mtm 58.28 37.87 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -132.53 -178.01 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 510' ' ' GLU . 31.9 mp0 -102.28 117.9 35.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.24 135.26 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 499' ' ' PHE . 66.5 tttt -107.91 111.7 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.72 161.22 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' A' ' 499' ' ' PHE . 72.8 mt -82.41 151.48 65.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -5.17 15.53 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -86.75 -12.98 46.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -115.63 9.13 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 87.2 mt -115.13 167.98 10.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . 0.424 ' OE1' ' CG2' ' A' ' 481' ' ' ILE . 13.4 pt20 -158.45 130.03 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.6 mt -59.83 163.9 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 32.4 t -106.9 -45.55 4.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 27.2 t -70.49 -47.49 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.42 ' C ' ' OE1' ' A' ' 523' ' ' GLU . 1.3 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 16.3 t -87.29 101.72 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.376 . . . . 0.0 110.873 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 84.7 p -127.53 129.86 48.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 69.15 -160.8 52.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.8 t -91.99 119.35 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 461' ' ' GLY . 89.0 p -101.41 124.89 47.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 460' ' ' SER . . . 35.55 -153.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.59 164.63 13.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -55.45 144.31 53.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.654 0.74 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -17.3 37.84 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.736 2.291 . . . . 0.0 112.314 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -76.98 76.76 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -135.22 121.48 20.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -126.75 113.01 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.6 mp -118.21 124.89 49.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -130.63 144.01 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 -36.02 2.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.87 179.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.444 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 8.7 m-30 -94.79 120.38 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.29 159.16 29.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -60.34 121.15 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 116.5 -11.43 16.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -98.83 150.85 21.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . 0.413 ' ND1' ' CB ' ' A' ' 521' ' ' CYS . 10.0 t-80 -85.1 131.5 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.85 154.45 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.42 157.62 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.69 125.44 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -108.54 -31.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.18 170.92 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.12 -153.8 17.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -89.94 -22.1 22.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.32 39.41 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 123.98 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 97.6 22.19 17.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 489' ' ' THR . 9.6 t70 -118.66 170.93 8.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' THR . . . . . 0.471 ' N ' ' OD1' ' A' ' 488' ' ' ASP . 40.8 p -149.34 157.12 43.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.73 -179.76 48.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.26 154.01 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.51 110.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.78 -34.6 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -143.37 120.76 11.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.5 117.21 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -103.96 161.42 13.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.97 -28.2 69.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -88.43 -66.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.531 ' CD1' ' HG3' ' A' ' 512' ' ' LYS . 1.2 p90 -123.36 179.62 4.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 48.8 t -125.69 129.81 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.139 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 512' ' ' LYS . 3.0 mm -97.95 111.14 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -111.66 137.25 49.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -81.7 138.7 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 18.1 t -91.43 147.31 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.18 -18.72 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.26 -54.32 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 42.8 p -81.74 -13.94 57.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.0 mtm 52.8 47.54 24.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -138.76 171.87 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -99.8 109.88 22.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.74 132.74 43.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.531 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 2.4 ttpm? -97.74 117.85 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.75 140.65 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 48.7 mt -64.55 152.1 90.27 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 2.78 3.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -98.98 -4.36 32.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -121.78 17.93 11.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 41.4 mt -123.31 163.13 21.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -153.61 127.12 8.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . 0.444 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 9.9 mt -61.59 161.67 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . 0.413 ' CB ' ' ND1' ' A' ' 477' ' ' HIS . 6.7 t -100.08 -32.57 10.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 13.8 t -82.5 -59.36 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 91.5 p -73.47 175.03 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 79.2 p -72.77 143.73 47.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -163.09 -128.65 0.96 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.7 p -105.08 112.41 25.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.895 0.378 . . . . 0.0 110.812 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 9.1 t -50.43 166.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 462' ' ' GLU . . . 64.83 166.53 1.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 461' ' ' GLY . 8.5 tt0 -35.17 143.1 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -73.48 144.43 83.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -54.16 107.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -111.01 104.52 13.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -96.01 38.48 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.56 138.26 36.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -105.4 38.01 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -86.22 40.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -74.0 136.65 43.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -87.45 98.7 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -109.81 146.46 34.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.4 ttp -42.26 133.66 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 106.91 -41.16 2.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.439 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.45 159.97 32.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -98.99 144.11 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.432 ' CG2' HD12 ' A' ' 502' ' ' LEU . 26.5 m -139.39 146.8 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -117.56 152.65 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.14 131.81 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.6 pt -116.82 -19.55 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.13 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.27 -176.92 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 90.94 -166.31 31.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.426 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -80.46 -6.04 57.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -122.96 44.05 2.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -71.89 112.3 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.32 7.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.05 168.45 9.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 33.4 p -151.55 151.14 31.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -174.54 178.42 46.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.64 158.71 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 36.1 mt -86.07 115.98 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.22 -24.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -150.41 133.75 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.78 130.8 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -125.52 155.97 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.96 -16.67 32.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -97.81 -61.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.549 ' CZ ' ' HD2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -138.61 164.97 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.25 123.97 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.1 mm -89.65 117.9 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . 0.432 HD12 ' CG2' ' A' ' 478' ' ' VAL . 2.6 pt? -114.12 143.33 44.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -83.85 131.6 34.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.5 t -101.3 141.7 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.74 -24.76 19.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.89 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 30.6 mt -71.27 -52.86 16.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 62.8 p -91.29 -17.65 25.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 9.5 mtt 63.96 40.61 7.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -143.7 171.87 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -92.49 126.71 37.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 58.2 mt -111.2 133.46 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.549 ' HD2' ' CZ ' ' A' ' 499' ' ' PHE . 0.8 OUTLIER -99.73 114.66 27.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.58 146.03 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.62 151.31 94.86 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -1.96 9.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.382 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -91.45 -14.31 30.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.91 2.42 19.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.66 153.66 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -141.65 131.3 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.57 156.97 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 33.2 t -116.77 -33.21 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 69.9 m -69.82 -52.05 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.862 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 30.4 t -147.92 145.11 28.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.896 0.379 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.6 m -91.2 -46.78 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.836 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -173.82 152.15 14.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.0 p -123.35 -37.54 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.842 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 3.6 m -168.4 134.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 128.72 127.85 3.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.442 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -44.1 -61.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -107.13 144.1 28.45 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 157.75 59.35 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.694 2.262 . . . . 0.0 112.333 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -102.66 118.31 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.088 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -99.75 156.13 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -82.68 138.67 34.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.55 120.58 14.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -119.68 170.15 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -113.43 36.07 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -92.38 133.87 35.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 0.3 OUTLIER -97.75 104.78 16.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -118.76 170.14 9.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.0 ttp -53.85 140.16 31.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 91.77 -23.1 27.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -85.91 149.1 25.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -98.03 131.79 44.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 22.3 m -125.56 170.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -134.79 144.82 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 18.3 t -90.57 122.15 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.0 pt -106.31 -23.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -140.71 178.39 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.63 -152.14 20.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -88.35 -25.36 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -103.75 40.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.42 111.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.34 -9.18 26.6 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -93.3 145.03 24.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.7 p -130.4 159.85 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.24 174.81 47.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.12 166.41 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 22.9 mt -99.97 107.76 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.81 -27.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -154.67 148.76 25.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 65.4 t -129.94 144.84 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.63 142.36 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -47.63 -22.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -93.43 -59.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.428 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 171.36 14.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 53.9 t -114.73 128.79 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.77 107.28 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -106.17 136.88 45.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -85.54 132.37 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -87.41 152.49 22.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -101.15 -18.5 16.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.69 -53.95 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 72.1 p -82.01 -12.64 58.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.082 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.4 mtp 54.33 28.19 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -122.1 174.28 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.22 121.23 32.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.22 137.72 44.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.428 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.8 tmtt? -116.62 124.08 48.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 17.8 t -151.99 150.94 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.85 152.52 96.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.583 0.706 . . . . 0.0 110.951 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.08 11.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -86.45 -21.74 26.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -108.2 20.31 18.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 67.3 mt -126.29 156.57 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -153.85 127.83 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 9.5 mt -54.68 160.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.83 -36.06 7.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 43.2 m -66.43 -55.08 17.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 40.7 m -83.85 90.39 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.2 m -55.49 166.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 121.31 -100.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.4 t -148.3 156.18 42.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 13.0 t -116.82 99.28 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -144.44 -162.67 9.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -138.34 109.38 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -109.14 145.08 31.02 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 162.4 42.2 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.709 2.273 . . . . 0.0 112.317 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -106.93 94.14 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.47 -60.09 4.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -93.67 133.17 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.41 95.45 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -76.78 87.71 3.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -110.19 27.45 9.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -88.7 153.77 20.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.539 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 1.5 m-30 -93.1 130.14 38.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -134.99 153.42 52.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 ttt -52.06 127.48 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 111.38 -10.89 28.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -102.21 164.27 11.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -103.44 137.9 40.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 32.3 m -139.58 168.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.15 147.15 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.1 104.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.4 pt -86.68 -27.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -137.8 171.99 13.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 106.85 -162.14 13.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -89.95 -0.03 57.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -120.36 15.35 12.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -39.67 121.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.68 53.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -110.24 131.49 55.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.3 p -123.81 163.18 21.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 178.91 -174.7 46.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -97.98 158.76 15.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 60.7 mt -89.73 114.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.5 -33.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -140.32 140.21 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.63 124.93 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.0 155.81 30.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -59.77 -17.26 33.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.36 -61.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.557 ' CD2' ' HE3' ' A' ' 512' ' ' LYS . 1.2 p90 -134.91 168.0 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.16 123.94 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.49 117.36 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -112.42 139.42 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -82.12 126.23 31.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 47.2 t -86.53 153.8 21.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -105.32 -28.98 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.55 -50.15 19.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.0 p -93.94 -13.55 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 79.1 mtp 59.49 30.27 19.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -123.46 158.98 30.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -84.26 112.29 20.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 26.2 mt -93.25 140.35 29.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.557 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 28.3 tttt -109.55 123.06 48.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 19.2 t -154.34 157.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 66.9 mt -73.65 152.12 89.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.933 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.64 8.84 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -89.91 -30.66 17.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.29 6.69 45.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.53 156.08 23.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -143.1 129.31 19.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 11.6 mt -59.3 153.16 19.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.83 -17.8 30.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 40.7 t -101.9 -66.26 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.843 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.2 t -113.86 122.73 47.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 75.1 m -60.5 160.36 9.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 134.52 104.72 0.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.3 t -42.58 -58.58 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 0.0 110.91 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 1.7 t -118.33 125.9 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -120.61 -163.6 12.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.59 146.96 45.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -100.35 143.98 27.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -22.86 31.67 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.226 . . . . 0.0 112.39 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.49 117.39 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -137.85 105.06 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -57.1 104.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.9 91.72 8.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -107.83 143.93 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -71.93 98.47 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -155.63 154.6 31.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 -86.31 107.94 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -120.16 156.41 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -56.62 126.05 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.78 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -72.09 158.21 36.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -98.13 130.9 44.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.424 ' CG1' HD13 ' A' ' 492' ' ' ILE . 22.6 m -126.34 161.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -129.63 148.18 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.13 116.76 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.46 -21.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.93 179.12 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.69 -149.46 19.23 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -89.92 -28.89 18.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -103.09 41.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -56.83 108.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.2 -17.3 19.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -75.15 141.77 43.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -128.78 151.17 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.47 39.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.21 158.78 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.424 HD13 ' CG1' ' A' ' 478' ' ' VAL . 45.7 mt -88.72 111.34 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 14.0 m -100.4 -28.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.06 142.43 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.8 146.88 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.106 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -139.79 140.83 36.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.15 -22.33 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -90.03 -62.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.546 ' CD2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -136.98 169.92 16.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 39.6 t -115.91 127.62 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.3 mm -95.23 121.68 46.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -118.74 138.04 52.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -82.39 126.3 32.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 8.1 t -81.23 151.96 27.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -96.62 -18.87 19.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.83 -53.07 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 54.3 p -81.56 -0.8 43.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.444 ' C ' ' O ' ' A' ' 507' ' ' THR . 20.8 mtp 35.14 50.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 507' ' ' THR . 29.7 m-70 -145.67 170.23 16.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.1 118.43 28.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.69 137.17 42.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.546 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 25.8 tttt -111.63 114.98 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.75 141.69 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.28 152.13 64.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 1.86 4.04 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.33 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -93.71 -10.8 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.41 21.35 13.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.546 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.3 mt -128.79 166.98 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 138.47 13.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.3 mt -72.11 156.24 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.75 -39.91 5.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 39.5 m -70.83 -53.9 13.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 4.4 m -162.58 151.83 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 18.2 m -62.82 99.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 178.56 95.15 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.1 m -88.5 99.08 12.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 85.2 p -88.83 110.19 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 88.6 132.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.482 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -96.57 145.25 25.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -99.39 143.97 27.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.675 0.75 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 465' ' ' ALA . 53.8 Cg_endo -69.75 120.36 7.16 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 464' ' ' PRO . . . -35.08 -58.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.112 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.98 136.06 51.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.91 133.82 51.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.24 135.83 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -132.79 162.74 30.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -33.58 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -53.98 133.85 43.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -73.84 114.53 12.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -118.73 155.84 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' MET . . . . . 0.443 ' HA ' ' CG2' ' A' ' 492' ' ' ILE . 0.3 OUTLIER -56.74 136.75 55.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . 0.432 ' N ' ' SD ' ' A' ' 474' ' ' MET . . . 101.01 -11.13 58.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.556 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.7 154.38 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -97.21 133.26 42.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 4.3 m -128.61 159.0 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -125.52 141.84 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 488' ' ' ASP . 15.4 t -82.92 128.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.6 pt -111.92 -23.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.62 172.37 12.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.26 -152.31 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -88.89 -26.58 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.813 0.339 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -102.94 38.17 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.37 106.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.33 -18.22 11.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 480' ' ' VAL . 3.1 t70 -77.39 146.1 36.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 65.5 p -134.07 153.2 51.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.31 -178.08 41.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -99.69 154.91 17.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 474' ' ' MET . 72.2 mt -86.57 122.43 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.4 m -112.72 -34.63 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -143.37 121.99 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.39 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -124.97 153.35 42.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.13 -28.22 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -84.63 -61.35 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.412 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -138.87 174.31 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.35 136.47 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 9.9 mm -105.78 108.88 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -107.85 141.94 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -84.35 124.22 31.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 12.2 t -76.14 154.81 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.97 -26.24 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.53 -57.89 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 508' ' ' MET . 77.1 p -79.99 3.76 19.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 507' ' ' THR . 45.7 mtt 35.08 49.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -139.71 177.75 7.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.99 121.82 38.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 27.5 mt -103.95 141.02 36.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.412 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.2 tmtt? -118.24 121.28 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . 0.406 HG21 ' C ' ' A' ' 512' ' ' LYS . 13.0 t -154.56 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 69.0 mt -62.63 150.25 86.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -1.14 7.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.289 . . . . 0.0 112.356 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.35 -10.67 45.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.1 11.88 15.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 22.4 mt -120.07 158.21 27.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -148.95 140.53 23.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.85 150.46 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 35.0 t -89.18 -45.52 9.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 14.5 m -71.81 -66.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 80.6 p -47.67 150.83 0.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.809 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.2 m -145.16 124.98 13.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -150.84 72.77 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.6 m -97.45 140.62 31.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 10.1 t -104.29 -48.38 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.43 -161.99 13.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -76.61 -46.07 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 110.84 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -101.43 145.04 29.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -22.87 31.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.356 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.21 147.94 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.85 167.32 21.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.65 87.76 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 39.6 mt -120.06 169.96 9.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 469' ' ' ARG . 0.3 OUTLIER -80.31 99.7 8.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.27 69.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -109.63 141.06 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.7 m-30 -93.68 104.67 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -121.09 154.01 36.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 27.8 ttp -49.89 133.77 21.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.52 -38.76 3.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.02 154.2 38.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -97.19 143.91 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 25.1 m -139.08 177.65 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.141 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 19.0 ttpt -142.88 156.6 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 40.3 t -99.59 109.2 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.3 pt -89.56 -23.94 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.56 170.96 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.24 -156.45 17.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -85.06 -27.15 26.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -99.13 28.34 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.74 119.78 5.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 98.01 16.66 32.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -117.06 138.74 51.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.8 p -118.65 157.72 26.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.6 171.74 44.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.61 164.88 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.9 108.51 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.02 -37.47 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -140.68 153.3 45.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.95 127.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 498' ' ' ASN . 2.4 mp0 -122.92 140.55 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -44.16 -23.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 496' ' ' GLU . 5.4 m-80 -88.67 -68.9 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.504 ' CG ' ' HE3' ' A' ' 512' ' ' LYS . 0.8 OUTLIER -130.74 171.26 13.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.24 137.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.0 mm -104.61 106.29 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -103.49 136.35 43.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -80.7 129.35 34.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.9 t -84.99 148.61 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -98.08 -14.01 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.87 -51.38 4.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 67.4 p -83.16 -4.34 58.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 4.7 mtt 45.87 34.86 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.05 176.42 8.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -94.73 117.53 30.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.86 135.14 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.504 ' HE3' ' CG ' ' A' ' 499' ' ' PHE . 3.0 tmtt? -107.74 131.03 54.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . 0.411 HG23 ' C ' ' A' ' 512' ' ' LYS . 6.7 t -156.89 149.57 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 52.0 mt -68.7 152.0 96.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 1.37 4.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.679 2.253 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -92.25 -27.67 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -106.76 40.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 57.1 mt -143.29 162.99 34.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -152.12 137.71 17.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.31 158.66 16.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.63 -27.79 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 51.7 m -120.78 47.77 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 20.2 m -111.04 -46.51 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 69.1 m -71.8 135.53 46.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 459' ' ' SER . . . 86.11 -153.17 26.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.454 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 458' ' ' GLY . 23.7 m -36.63 106.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 5.3 t -161.39 106.84 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.41 -154.47 20.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.66 157.28 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -95.92 145.07 28.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.648 2.232 . . . . 0.0 112.331 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -110.1 36.36 3.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -81.67 91.34 6.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.8 100.52 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.5 mt -132.46 158.49 41.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -122.37 77.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -106.69 82.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.93 133.77 46.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.6 m-85 -77.36 99.43 5.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 492' ' ' ILE . 9.2 ptmm? -112.7 159.84 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.6 ttt -59.84 126.18 26.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.03 -37.49 3.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -75.29 160.09 30.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -100.0 130.47 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.56 153.0 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.97 138.3 54.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.6 t -91.4 121.79 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.152 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 44.9 pt -106.15 -23.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.24 172.4 12.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 103.09 -156.81 18.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.497 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -83.23 -20.04 35.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -112.87 43.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -61.29 138.84 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.78 -16.06 22.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.39 149.18 25.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 4.8 p -140.97 159.15 42.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -172.51 -169.72 35.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.99 160.17 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.468 ' CD1' ' O ' ' A' ' 473' ' ' LYS . 24.0 mt -91.67 112.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.114 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.35 -31.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -153.4 131.81 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.24 151.66 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.7 157.57 46.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.61 -17.31 46.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.95 -66.48 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.516 ' CG ' ' HD3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -127.42 174.79 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.85 127.57 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 108.57 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -109.97 141.65 42.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -86.5 135.28 33.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.7 t -91.71 142.9 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.45 -5.4 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 44.5 mt -90.81 -73.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.2 p -82.35 7.57 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.8 mmm 44.13 30.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -111.63 159.24 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -82.78 117.67 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.38 153.7 19.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.516 ' HD3' ' CG ' ' A' ' 499' ' ' PHE . 6.1 tmmm? -123.77 124.52 42.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.0 143.65 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.123 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.57 156.01 92.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.959 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -0.34 6.79 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.713 2.276 . . . . 0.0 112.319 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -97.25 -15.52 20.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -115.8 34.51 4.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.564 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.9 mt -134.26 157.52 46.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -145.44 129.17 17.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.1 mt -68.95 153.78 43.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.75 -50.4 1.96 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 6.9 t -107.49 45.33 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 80.7 p -83.52 -37.38 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.4 m 46.13 45.73 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -172.17 -55.9 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.536 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 83.4 p -92.34 128.04 38.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 110.825 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 1.5 t -163.9 158.05 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 111.15 -178.78 19.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.2 161.0 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -127.34 144.58 51.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.678 0.752 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.96 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.299 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -93.07 81.04 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.06 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.69 134.09 40.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -104.08 58.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 30.6 mt -100.11 56.38 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -108.84 146.82 33.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.524 ' O ' ' CE1' ' A' ' 472' ' ' PHE . 0.1 OUTLIER -105.98 -20.66 13.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -54.52 128.07 30.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 470' ' ' LYS . 1.3 m-30 -85.29 113.84 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.83 -178.17 3.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.4 ttt -74.18 156.73 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 76.53 -9.63 21.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -93.51 148.39 22.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -95.8 113.51 25.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.829 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 10.8 m -106.36 161.39 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -121.78 141.55 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 19.4 t -89.49 116.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 482' ' ' ALA . 24.6 pt -100.55 -30.37 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . 0.458 ' N ' HG13 ' A' ' 481' ' ' ILE . . . -139.96 171.0 14.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.56 -157.17 15.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.533 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -87.92 -9.89 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.23 38.74 3.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -60.19 137.73 58.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.31 -20.22 27.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.61 160.19 21.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -143.57 165.43 27.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.82 -178.83 48.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.2 mt -99.37 160.98 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.455 HG22 ' CG1' ' A' ' 500' ' ' VAL . 6.1 mt -94.51 105.01 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.89 -28.11 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -153.34 141.98 20.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 496' ' ' GLU . 60.5 t -126.23 139.24 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.445 ' N ' HG12 ' A' ' 495' ' ' VAL . 7.2 mm-40 -126.46 146.53 50.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -49.11 -29.08 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -85.31 -60.25 2.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.49 178.06 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 492' ' ' ILE . 39.8 t -119.79 132.52 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.1 mm -97.09 110.94 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -112.72 137.55 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -84.25 135.62 34.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -91.36 142.3 27.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.66 -10.5 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.12 -48.49 4.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 9.0 p -92.96 -3.57 54.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 44.6 mmm 42.55 34.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -123.29 164.43 18.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -85.28 104.03 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt -87.91 143.26 27.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -114.89 113.37 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.29 139.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.89 153.69 71.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.584 0.707 . . . . 0.0 110.933 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 2.1 3.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.631 2.221 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -97.46 -4.65 37.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -118.27 1.27 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 472' ' ' PHE . 20.1 mt -113.98 152.84 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . 0.452 ' OE1' ' CG2' ' A' ' 481' ' ' ILE . 9.4 pt20 -143.97 132.28 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.38 153.46 18.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.9 t -92.41 103.57 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 16.6 m 57.2 53.0 8.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 523' ' ' GLU . 1.1 pm0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 37.8 m -110.96 -60.07 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.0 t -67.53 96.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.824 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 80.07 -137.6 18.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.477 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 3.2 t -119.42 163.7 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.896 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 27.1 m -78.91 -62.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -151.34 153.38 24.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.501 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -56.31 -49.53 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -101.99 144.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 158.78 55.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -80.11 99.6 7.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -92.89 -59.76 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -120.48 131.04 54.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.0 168.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -84.78 82.76 8.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.19 102.43 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 471' ' ' TYR . 11.4 p90 -143.19 141.88 31.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.8 m-30 -79.13 121.02 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -136.34 153.53 51.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 19.4 ttp -51.26 125.58 14.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.52 -29.61 7.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -84.77 158.92 20.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -102.69 131.77 49.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.411 ' CG2' HD12 ' A' ' 502' ' ' LEU . 14.8 m -123.45 159.39 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -125.04 136.5 53.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.24 114.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 33.2 pt -97.97 -24.72 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.45 -179.42 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.93 -160.59 21.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -86.13 -7.76 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -119.15 35.83 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -57.66 138.6 55.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 84.02 -13.92 46.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -87.98 151.58 22.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 24.3 p -139.6 162.27 35.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.82 178.39 48.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.42 161.26 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -90.26 117.91 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -107.61 -31.65 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -149.18 137.79 21.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.53 138.34 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.407 ' OE2' ' CD1' ' A' ' 501' ' ' ILE . 11.8 mt-10 -126.42 148.82 49.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -54.63 -21.09 9.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . 0.412 ' HB3' ' CD2' ' A' ' 499' ' ' PHE . 4.2 t-20 -94.14 -53.7 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.454 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.2 p90 -142.36 172.0 13.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.75 125.34 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.079 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . 0.407 ' CD1' ' OE2' ' A' ' 496' ' ' GLU . 9.1 mm -90.85 119.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . 0.411 HD12 ' CG2' ' A' ' 478' ' ' VAL . 2.3 pt? -116.54 140.53 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -85.58 132.03 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 13.4 t -85.95 154.82 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.92 -26.29 14.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.1 mt -86.85 -54.25 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 38.7 p -80.16 -7.23 58.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.7 mtm 45.55 36.94 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 507' ' ' THR . 17.9 m-70 -135.67 163.58 29.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.21 125.73 32.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 42.9 mt -109.92 133.99 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.454 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 49.6 tttt -101.68 111.65 23.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.79 143.41 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.6 153.22 83.95 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.643 0.735 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -0.89 7.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -91.18 -11.2 39.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -112.21 1.94 16.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 44.0 mt -116.45 159.58 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -151.96 133.79 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.53 160.55 6.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.5 t -105.97 94.17 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 11.6 m 61.04 50.8 4.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t 59.44 40.98 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.858 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 18.1 t -135.76 164.22 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -58.91 146.27 42.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 32.3 m -113.87 121.09 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 3.5 m -61.24 130.87 48.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 67.99 158.07 1.06 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -127.96 -55.64 1.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.46 145.96 85.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.638 0.732 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 94.22 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.633 2.222 . . . . 0.0 112.408 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -103.46 179.03 4.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.061 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -133.56 153.51 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.03 140.71 50.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.5 40.75 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.45 83.24 3.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -137.03 116.33 12.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 -60.01 102.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 492' ' ' ILE . 97.2 mttt -121.0 149.33 42.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 13.7 ttp -42.47 140.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 96.05 -49.52 1.74 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.78 152.05 37.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -94.7 130.09 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.54 158.14 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.37 148.45 50.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.07 121.6 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -103.8 -23.64 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.39 -177.89 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.04 -152.5 19.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -89.9 -5.52 56.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -128.08 37.82 4.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.96 136.78 57.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.84 17.01 71.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.4 172.87 6.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 72.1 p -151.44 160.6 43.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 177.33 177.27 46.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.0 mt -102.58 154.44 19.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 473' ' ' LYS . 39.7 mt -82.93 119.68 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.24 -26.34 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -160.56 120.83 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 11.5 t -109.57 146.42 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -132.31 150.96 52.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.52 -27.03 23.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -85.35 -59.64 2.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.485 ' CD1' ' HG3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -139.55 174.13 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 36.6 t -113.82 134.33 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.7 mm -103.79 111.42 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -114.51 138.99 49.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -79.74 132.08 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -90.02 152.06 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.21 -20.89 17.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.08 -49.44 6.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 508' ' ' MET . 76.9 p -89.3 2.72 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 507' ' ' THR . 14.0 mtp 36.3 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.94 171.74 12.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.56 117.22 28.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 42.9 mt -101.03 127.33 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.485 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 18.3 ttpt -101.55 117.07 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.65 157.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.18 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 92.4 mt -77.42 153.88 81.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.615 0.721 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 0.86 5.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.257 . . . . 0.0 112.338 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -95.15 -12.41 26.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.75 13.04 16.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.529 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 92.9 mt -115.56 162.35 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . 0.411 ' HG2' ' C ' ' A' ' 518' ' ' LEU . 12.9 mm-40 -152.07 137.74 17.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.9 mt -76.04 155.25 35.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 13.4 t -116.13 -27.91 6.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 2.3 m -124.62 40.54 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.922 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.3 t -91.77 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 m -97.04 175.86 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 60.58 147.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.4 m -111.62 -58.51 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 20.8 p -84.04 135.7 34.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -177.9 152.52 11.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -92.07 104.12 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.868 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -121.61 77.8 37.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.637 0.732 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 100.77 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -102.41 89.28 3.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -60.42 150.94 29.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.37 157.94 16.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.26 163.79 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.945 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 469' ' ' ARG . 11.7 ttm105 -137.79 140.59 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 469' ' ' ARG . 11.3 mptt -38.03 103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -154.26 136.49 14.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.3 m-30 -62.16 98.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.459 ' N ' HD12 ' A' ' 492' ' ' ILE . 44.2 pttt -123.48 141.17 52.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 473' ' ' LYS . 13.6 ttt -34.61 128.92 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 107.04 -49.58 0.86 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.79 154.03 31.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . 0.413 ' ND1' ' CB ' ' A' ' 521' ' ' CYS . 11.9 t-160 -94.93 137.49 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.02 156.29 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.159 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 480' ' ' VAL . 21.8 tttt -128.37 148.39 50.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.407 ' N ' ' HG3' ' A' ' 479' ' ' LYS . 36.1 t -95.27 111.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.8 pt -94.53 -25.09 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.71 178.21 7.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.96 -154.48 19.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -86.33 -28.62 23.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 485' ' ' PHE . 6.0 m-85 -100.55 34.5 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.05 137.27 46.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.9 -21.15 24.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.34 158.29 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 27.8 p -145.34 159.82 42.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.62 178.8 43.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -97.08 155.17 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 473' ' ' LYS . 24.5 mt -81.82 111.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.01 -25.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -155.83 150.22 25.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.9 137.8 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.87 140.59 49.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.66 -29.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -83.7 -64.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.47 173.61 11.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.2 t -114.41 140.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.8 mm -105.01 118.95 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -116.79 137.37 52.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -84.25 129.69 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.6 t -85.53 152.81 22.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.41 -21.41 17.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 68.0 mt -90.49 -52.89 4.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 22.8 p -82.41 -9.0 59.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.6 mtt 46.24 41.09 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -136.25 167.97 20.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.96 113.88 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt -96.99 131.85 43.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -105.37 108.34 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 514' ' ' LEU . 39.8 t -133.76 154.08 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.409 ' N ' HG13 ' A' ' 513' ' ' VAL . 78.3 mt -71.82 155.26 92.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.33 15.93 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.232 . . . . 0.0 112.378 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.95 -26.99 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.57 18.33 16.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 48.8 mt -132.8 155.23 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -140.42 138.57 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.06 159.95 6.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . 0.413 ' CB ' ' ND1' ' A' ' 477' ' ' HIS . 3.8 m -134.23 -42.41 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 21.9 t -119.58 56.84 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 22.8 t -47.67 -46.49 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.828 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 458' ' ' GLY . 16.3 m 40.35 41.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 457' ' ' SER . . . -34.49 127.91 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.6 m -146.14 175.69 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 15.0 m -120.45 173.38 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.34 -134.24 7.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.459 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -73.42 144.02 46.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.95 144.0 45.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.71 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.47 16.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -115.21 140.99 48.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -100.68 -36.48 9.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.12 123.05 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.4 mt -54.26 168.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -109.84 142.41 41.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.18 51.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -114.17 138.62 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.0 m-30 -61.63 109.15 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -120.64 144.57 48.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 9.0 mtm -45.86 143.09 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.79 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.31 160.58 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -104.66 133.01 50.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.05 159.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -120.23 149.94 41.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 25.5 t -95.12 123.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.128 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . 0.41 ' CG2' ' OE1' ' A' ' 519' ' ' GLN . 15.6 pt -103.54 -26.57 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.75 -175.65 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.74 -153.9 20.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -89.15 -3.89 58.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.36 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.65 33.47 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -56.95 108.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.13 -13.17 16.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.52 157.48 17.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -138.03 164.44 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.12 175.53 47.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 mt -92.2 165.58 13.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 46.8 mt -97.67 113.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 9.5 m -103.37 -33.4 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -148.62 148.55 30.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 15.9 t -133.46 140.93 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -129.52 145.9 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -48.46 -33.4 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.94 -60.48 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 -179.0 5.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 6.1 t -118.62 144.25 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.68 110.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -110.07 137.18 48.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -82.75 131.11 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 146.51 26.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -98.5 -22.43 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 66.6 mt -81.64 -59.57 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 56.4 p -84.04 -2.23 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 42.6 mtt 48.23 36.82 7.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.27 172.22 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -92.19 123.38 35.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 13.8 mt -104.5 135.24 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.553 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.6 tttt -113.4 112.18 23.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.63 162.2 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.34 152.15 85.74 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.611 0.72 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -2.0 9.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -89.07 -28.4 20.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.9 15.05 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 50.8 mt -125.33 169.07 12.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . 0.41 ' OE1' ' CG2' ' A' ' 481' ' ' ILE . 17.2 pt20 -163.52 134.23 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.85 155.5 16.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.8 t -105.06 -41.9 5.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 11.6 t -130.15 92.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 24.9 m -141.59 150.94 42.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 56.7 p -45.87 166.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.87 -57.22 0.48 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.4 t -60.64 131.61 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 6.4 p 45.36 42.11 7.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -115.17 -39.09 0.97 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.83 -42.12 41.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.901 0.382 . . . . 0.0 110.89 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.31 80.74 1.18 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.655 0.741 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 110.69 2.6 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.382 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -79.53 126.18 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.46 80.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.7 89.52 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.3 146.57 54.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -100.9 157.68 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -78.62 83.16 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -133.57 145.09 49.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -72.16 98.64 2.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 474' ' ' MET . 58.9 mttm -117.63 137.82 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' MET . . . . . 0.418 ' C ' ' O ' ' A' ' 473' ' ' LYS . 28.4 ttm -36.81 133.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.95 -45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -67.31 155.45 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.879 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -94.78 124.97 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.27 162.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -135.0 149.33 50.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.3 t -93.02 124.81 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . 0.436 ' CG2' ' NE2' ' A' ' 519' ' ' GLN . 35.4 pt -103.29 -27.35 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.89 -177.16 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.94 -151.31 19.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -88.4 -24.08 23.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 39.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.28 119.67 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 103.08 -13.39 55.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.62 155.07 19.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.868 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 33.0 p -135.98 170.95 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 176.12 174.89 43.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.6 mt -96.7 151.71 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.3 . . . . 0.0 110.976 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 25.2 mt -80.77 106.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 m -97.45 -33.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -147.63 146.73 29.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.08 151.5 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -145.94 145.89 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -49.23 -30.43 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -82.27 -65.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.464 ' CE1' ' NZ ' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -133.87 171.25 14.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 9.4 t -113.98 134.38 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 20.5 mm -100.26 132.12 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -133.94 146.27 50.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -91.6 129.76 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -91.83 127.91 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.58 -18.31 61.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.4 -61.36 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 18.3 p -82.74 -5.03 58.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 36.7 mtm 47.3 39.93 9.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -136.14 170.85 15.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -87.54 114.99 24.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 38.1 mt -95.84 142.79 27.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.464 ' NZ ' ' CE1' ' A' ' 499' ' ' PHE . 5.8 tttp -112.58 118.31 34.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 11.5 t -148.12 143.11 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.152 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.77 155.1 90.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -1.18 8.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 22.0 ptt85 -93.22 -7.46 45.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.14 5.16 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 46.0 mt -112.75 159.41 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . 0.436 ' NE2' ' CG2' ' A' ' 481' ' ' ILE . 15.5 pt20 -152.88 131.02 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.16 166.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.58 114.79 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 8.0 t 71.94 53.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.939 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.6 t -90.52 163.1 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 69.0 m -137.62 150.04 47.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 112.94 145.26 9.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 79.3 p -151.13 166.73 29.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 54.9 p -79.81 146.88 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 128.13 116.27 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -66.49 147.1 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -127.69 80.69 71.56 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 160.62 49.04 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.364 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -114.37 -44.4 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.87 142.41 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.35 157.39 20.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.78 179.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.42 123.43 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -111.18 82.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -140.16 126.02 19.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 4.8 m-85 -59.3 100.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -115.98 148.31 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -45.16 137.67 4.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 97.95 -39.41 2.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.42 156.52 38.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 34.8 t-80 -97.68 129.85 44.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 492' ' ' ILE . 30.0 m -119.44 158.86 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -126.65 152.14 47.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 50.5 t -100.38 117.29 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.85 -23.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -141.86 -179.65 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.82 -159.05 21.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -81.63 -21.02 38.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.555 ' CE2' HD22 ' A' ' 511' ' ' LEU . 26.8 m-85 -111.64 40.21 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.8 108.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.96 -24.53 8.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.75 155.14 41.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 61.0 p -143.43 148.39 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -165.25 -173.83 34.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.451 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.06 159.47 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.443 HD12 ' CG1' ' A' ' 478' ' ' VAL . 54.8 mt -87.06 124.97 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.93 -35.1 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -151.4 117.14 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.59 131.44 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.174 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.15 -20.83 66.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -95.62 -65.57 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.553 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -124.2 173.16 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.49 137.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 8.6 mm -106.73 120.5 58.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -119.03 140.19 50.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 508' ' ' MET . 83.4 t80 -78.95 129.55 34.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 24.0 t -83.33 138.43 33.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.44 2.31 55.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.01 -67.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 508' ' ' MET . 16.2 p -108.58 29.11 7.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 503' ' ' PHE . 0.4 OUTLIER 34.52 49.61 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -116.55 159.0 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -94.24 116.26 28.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.555 HD22 ' CE2' ' A' ' 485' ' ' PHE . 83.1 mt -99.29 138.76 35.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.553 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 6.5 tmtt? -114.9 110.32 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.45 145.1 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.25 152.9 77.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.34 30.57 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -19.48 53.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -112.32 21.18 16.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.568 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 25.8 mt -120.78 162.19 20.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -149.9 142.09 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.91 155.96 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 34.5 t -128.5 -42.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 523' ' ' GLU . 68.7 m -61.87 -45.85 91.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.482 ' CD ' ' C ' ' A' ' 523' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 93.3 p -52.11 141.68 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 39.0 m -90.15 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -85.08 94.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.462 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 75.6 m -91.11 -49.87 6.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 110.86 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -114.06 82.21 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 165.07 -149.21 15.5 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.4 134.4 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.06 80.48 1.07 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 111.68 2.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.24 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -99.05 177.23 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -38.84 106.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.93 134.36 56.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 9.0 mt -102.41 90.43 3.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 -86.25 50.9 2.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -113.95 84.29 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 471' ' ' TYR . 0.3 OUTLIER -118.24 155.83 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 -108.23 99.75 9.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -120.46 138.73 53.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' MET . . . . . 0.459 ' HA ' ' CG2' ' A' ' 492' ' ' ILE . 2.6 ttp -38.33 132.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 109.35 -34.74 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -79.92 163.16 24.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 110.843 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 9.7 t-80 -100.36 121.92 42.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.405 ' CG1' HD12 ' A' ' 492' ' ' ILE . 14.4 m -114.71 148.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -124.11 143.32 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 24.7 t -93.88 124.05 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.9 pt -107.13 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . 0.46 ' CB ' ' OD1' ' A' ' 517' ' ' ASP . . . -140.29 -176.94 4.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.58 -159.39 25.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.17 -10.55 54.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.55 32.08 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -56.39 125.11 20.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.03 64.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -99.82 129.96 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 67.1 p -124.78 146.63 49.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -168.7 -170.26 33.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.49 158.95 16.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 474' ' ' MET . 45.3 mt -89.29 121.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.37 -35.55 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -144.27 121.44 11.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.12 126.96 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.47 157.15 21.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.78 -36.82 77.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.63 -59.15 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.564 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.7 OUTLIER -136.56 176.7 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.9 t -115.01 140.03 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.107 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.6 mm -109.0 109.68 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.26 137.16 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 504' ' ' SER . 65.1 t80 -79.69 132.37 36.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 503' ' ' PHE . 1.4 t -84.9 149.0 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.76 -31.6 10.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.7 -44.63 18.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 2.7 p -90.34 -10.01 45.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 29.1 mtt 51.96 36.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -137.08 159.88 40.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -80.84 128.9 34.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 30.6 mt -116.47 135.06 54.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.564 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.4 tmtt? -103.63 129.12 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.47 161.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.07 154.02 72.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.607 0.717 . . . . 0.0 110.961 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 2.28 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -95.57 -25.64 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.816 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . 0.46 ' OD1' ' CB ' ' A' ' 482' ' ' ALA . 31.7 m-20 -105.0 22.69 14.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.546 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 72.1 mt -121.78 150.79 41.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -141.95 126.42 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt -62.27 151.8 35.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.0 t -120.27 106.26 11.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 9.5 t 70.17 31.24 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.916 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 45.6 t -99.1 -45.85 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.813 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.3 m -94.08 148.56 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -167.02 -62.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.0 t -58.18 133.21 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 50.6 m -43.11 155.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 165.48 132.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -65.37 103.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 0.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -81.88 144.04 51.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.31 6.28 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -114.57 -46.24 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.07 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -39.56 114.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.6 149.36 39.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.69 163.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -81.56 177.89 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -109.8 50.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -127.56 127.78 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 472' ' ' PHE . 1.6 m-85 -52.71 98.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 474' ' ' MET . 41.4 mttp -120.9 139.67 52.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 473' ' ' LYS . 18.1 ttt -34.65 132.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 102.33 -40.7 2.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.83 157.28 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -101.94 136.76 41.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 492' ' ' ILE . 3.8 m -139.03 159.42 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 480' ' ' VAL . 3.1 ttpm? -123.19 159.36 28.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 488' ' ' ASP . 48.0 t -104.39 121.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 20.3 pt -101.73 -23.43 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.79 171.29 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.29 -166.03 15.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -76.52 -7.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -124.7 42.19 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -55.54 135.03 51.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 72.78 10.63 77.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . 0.478 ' O ' ' CG2' ' A' ' 480' ' ' VAL . 19.9 t0 -95.99 125.03 40.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 18.9 p -109.79 155.55 21.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . 0.408 ' CA ' HD12 ' A' ' 502' ' ' LEU . . . -177.23 174.62 47.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.76 153.08 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.429 ' CD1' HG13 ' A' ' 478' ' ' VAL . 14.5 mt -83.41 118.84 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.5 m -111.23 -31.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -146.16 141.02 27.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.39 128.67 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -124.75 148.45 48.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -52.22 -24.62 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -87.75 -61.73 1.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.562 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -140.09 169.11 18.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 62.6 t -114.24 134.77 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.28 119.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . 0.408 HD12 ' CA ' ' A' ' 490' ' ' GLY . 2.6 pt? -115.63 139.54 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.74 125.77 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 6.1 t -86.01 153.1 22.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.25 -32.37 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.24 -56.08 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 81.7 p -80.73 -8.41 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.4 mtt 49.56 31.07 3.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -130.02 172.4 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.6 124.24 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 29.3 mt -104.1 133.7 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.562 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 16.5 tttm -103.0 114.96 29.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 514' ' ' LEU . 23.0 t -140.15 151.81 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.447 ' N ' HG13 ' A' ' 513' ' ' VAL . 66.4 mt -72.04 155.16 92.13 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.609 0.719 . . . . 0.0 110.86 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.24 4.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.334 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -34.05 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 22.34 7.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 23.9 mt -122.64 149.27 44.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -138.48 135.51 35.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . 0.421 HD22 ' CG1' ' A' ' 478' ' ' VAL . 9.8 mt -69.07 159.72 32.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.38 -33.94 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 19.4 t -157.67 113.78 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 41.2 t -90.26 -49.27 6.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.355 . . . . 0.0 110.829 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.1 t -63.57 -56.67 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 40.58 59.01 2.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.4 m -59.77 -51.8 68.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.901 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 30.3 m -155.49 164.42 38.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 156.7 66.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.71 146.35 24.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 463' ' ' PHE . 0.1 OUTLIER -134.09 65.38 69.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.697 0.76 . . . . 0.0 110.895 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 96.11 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.363 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -88.77 114.86 25.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -81.43 -45.26 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -86.89 158.3 19.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 469' ' ' ARG . 26.9 mt -133.81 110.77 10.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 468' ' ' LEU . 0.0 OUTLIER -36.89 139.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -99.32 88.0 3.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -93.5 159.82 15.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.512 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 -115.8 98.84 6.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -111.79 153.75 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.9 ttt -52.41 138.25 27.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 99.8 -26.72 23.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.83 147.99 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 21.7 t-80 -92.54 144.32 25.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.67 166.61 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 480' ' ' VAL . 6.9 tptm -130.72 131.58 44.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.455 HG23 ' CD2' ' A' ' 518' ' ' LEU . 24.8 t -80.88 108.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 -26.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -130.68 176.36 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.64 -164.06 25.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -84.68 -19.21 33.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 511' ' ' LEU . 31.2 m-85 -105.97 41.28 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.31 133.92 46.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.05 55.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.03 137.99 53.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 7.1 p -117.73 152.19 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . 0.43 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -176.19 176.84 47.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.56 165.54 12.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 71.5 mt -94.31 113.31 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.57 -33.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -142.14 150.06 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 11.4 t -138.5 128.87 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -126.35 143.61 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -48.89 -22.42 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.02 -57.87 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.547 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -142.7 169.75 17.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.36 133.43 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.139 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.9 mm -100.04 117.5 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -114.95 138.25 51.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.3 125.57 32.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 20.8 t -83.57 130.86 35.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.14 -11.7 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 92.9 mt -98.0 -57.24 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 508' ' ' MET . 73.3 p -84.05 2.02 41.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 507' ' ' THR . 35.6 mmm 36.64 49.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -140.86 166.36 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -91.98 115.18 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.464 HD23 ' CE2' ' A' ' 485' ' ' PHE . 60.1 mt -99.95 137.55 38.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.547 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.7 tttt -109.08 110.43 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 514' ' ' LEU . 5.6 t -136.4 150.76 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 513' ' ' VAL . 92.7 mt -70.86 154.54 94.21 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.586 0.707 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -2.24 9.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -95.4 -9.73 31.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -121.29 38.39 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.512 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 71.2 mt -143.5 155.5 44.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -140.27 132.34 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.2 mt -63.9 148.05 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 522' ' ' SER . 1.4 p -74.53 -44.32 51.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' SER . . . . . 0.49 ' N ' ' SG ' ' A' ' 521' ' ' CYS . 38.8 m -134.39 86.5 2.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 55.1 p -138.66 153.57 48.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.2 t -166.17 142.47 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -125.04 -84.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.486 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 11.1 t -62.54 142.3 58.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 4.1 m -148.38 154.74 40.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 141.04 -175.1 22.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -105.88 92.37 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 0.0 110.864 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.05 150.76 63.97 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -25.13 28.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.46 139.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -70.78 134.24 47.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -80.31 137.45 36.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.6 mp -104.26 96.96 6.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 471' ' ' TYR . 53.1 mtt-85 -99.75 131.91 45.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.58 90.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 469' ' ' ARG . 22.0 m-85 -134.78 137.22 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.1 m-30 -69.36 100.9 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -121.61 155.15 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -52.52 134.86 34.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 98.38 -25.81 26.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.71 148.22 25.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -88.21 142.08 28.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' VAL . . . . . 0.459 ' CG2' HD11 ' A' ' 502' ' ' LEU . 10.9 m -136.94 157.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 1.9 ttmp? -121.91 147.8 45.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 48.1 t -97.88 99.13 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 22.4 pt -87.56 -18.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -134.94 170.98 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.74 -158.04 20.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -89.98 -16.96 28.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.84 39.26 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.54 109.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.89 -13.86 14.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.63 137.86 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -118.29 165.77 13.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.166 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.63 176.71 48.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.48 156.08 16.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.23 114.1 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.46 -33.89 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -142.61 144.04 32.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.15 120.63 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.28 149.86 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.79 -30.75 46.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -80.6 -59.37 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' PHE . . . . . 0.532 ' CD1' ' CG ' ' A' ' 512' ' ' LYS . 1.1 p90 -141.15 173.53 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.17 134.09 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 mm -99.66 121.83 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' LEU . . . . . 0.459 HD11 ' CG2' ' A' ' 478' ' ' VAL . 2.3 pt? -119.75 137.91 53.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -82.48 124.79 30.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 3.0 t -82.0 154.97 25.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -101.78 -9.34 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 35.9 mt -99.19 -55.19 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 81.1 p -84.87 4.05 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 507' ' ' THR . 3.4 mtt 35.1 54.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 507' ' ' THR . 53.9 m-70 -149.3 177.85 9.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -98.53 115.84 29.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 18.2 mt -104.55 139.89 38.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' LYS . . . . . 0.532 ' CG ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -108.12 118.11 35.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.35 146.72 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . . . . . . . . . 80.7 mt -68.4 153.24 95.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -1.61 8.78 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.54 -11.13 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.62 23.57 12.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 88.8 mt -131.69 153.09 50.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 520' ' ' LEU . 2.7 pp0? -145.39 127.94 16.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' LEU . . . . . 0.442 ' O ' ' NE2' ' A' ' 519' ' ' GLN . 13.1 mt -62.87 154.85 28.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 46.6 t -113.28 -30.03 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 22.8 m -117.91 45.3 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 492' ' ' ILE . 26.6 mttm -114.45 159.55 20.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.1 146.54 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 89.0 -17.57 50.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -92.19 152.32 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.413 ' O ' HD23 ' A' ' 520' ' ' LEU . 86.2 t60 -92.98 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.74 151.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 489' ' ' THR . 30.2 tttm -114.69 159.73 20.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 518' ' ' LEU . 41.8 t -106.23 111.06 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' ILE . . . . . 0.665 HG21 ' OE1' ' A' ' 519' ' ' GLN . 28.5 pt -92.99 -30.39 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.0 -179.32 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.35 -167.04 23.37 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.41 4.23 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -129.19 25.61 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.51 112.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.39 24.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.494 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.53 153.03 25.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 479' ' ' LYS . 32.6 p -137.5 164.06 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 177.78 -173.93 46.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.5 162.51 12.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 473' ' ' LYS . 56.2 mt -93.46 114.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.3 m -104.88 -28.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -146.44 142.37 28.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.54 142.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.71 159.47 41.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.58 -18.63 65.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.85 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.905 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.4 p90 -135.2 179.71 6.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.94 129.1 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.5 mm -94.56 118.81 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.62 137.02 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -82.87 121.5 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 4.9 t -78.46 151.91 32.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.79 -12.79 17.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.6 mt -90.7 -54.94 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 23.6 p -85.39 -11.91 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.4 mtm 58.28 37.87 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -132.53 -178.01 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 510' ' ' GLU . 31.9 mp0 -102.28 117.9 35.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.24 135.26 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 499' ' ' PHE . 66.5 tttt -107.91 111.7 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 513' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 514' ' ' LEU . 21.2 t -142.72 161.22 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 499' ' ' PHE . 72.8 mt -82.41 151.48 65.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -5.17 15.53 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -86.75 -12.98 46.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -115.63 9.13 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.468 ' CD2' HG22 ' A' ' 480' ' ' VAL . 87.2 mt -115.13 167.98 10.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.665 ' OE1' HG21 ' A' ' 481' ' ' ILE . 13.4 pt20 -158.45 130.03 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 477' ' ' HIS . 14.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.445 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 8.7 m-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.29 159.16 29.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -60.34 121.15 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 116.5 -11.43 16.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' A' ' 520' ' ' LEU . 9.8 m-20 -98.83 150.85 21.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 520' ' ' LEU . 10.0 t-80 -85.1 131.5 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.85 154.45 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.42 157.62 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.69 125.44 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -108.54 -31.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.18 170.92 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.12 -153.8 17.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -89.94 -22.1 22.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 511' ' ' LEU . 86.1 m-85 -105.32 39.41 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 123.98 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 97.6 22.19 17.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 489' ' ' THR . 9.6 t70 -118.66 170.93 8.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.471 ' N ' ' OD1' ' A' ' 488' ' ' ASP . 40.8 p -149.34 157.12 43.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.73 -179.76 48.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.26 154.01 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.51 110.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.78 -34.6 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -143.37 120.76 11.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.5 117.21 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -103.96 161.42 13.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.97 -28.2 69.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -88.43 -66.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -123.36 179.62 4.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.422 ' C ' HD13 ' A' ' 501' ' ' ILE . 48.8 t -125.69 129.81 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.139 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 501' ' ' ILE . 3.0 mm -97.95 111.14 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -111.66 137.25 49.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -81.7 138.7 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 18.1 t -91.43 147.31 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.18 -18.72 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.26 -54.32 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 42.8 p -81.74 -13.94 57.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.0 mtm 52.8 47.54 24.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -138.76 171.87 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -99.8 109.88 22.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 485' ' ' PHE . 24.2 mt -98.74 132.74 43.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.542 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 2.4 ttpm? -97.74 117.85 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.75 140.65 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 499' ' ' PHE . 48.7 mt -64.55 152.1 90.27 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 2.78 3.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -98.98 -4.36 32.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 518' ' ' LEU . 59.7 m-20 -121.78 17.93 11.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 517' ' ' ASP . 41.4 mt -123.31 163.13 21.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -153.61 127.12 8.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 477' ' ' HIS . 9.9 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.925 0.393 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -109.81 146.46 34.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.4 ttp -42.26 133.66 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 106.91 -41.16 2.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.439 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.45 159.97 32.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -98.99 144.11 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.548 HG23 HD13 ' A' ' 502' ' ' LEU . 26.5 m -139.39 146.8 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.48 ' HB2' HG22 ' A' ' 489' ' ' THR . 19.8 tttp -117.56 152.65 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 485' ' ' PHE . 3.2 t -95.14 131.81 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' ILE . . . . . 0.54 HG21 ' HG3' ' A' ' 519' ' ' GLN . 21.6 pt -116.82 -19.55 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.27 -176.92 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 90.94 -166.31 31.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.426 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -80.46 -6.04 57.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.409 ' O ' HG11 ' A' ' 480' ' ' VAL . 24.6 m-85 -122.96 44.05 2.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -71.89 112.3 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.32 7.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.05 168.45 9.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 479' ' ' LYS . 33.4 p -151.55 151.14 31.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -174.54 178.42 46.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.64 158.71 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 36.1 mt -86.07 115.98 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.22 -24.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -150.41 133.75 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.898 HG13 HG22 ' A' ' 500' ' ' VAL . 7.3 t -124.78 130.8 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -125.52 155.97 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.96 -16.67 32.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -97.81 -61.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -138.61 164.97 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.898 HG22 HG13 ' A' ' 495' ' ' VAL . 60.1 t -113.25 123.97 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.1 mm -89.65 117.9 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -114.12 143.33 44.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -83.85 131.6 34.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.5 t -101.3 141.7 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.74 -24.76 19.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.89 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 30.6 mt -71.27 -52.86 16.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 62.8 p -91.29 -17.65 25.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 9.5 mtt 63.96 40.61 7.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -143.7 171.87 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -92.49 126.71 37.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 58.2 mt -111.2 133.46 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 0.8 OUTLIER -99.73 114.66 27.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.58 146.03 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' ' 499' ' ' PHE . 84.4 mt -65.62 151.31 94.86 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -1.96 9.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.382 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -91.45 -14.31 30.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.91 2.42 19.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.66 153.66 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.54 ' HG3' HG21 ' A' ' 481' ' ' ILE . 4.5 mm-40 -141.65 131.3 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.63 ' HB3' HD11 ' A' ' 492' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -118.76 170.14 9.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.0 ttp -53.85 140.16 31.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 91.77 -23.1 27.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -85.91 149.1 25.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.491 ' O ' HD23 ' A' ' 520' ' ' LEU . 23.5 t-80 -98.03 131.79 44.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 22.3 m -125.56 170.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.64 ' HG3' HG22 ' A' ' 489' ' ' THR . 50.6 tttt -134.79 144.82 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 488' ' ' ASP . 18.3 t -90.57 122.15 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.0 pt -106.31 -23.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -140.71 178.39 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.63 -152.14 20.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -88.35 -25.36 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -103.75 40.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.42 111.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.34 -9.18 26.6 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 480' ' ' VAL . 36.6 m-20 -93.3 145.03 24.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 479' ' ' LYS . 3.7 p -130.4 159.85 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.24 174.81 47.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.12 166.41 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 472' ' ' PHE . 22.9 mt -99.97 107.76 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.81 -27.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -154.67 148.76 25.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.835 HG13 HG22 ' A' ' 500' ' ' VAL . 65.4 t -129.94 144.84 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.63 142.36 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -47.63 -22.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -93.43 -59.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.455 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 171.36 14.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.835 HG22 HG13 ' A' ' 495' ' ' VAL . 53.9 t -114.73 128.79 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.77 107.28 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -106.17 136.88 45.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -85.54 132.37 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -87.41 152.49 22.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -101.15 -18.5 16.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.69 -53.95 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 72.1 p -82.01 -12.64 58.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.082 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.4 mtp 54.33 28.19 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -122.1 174.28 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.22 121.23 32.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.22 137.72 44.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.455 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.8 tmtt? -116.62 124.08 48.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 17.8 t -151.99 150.94 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.7 mt -67.85 152.52 96.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.583 0.706 . . . . 0.0 110.951 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.08 11.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -86.45 -21.74 26.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -108.2 20.31 18.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 480' ' ' VAL . 67.3 mt -126.29 156.57 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -153.85 127.83 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 477' ' ' HIS . 9.5 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.542 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 1.5 m-30 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -134.99 153.42 52.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 ttt -52.06 127.48 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 111.38 -10.89 28.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 491' ' ' LEU . 2.2 m-20 -102.21 164.27 11.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -103.44 137.9 40.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.537 HG12 HD23 ' A' ' 520' ' ' LEU . 32.3 m -139.58 168.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.15 147.15 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 518' ' ' LEU . 60.1 t -91.1 104.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.4 pt -86.68 -27.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -137.8 171.99 13.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 106.85 -162.14 13.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -89.95 -0.03 57.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -120.36 15.35 12.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -39.67 121.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.68 53.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.5 m-20 -110.24 131.49 55.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.3 p -123.81 163.18 21.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 178.91 -174.7 46.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 476' ' ' ASP . 13.2 mt -97.98 158.76 15.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 60.7 mt -89.73 114.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.5 -33.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -140.32 140.21 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 500' ' ' VAL . 36.5 t -129.63 124.93 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.0 155.81 30.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -59.77 -17.26 33.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.36 -61.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.622 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -134.91 168.0 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.908 HG22 HG13 ' A' ' 495' ' ' VAL . 77.7 t -117.16 123.94 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.49 117.36 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -112.42 139.42 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -82.12 126.23 31.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 47.2 t -86.53 153.8 21.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -105.32 -28.98 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.55 -50.15 19.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.0 p -93.94 -13.55 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 79.1 mtp 59.49 30.27 19.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -123.46 158.98 30.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -84.26 112.29 20.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 26.2 mt -93.25 140.35 29.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 28.3 tttt -109.55 123.06 48.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 514' ' ' LEU . 19.2 t -154.34 157.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.9 mt -73.65 152.12 89.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.64 8.84 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -89.91 -30.66 17.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.29 6.69 45.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.572 HD21 HG22 ' A' ' 480' ' ' VAL . 78.7 mt -112.53 156.08 23.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -143.1 129.31 19.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.542 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 11.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.678 ' O ' HD12 ' A' ' 492' ' ' ILE . 2.0 mmmm -120.16 156.41 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 492' ' ' ILE . 1.1 tmt? -56.62 126.05 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.78 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -72.09 158.21 36.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -98.13 130.9 44.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.545 ' CG1' HD11 ' A' ' 492' ' ' ILE . 22.6 m -126.34 161.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 489' ' ' THR . 45.8 tttp -129.63 148.18 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 518' ' ' LEU . 40.8 t -92.13 116.76 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.46 -21.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.93 179.12 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.69 -149.46 19.23 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -89.92 -28.89 18.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -103.09 41.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -56.83 108.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.2 -17.3 19.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.0 t70 -75.15 141.77 43.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 479' ' ' LYS . 69.6 p -128.78 151.17 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.47 39.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.21 158.78 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 473' ' ' LYS . 45.7 mt -88.72 111.34 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 14.0 m -100.4 -28.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.06 142.43 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.81 HG13 HG22 ' A' ' 500' ' ' VAL . 5.0 t -127.8 146.88 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -139.79 140.83 36.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.15 -22.33 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -90.03 -62.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -136.98 169.92 16.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.81 HG22 HG13 ' A' ' 495' ' ' VAL . 39.6 t -115.91 127.62 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.3 mm -95.23 121.68 46.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -118.74 138.04 52.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -82.39 126.3 32.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 8.1 t -81.23 151.96 27.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -96.62 -18.87 19.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.83 -53.07 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 54.3 p -81.56 -0.8 43.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.444 ' C ' ' O ' ' A' ' 507' ' ' THR . 20.8 mtp 35.14 50.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 507' ' ' THR . 29.7 m-70 -145.67 170.23 16.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.1 118.43 28.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.69 137.17 42.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 25.8 tttt -111.63 114.98 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.75 141.69 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 499' ' ' PHE . 90.7 mt -60.28 152.13 64.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 1.86 4.04 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.33 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -93.71 -10.8 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.41 21.35 13.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.3 mt -128.79 166.98 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 138.47 13.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.926 0.393 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -118.73 155.84 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 492' ' ' ILE . 0.3 OUTLIER -56.74 136.75 55.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 475' ' ' GLY . . . . . 0.432 ' N ' ' SD ' ' A' ' 474' ' ' MET . . . 101.01 -11.13 58.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.556 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.7 154.38 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -97.21 133.26 42.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 518' ' ' LEU . 4.3 m -128.61 159.0 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 489' ' ' THR . 69.3 tttt -125.52 141.84 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 488' ' ' ASP . 15.4 t -82.92 128.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.6 pt -111.92 -23.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.62 172.37 12.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.26 -152.31 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -88.89 -26.58 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.813 0.339 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -102.94 38.17 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.37 106.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.33 -18.22 11.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.847 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.1 t70 -77.39 146.1 36.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 479' ' ' LYS . 65.5 p -134.07 153.2 51.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.31 -178.08 41.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -99.69 154.91 17.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 474' ' ' MET . 72.2 mt -86.57 122.43 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.4 m -112.72 -34.63 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -143.37 121.99 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.39 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -124.97 153.35 42.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.13 -28.22 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -84.63 -61.35 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.558 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -138.87 174.31 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.35 136.47 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 9.9 mm -105.78 108.88 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -107.85 141.94 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -84.35 124.22 31.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 511' ' ' LEU . 12.2 t -76.14 154.81 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.97 -26.24 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.53 -57.89 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 508' ' ' MET . 77.1 p -79.99 3.76 19.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 507' ' ' THR . 45.7 mtt 35.08 49.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -139.71 177.75 7.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.99 121.82 38.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 504' ' ' SER . 27.5 mt -103.95 141.02 36.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.2 tmtt? -118.24 121.28 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 13.0 t -154.56 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 499' ' ' PHE . 69.0 mt -62.63 150.25 86.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -1.14 7.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.289 . . . . 0.0 112.356 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.35 -10.67 45.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 518' ' ' LEU . 3.1 m-20 -116.1 11.88 15.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 517' ' ' ASP . 22.4 mt -120.07 158.21 27.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.95 140.53 23.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.7 m-30 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -121.09 154.01 36.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 27.8 ttp -49.89 133.77 21.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.52 -38.76 3.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.02 154.2 38.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -97.19 143.91 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 502' ' ' LEU . 25.1 m -139.08 177.65 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.715 ' HG3' HG22 ' A' ' 489' ' ' THR . 19.0 ttpt -142.88 156.6 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.425 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 40.3 t -99.59 109.2 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' ILE . . . . . 0.581 HG23 ' HG2' ' A' ' 519' ' ' GLN . 34.3 pt -89.56 -23.94 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.56 170.96 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.24 -156.45 17.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -85.06 -27.15 26.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -99.13 28.34 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.74 119.78 5.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 98.01 16.66 32.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -117.06 138.74 51.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.715 HG22 ' HG3' ' A' ' 479' ' ' LYS . 12.8 p -118.65 157.72 26.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.6 171.74 44.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.61 164.88 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.409 HD11 ' CG1' ' A' ' 478' ' ' VAL . 60.8 mt -95.9 108.51 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.02 -37.47 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -140.68 153.3 45.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 500' ' ' VAL . 12.1 t -139.95 127.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 498' ' ' ASN . 2.4 mp0 -122.92 140.55 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -44.16 -23.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 496' ' ' GLU . 5.4 m-80 -88.67 -68.9 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.634 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.8 OUTLIER -130.74 171.26 13.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 495' ' ' VAL . 22.0 t -116.24 137.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.0 mm -104.61 106.29 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.1 pt? -103.49 136.35 43.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -80.7 129.35 34.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.9 t -84.99 148.61 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -98.08 -14.01 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.87 -51.38 4.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 67.4 p -83.16 -4.34 58.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 4.7 mtt 45.87 34.86 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.05 176.42 8.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -94.73 117.53 30.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.86 135.14 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.519 ' HE3' ' CG ' ' A' ' 499' ' ' PHE . 3.0 tmtt? -107.74 131.03 54.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.7 t -156.89 149.57 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 499' ' ' PHE . 52.0 mt -68.7 152.0 96.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 1.37 4.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.679 2.253 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' ARG . . . . . 0.429 ' HE ' HD12 ' A' ' 514' ' ' LEU . 10.7 ptt180 -92.25 -27.67 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' ASP . . . . . 0.533 ' O ' HD23 ' A' ' 518' ' ' LEU . 23.8 m-20 -106.76 40.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 517' ' ' ASP . 57.1 mt -143.29 162.99 34.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.581 ' HG2' HG23 ' A' ' 481' ' ' ILE . 1.2 pt20 -152.12 137.71 17.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.6 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.934 0.397 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.706 ' O ' HD12 ' A' ' 492' ' ' ILE . 9.2 ptmm? -112.7 159.84 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.6 ttt -59.84 126.18 26.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.03 -37.49 3.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -75.29 160.09 30.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -100.0 130.47 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 492' ' ' ILE . 26.9 m -122.56 153.0 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.97 138.3 54.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 488' ' ' ASP . 10.6 t -91.4 121.79 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.152 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 44.9 pt -106.15 -23.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.24 172.4 12.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 103.09 -156.81 18.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.497 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -83.23 -20.04 35.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -112.87 43.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -61.29 138.84 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.78 -16.06 22.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.552 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -85.39 149.18 25.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 4.8 p -140.97 159.15 42.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -172.51 -169.72 35.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.99 160.17 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 473' ' ' LYS . 24.0 mt -91.67 112.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.114 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.35 -31.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -153.4 131.81 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.769 HG22 HG13 ' A' ' 500' ' ' VAL . 41.2 t -118.24 151.66 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.7 157.57 46.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.61 -17.31 46.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.95 -66.48 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.514 ' CG ' ' HD3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -127.42 174.79 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.769 HG13 HG22 ' A' ' 495' ' ' VAL . 26.1 t -119.85 127.57 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 108.57 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -109.97 141.65 42.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -86.5 135.28 33.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.7 t -91.71 142.9 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.45 -5.4 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 44.5 mt -90.81 -73.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.2 p -82.35 7.57 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.8 mmm 44.13 30.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -111.63 159.24 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -82.78 117.67 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.38 153.7 19.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.514 ' HD3' ' CG ' ' A' ' 499' ' ' PHE . 6.1 tmmm? -123.77 124.52 42.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.0 143.65 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.123 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.3 mt -69.57 156.01 92.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -0.34 6.79 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.713 2.276 . . . . 0.0 112.319 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -97.25 -15.52 20.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -115.8 34.51 4.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.9 mt -134.26 157.52 46.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -145.44 129.17 17.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 520' ' ' LEU . 11.1 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.3 m-30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.906 0.384 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 492' ' ' ILE . 0.7 OUTLIER -112.83 -178.17 3.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.4 ttt -74.18 156.73 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 76.53 -9.63 21.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' ASP . . . . . 0.424 ' C ' HD23 ' A' ' 491' ' ' LEU . 86.5 m-20 -93.51 148.39 22.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -95.8 113.51 25.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.829 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 492' ' ' ILE . 10.8 m -106.36 161.39 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -121.78 141.55 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 19.4 t -89.49 116.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' ILE . . . . . 0.634 HG21 ' OE1' ' A' ' 519' ' ' GLN . 24.6 pt -100.55 -30.37 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 481' ' ' ILE . . . -139.96 171.0 14.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.56 -157.17 15.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.533 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -87.92 -9.89 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.759 ' CE1' HD22 ' A' ' 511' ' ' LEU . 52.3 m-85 -119.23 38.74 3.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -60.19 137.73 58.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.31 -20.22 27.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.61 160.19 21.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -143.57 165.43 27.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.82 -178.83 48.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 476' ' ' ASP . 10.2 mt -99.37 160.98 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 473' ' ' LYS . 6.1 mt -94.51 105.01 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.89 -28.11 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -153.34 141.98 20.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.874 HG22 HG13 ' A' ' 500' ' ' VAL . 60.5 t -126.23 139.24 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -126.46 146.53 50.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -49.11 -29.08 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -85.31 -60.25 2.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -136.49 178.06 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.874 HG13 HG22 ' A' ' 495' ' ' VAL . 39.8 t -119.79 132.52 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.1 mm -97.09 110.94 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -112.72 137.55 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -84.25 135.62 34.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -91.36 142.3 27.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.66 -10.5 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.12 -48.49 4.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 9.0 p -92.96 -3.57 54.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 44.6 mmm 42.55 34.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -123.29 164.43 18.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -85.28 104.03 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.759 HD22 ' CE1' ' A' ' 485' ' ' PHE . 88.2 mt -87.91 143.26 27.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -114.89 113.37 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.29 139.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 499' ' ' PHE . 83.8 mt -61.89 153.69 71.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.584 0.707 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 2.1 3.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.631 2.221 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -97.46 -4.65 37.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -118.27 1.27 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 472' ' ' PHE . 20.1 mt -113.98 152.84 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.634 ' OE1' HG21 ' A' ' 481' ' ' ILE . 9.4 pt20 -143.97 132.28 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.8 m-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.932 0.396 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -136.34 153.53 51.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 19.4 ttp -51.26 125.58 14.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.52 -29.61 7.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -84.77 158.92 20.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -102.69 131.77 49.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.426 HG12 HD23 ' A' ' 520' ' ' LEU . 14.8 m -123.45 159.39 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -125.04 136.5 53.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.719 HG22 ' CD2' ' A' ' 518' ' ' LEU . 29.9 t -86.24 114.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 33.2 pt -97.97 -24.72 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.45 -179.42 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.93 -160.59 21.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -86.13 -7.76 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.542 ' CE2' HD22 ' A' ' 511' ' ' LEU . 69.3 m-85 -119.15 35.83 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -57.66 138.6 55.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 84.02 -13.92 46.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -87.98 151.58 22.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 24.3 p -139.6 162.27 35.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.82 178.39 48.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.42 161.26 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -90.26 117.91 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -107.61 -31.65 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -149.18 137.79 21.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 500' ' ' VAL . 1.8 t -122.53 138.34 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.677 ' OE2' HD11 ' A' ' 501' ' ' ILE . 11.8 mt-10 -126.42 148.82 49.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -54.63 -21.09 9.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' ASN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 499' ' ' PHE . 4.2 t-20 -94.14 -53.7 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.701 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -142.36 172.0 13.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 495' ' ' VAL . 18.6 t -116.75 125.34 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ILE . . . . . 0.677 HD11 ' OE2' ' A' ' 496' ' ' GLU . 9.1 mm -90.85 119.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.54 140.53 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -85.58 132.03 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 13.4 t -85.95 154.82 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.92 -26.29 14.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.1 mt -86.85 -54.25 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 38.7 p -80.16 -7.23 58.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.7 mtm 45.55 36.94 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 507' ' ' THR . 17.9 m-70 -135.67 163.58 29.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.21 125.73 32.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.542 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -109.92 133.99 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 49.6 tttt -101.68 111.65 23.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.79 143.41 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 499' ' ' PHE . 96.0 mt -63.6 153.22 83.95 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.643 0.735 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -0.89 7.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -91.18 -11.2 39.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -112.21 1.94 16.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 480' ' ' VAL . 44.0 mt -116.45 159.58 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -151.96 133.79 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 478' ' ' VAL . 15.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.51 ' O ' HD12 ' A' ' 492' ' ' ILE . 97.2 mttt -121.0 149.33 42.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 13.7 ttp -42.47 140.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 491' ' ' LEU . . . 96.05 -49.52 1.74 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.78 152.05 37.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.46 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.5 t-80 -94.7 130.09 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.45 HG23 HD13 ' A' ' 502' ' ' LEU . 3.6 m -124.54 158.14 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.37 148.45 50.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.07 121.6 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -103.8 -23.64 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.39 -177.89 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.04 -152.5 19.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -89.9 -5.52 56.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.41 ' CE2' HD22 ' A' ' 511' ' ' LEU . 32.1 m-85 -128.08 37.82 4.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.96 136.78 57.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.84 17.01 71.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.4 172.87 6.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 72.1 p -151.44 160.6 43.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 177.33 177.27 46.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 475' ' ' GLY . 11.0 mt -102.58 154.44 19.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 473' ' ' LYS . 39.7 mt -82.93 119.68 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.24 -26.34 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -160.56 120.83 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 500' ' ' VAL . 11.5 t -109.57 146.42 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -132.31 150.96 52.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.52 -27.03 23.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -85.35 -59.64 2.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.576 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -139.55 174.13 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.873 HG22 HG13 ' A' ' 495' ' ' VAL . 36.6 t -113.82 134.33 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ILE . . . . . 0.417 HD13 ' C ' ' A' ' 500' ' ' VAL . 4.7 mm -103.79 111.42 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.5 pt? -114.51 138.99 49.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -79.74 132.08 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -90.02 152.06 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.21 -20.89 17.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.08 -49.44 6.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 508' ' ' MET . 76.9 p -89.3 2.72 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 507' ' ' THR . 14.0 mtp 36.3 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.94 171.74 12.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.56 117.22 28.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -101.03 127.33 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.501 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 18.3 ttpt -101.55 117.07 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.7 t -139.65 157.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.18 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.4 mt -77.42 153.88 81.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.615 0.721 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 0.86 5.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.257 . . . . 0.0 112.338 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -95.15 -12.41 26.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.75 13.04 16.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.55 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 92.9 mt -115.56 162.35 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.401 ' HG2' ' C ' ' A' ' 518' ' ' LEU . 12.9 mm-40 -152.07 137.74 17.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 520' ' ' LEU . 12.9 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.3 m-30 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 474' ' ' MET . 44.2 pttt -123.48 141.17 52.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 473' ' ' LYS . 13.6 ttt -34.61 128.92 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 107.04 -49.58 0.86 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' ASP . . . . . 0.451 ' HB2' HD12 ' A' ' 492' ' ' ILE . 0.9 OUTLIER -62.79 154.03 31.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.555 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.9 t-160 -94.93 137.49 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 520' ' ' LEU . 19.8 m -133.02 156.29 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.159 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 480' ' ' VAL . 21.8 tttt -128.37 148.39 50.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.714 HG22 ' CD2' ' A' ' 518' ' ' LEU . 36.1 t -95.27 111.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.8 pt -94.53 -25.09 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.71 178.21 7.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.96 -154.48 19.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -86.33 -28.62 23.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 511' ' ' LEU . 6.0 m-85 -100.55 34.5 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.05 137.27 46.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.9 -21.15 24.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.34 158.29 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 27.8 p -145.34 159.82 42.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.62 178.8 43.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.3 mt -97.08 155.17 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.465 HD11 HG13 ' A' ' 478' ' ' VAL . 24.5 mt -81.82 111.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 503' ' ' PHE . 4.4 m -101.01 -25.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -155.83 150.22 25.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 500' ' ' VAL . 2.4 t -131.9 137.8 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.87 140.59 49.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.66 -29.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -83.7 -64.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.648 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -137.47 173.61 11.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 495' ' ' VAL . 26.2 t -114.41 140.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.8 mm -105.01 118.95 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -116.79 137.37 52.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' PHE . . . . . 0.429 ' HB2' HG11 ' A' ' 493' ' ' VAL . 54.6 t80 -84.25 129.69 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.6 t -85.53 152.81 22.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.41 -21.41 17.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 68.0 mt -90.49 -52.89 4.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 22.8 p -82.41 -9.0 59.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.6 mtt 46.24 41.09 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -136.25 167.97 20.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.96 113.88 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.848 HD22 ' CE2' ' A' ' 485' ' ' PHE . 85.7 mt -96.99 131.85 43.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 9.3 tttm -105.37 108.34 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 513' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 514' ' ' LEU . 39.8 t -133.76 154.08 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 499' ' ' PHE . 78.3 mt -71.82 155.26 92.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.33 15.93 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.232 . . . . 0.0 112.378 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.95 -26.99 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.57 18.33 16.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.714 ' CD2' HG22 ' A' ' 480' ' ' VAL . 48.8 mt -132.8 155.23 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -140.42 138.57 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 478' ' ' VAL . 9.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.0 m-30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.912 0.387 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -120.64 144.57 48.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 9.0 mtm -45.86 143.09 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.79 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.31 160.58 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -104.66 133.01 50.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 492' ' ' ILE . 27.6 m -126.05 159.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.459 ' HG3' HG22 ' A' ' 489' ' ' THR . 51.4 tttt -120.23 149.94 41.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.452 HG22 ' CD2' ' A' ' 518' ' ' LEU . 25.5 t -95.12 123.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.128 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 481' ' ' ILE . . . . . 0.5 HG21 ' OE1' ' A' ' 519' ' ' GLN . 15.6 pt -103.54 -26.57 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.75 -175.65 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.74 -153.9 20.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -89.15 -3.89 58.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.36 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.65 33.47 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -56.95 108.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.13 -13.17 16.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 480' ' ' VAL . 1.0 OUTLIER -91.52 157.48 17.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.459 HG22 ' HG3' ' A' ' 479' ' ' LYS . 30.6 p -138.03 164.44 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.12 175.53 47.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 mt -92.2 165.58 13.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 478' ' ' VAL . 46.8 mt -97.67 113.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 9.5 m -103.37 -33.4 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -148.62 148.55 30.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.533 HG22 HG13 ' A' ' 500' ' ' VAL . 15.9 t -133.46 140.93 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -129.52 145.9 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -48.46 -33.4 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.94 -60.48 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.707 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -137.86 -179.0 5.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 495' ' ' VAL . 6.1 t -118.62 144.25 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.68 110.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -110.07 137.18 48.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -82.75 131.11 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 146.51 26.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -98.5 -22.43 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 66.6 mt -81.64 -59.57 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 56.4 p -84.04 -2.23 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 42.6 mtt 48.23 36.82 7.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.27 172.22 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -92.19 123.38 35.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 13.8 mt -104.5 135.24 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.6 tttt -113.4 112.18 23.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 514' ' ' LEU . 2.8 t -141.63 162.2 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 499' ' ' PHE . 97.0 mt -75.34 152.15 85.74 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.611 0.72 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -2.0 9.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -89.07 -28.4 20.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.9 15.05 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.452 ' CD2' HG22 ' A' ' 480' ' ' VAL . 50.8 mt -125.33 169.07 12.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.5 ' OE1' HG21 ' A' ' 481' ' ' ILE . 17.2 pt20 -163.52 134.23 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.931 0.396 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 474' ' ' MET . 58.9 mttm -117.63 137.82 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.418 ' C ' ' O ' ' A' ' 473' ' ' LYS . 28.4 ttm -36.81 133.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.95 -45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 492' ' ' ILE . 39.5 m-20 -67.31 155.45 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.473 ' HA ' HD23 ' A' ' 491' ' ' LEU . 9.4 t-80 -94.78 124.97 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.622 HG13 HD11 ' A' ' 492' ' ' ILE . 4.7 m -117.27 162.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.617 ' HG3' HG22 ' A' ' 489' ' ' THR . 61.8 tttt -135.0 149.33 50.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 488' ' ' ASP . 6.3 t -93.02 124.81 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 481' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 519' ' ' GLN . 35.4 pt -103.29 -27.35 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.89 -177.16 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.94 -151.31 19.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -88.4 -24.08 23.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 39.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.28 119.67 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 103.08 -13.39 55.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -88.62 155.07 19.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.868 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.617 HG22 ' HG3' ' A' ' 479' ' ' LYS . 33.0 p -135.98 170.95 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 176.12 174.89 43.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.6 mt -96.7 151.71 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.3 . . . . 0.0 110.976 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.622 HD11 HG13 ' A' ' 478' ' ' VAL . 25.2 mt -80.77 106.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 m -97.45 -33.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -147.63 146.73 29.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 500' ' ' VAL . 1.2 t -131.08 151.5 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -145.94 145.89 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -49.23 -30.43 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -82.27 -65.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.663 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -133.87 171.25 14.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 495' ' ' VAL . 9.4 t -113.98 134.38 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 20.5 mm -100.26 132.12 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.5 pt? -133.94 146.27 50.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -91.6 129.76 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 511' ' ' LEU . 1.3 t -91.83 127.91 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.58 -18.31 61.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.4 -61.36 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 18.3 p -82.74 -5.03 58.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 36.7 mtm 47.3 39.93 9.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -136.14 170.85 15.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -87.54 114.99 24.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 504' ' ' SER . 38.1 mt -95.84 142.79 27.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.42 ' NZ ' ' CZ ' ' A' ' 499' ' ' PHE . 5.8 tttp -112.58 118.31 34.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' VAL . . . . . 0.432 ' HB ' HD21 ' A' ' 518' ' ' LEU . 11.5 t -148.12 143.11 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 499' ' ' PHE . 79.6 mt -66.77 155.1 90.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -1.18 8.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 22.0 ptt85 -93.22 -7.46 45.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.14 5.16 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.432 HD21 ' HB ' ' A' ' 513' ' ' VAL . 46.0 mt -112.75 159.41 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' A' ' 481' ' ' ILE . 15.5 pt20 -152.88 131.02 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.487 HD23 HG12 ' A' ' 478' ' ' VAL . 9.1 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 4.8 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.949 0.404 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 492' ' ' ILE . 6.6 mmmt -115.98 148.31 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -45.16 137.67 4.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 97.95 -39.41 2.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.42 156.52 38.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.478 ' HA ' HD23 ' A' ' 491' ' ' LEU . 81.0 t60 -97.68 129.85 44.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 502' ' ' LEU . 30.0 m -119.44 158.86 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -126.65 152.14 47.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 50.5 t -100.38 117.29 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.85 -23.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -141.86 -179.65 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.82 -159.05 21.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -81.63 -21.02 38.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.489 ' CE2' HD22 ' A' ' 511' ' ' LEU . 26.8 m-85 -111.64 40.21 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.8 108.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.96 -24.53 8.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.75 155.14 41.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 61.0 p -143.43 148.39 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -165.25 -173.83 34.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.451 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.4 mt -102.06 159.47 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 473' ' ' LYS . 54.8 mt -87.06 124.97 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.93 -35.1 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -151.4 117.14 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 500' ' ' VAL . 1.7 p -113.59 131.44 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.15 -20.83 66.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -95.62 -65.57 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.566 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -124.2 173.16 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 495' ' ' VAL . 26.3 t -117.49 137.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 8.6 mm -106.73 120.5 58.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.0 pt? -119.03 140.19 50.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 503' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 508' ' ' MET . 83.4 t80 -78.95 129.55 34.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 24.0 t -83.33 138.43 33.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.44 2.31 55.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.01 -67.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 508' ' ' MET . 16.2 p -108.58 29.11 7.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 503' ' ' PHE . 0.4 OUTLIER 34.52 49.61 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -116.55 159.0 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -94.24 116.26 28.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 485' ' ' PHE . 83.1 mt -99.29 138.76 35.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.566 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 6.5 tmtt? -114.9 110.32 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.45 145.1 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.534 HD23 ' HB3' ' A' ' 499' ' ' PHE . 91.2 mt -62.25 152.9 77.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.34 30.57 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -19.48 53.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -112.32 21.18 16.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 25.8 mt -120.78 162.19 20.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -149.9 142.09 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.5 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -120.46 138.73 53.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.55 ' HA ' HG22 ' A' ' 492' ' ' ILE . 2.6 ttp -38.33 132.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 109.35 -34.74 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' ASP . . . . . 0.529 ' HB2' HD12 ' A' ' 492' ' ' ILE . 10.3 m-20 -79.92 163.16 24.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 110.843 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' HIS . . . . . 0.423 ' HA ' HD23 ' A' ' 491' ' ' LEU . 45.6 t60 -100.36 121.92 42.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.764 HG13 HD11 ' A' ' 492' ' ' ILE . 14.4 m -114.71 148.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -124.11 143.32 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 488' ' ' ASP . 24.7 t -93.88 124.05 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.9 pt -107.13 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 517' ' ' ASP . . . -140.29 -176.94 4.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.58 -159.39 25.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.17 -10.55 54.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.55 32.08 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -56.39 125.11 20.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.03 64.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.3 t70 -99.82 129.96 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 67.1 p -124.78 146.63 49.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -168.7 -170.26 33.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.7 mt -104.49 158.95 16.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.764 HD11 HG13 ' A' ' 478' ' ' VAL . 45.3 mt -89.29 121.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.37 -35.55 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -144.27 121.44 11.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 500' ' ' VAL . 3.0 t -112.12 126.96 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.47 157.15 21.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.78 -36.82 77.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.63 -59.15 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.716 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.7 OUTLIER -136.56 176.7 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 495' ' ' VAL . 14.9 t -115.01 140.03 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.6 mm -109.0 109.68 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.679 HD13 HG23 ' A' ' 478' ' ' VAL . 2.4 pt? -109.26 137.16 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 503' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 504' ' ' SER . 65.1 t80 -79.69 132.37 36.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 504' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 503' ' ' PHE . 1.4 t -84.9 149.0 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.76 -31.6 10.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.7 -44.63 18.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 2.7 p -90.34 -10.01 45.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 29.1 mtt 51.96 36.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -137.08 159.88 40.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -80.84 128.9 34.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 30.6 mt -116.47 135.06 54.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.4 tmtt? -103.63 129.12 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.0 t -149.47 161.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 499' ' ' PHE . 95.1 mt -81.07 154.02 72.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.607 0.717 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 2.28 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -95.57 -25.64 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.816 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' ASP . . . . . 0.812 ' OD1' ' HB3' ' A' ' 482' ' ' ALA . 31.7 m-20 -105.0 22.69 14.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 72.1 mt -121.78 150.79 41.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -141.95 126.42 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 520' ' ' LEU . 12.6 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 1.6 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.932 0.396 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 474' ' ' MET . 41.4 mttp -120.9 139.67 52.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 473' ' ' LYS . 18.1 ttt -34.65 132.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 102.33 -40.7 2.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' ASP . . . . . 0.626 ' HB2' HD12 ' A' ' 492' ' ' ILE . 7.8 m-20 -70.83 157.28 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -101.94 136.76 41.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.887 HG12 HD23 ' A' ' 520' ' ' LEU . 3.8 m -139.03 159.42 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 489' ' ' THR . 3.1 ttpm? -123.19 159.36 28.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 488' ' ' ASP . 48.0 t -104.39 121.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 20.3 pt -101.73 -23.43 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.79 171.29 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.29 -166.03 15.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -76.52 -7.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 511' ' ' LEU . 12.9 m-85 -124.7 42.19 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -55.54 135.03 51.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 72.78 10.63 77.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 480' ' ' VAL . 19.9 t0 -95.99 125.03 40.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 479' ' ' LYS . 18.9 p -109.79 155.55 21.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.23 174.62 47.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.76 153.08 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 476' ' ' ASP . 14.5 mt -83.41 118.84 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.5 m -111.23 -31.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -146.16 141.02 27.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.85 HG13 HG22 ' A' ' 500' ' ' VAL . 15.9 t -129.39 128.67 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -124.75 148.45 48.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -52.22 -24.62 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -87.75 -61.73 1.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -140.09 169.11 18.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 495' ' ' VAL . 62.6 t -114.24 134.77 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.28 119.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -115.63 139.54 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.74 125.77 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 6.1 t -86.01 153.1 22.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.25 -32.37 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.24 -56.08 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 81.7 p -80.73 -8.41 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.4 mtt 49.56 31.07 3.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -130.02 172.4 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.6 124.24 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 485' ' ' PHE . 29.3 mt -104.1 133.7 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 16.5 tttm -103.0 114.96 29.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 23.0 t -140.15 151.81 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.4 mt -72.04 155.16 92.13 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.609 0.719 . . . . 0.0 110.86 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.24 4.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.334 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -34.05 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 22.34 7.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.484 ' CD2' HG22 ' A' ' 480' ' ' VAL . 23.9 mt -122.64 149.27 44.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -138.48 135.51 35.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 478' ' ' VAL . 9.8 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -111.79 153.75 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.9 ttt -52.41 138.25 27.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 99.8 -26.72 23.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.83 147.99 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -92.54 144.32 25.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 520' ' ' LEU . 34.0 m -140.67 166.61 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.87 ' HD3' HG22 ' A' ' 489' ' ' THR . 6.9 tptm -130.72 131.58 44.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.471 HG22 ' CD2' ' A' ' 518' ' ' LEU . 24.8 t -80.88 108.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 -26.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 517' ' ' ASP . . . -130.68 176.36 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.64 -164.06 25.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -84.68 -19.21 33.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 511' ' ' LEU . 31.2 m-85 -105.97 41.28 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.31 133.92 46.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.05 55.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.03 137.99 53.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.87 HG22 ' HD3' ' A' ' 479' ' ' LYS . 7.1 p -117.73 152.19 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.19 176.84 47.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.56 165.54 12.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 71.5 mt -94.31 113.31 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.57 -33.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -142.14 150.06 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.773 HG13 HG22 ' A' ' 500' ' ' VAL . 11.4 t -138.5 128.87 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -126.35 143.61 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -48.89 -22.42 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.02 -57.87 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.548 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -142.7 169.75 17.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.773 HG22 HG13 ' A' ' 495' ' ' VAL . 50.1 t -116.36 133.43 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.9 mm -100.04 117.5 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.1 pt? -114.95 138.25 51.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.3 125.57 32.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 20.8 t -83.57 130.86 35.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.14 -11.7 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 92.9 mt -98.0 -57.24 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 508' ' ' MET . 73.3 p -84.05 2.02 41.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 507' ' ' THR . 35.6 mmm 36.64 49.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -140.86 166.36 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -91.98 115.18 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 485' ' ' PHE . 60.1 mt -99.95 137.55 38.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.548 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.7 tttt -109.08 110.43 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 5.6 t -136.4 150.76 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.7 mt -70.86 154.54 94.21 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.586 0.707 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -2.24 9.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -95.4 -9.73 31.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 482' ' ' ALA . 4.0 m-20 -121.29 38.39 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.527 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 71.2 mt -143.5 155.5 44.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -140.27 132.34 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.598 HD23 HG12 ' A' ' 478' ' ' VAL . 12.2 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.1 m-30 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 492' ' ' ILE . 57.1 mttm -121.61 155.15 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -52.52 134.86 34.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 98.38 -25.81 26.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.71 148.22 25.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -88.21 142.08 28.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' A' ' 492' ' ' ILE . 10.9 m -136.94 157.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 479' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 1.9 ttmp? -121.91 147.8 45.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 480' ' ' VAL . . . . . 0.479 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 48.1 t -97.88 99.13 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 22.4 pt -87.56 -18.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -134.94 170.98 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.74 -158.04 20.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -89.98 -16.96 28.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.84 39.26 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.54 109.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.89 -13.86 14.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.63 137.86 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -118.29 165.77 13.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.166 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.63 176.71 48.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.48 156.08 16.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 473' ' ' LYS . 59.8 mt -86.23 114.1 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.46 -33.89 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -142.61 144.04 32.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 500' ' ' VAL . 21.3 t -130.15 120.63 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.28 149.86 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.79 -30.75 46.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -80.6 -59.37 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -141.15 173.53 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 495' ' ' VAL . 44.9 t -116.17 134.09 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 mm -99.66 121.83 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -119.75 137.91 53.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -82.48 124.79 30.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 3.0 t -82.0 154.97 25.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -101.78 -9.34 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 35.9 mt -99.19 -55.19 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 508' ' ' MET . 81.1 p -84.87 4.05 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 508' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 507' ' ' THR . 3.4 mtt 35.1 54.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -149.3 177.85 9.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -98.53 115.84 29.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 18.2 mt -104.55 139.89 38.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' LYS . . . . . 0.532 ' CG ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -108.12 118.11 35.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.35 146.72 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 499' ' ' PHE . 80.7 mt -68.4 153.24 95.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -1.61 8.78 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.54 -11.13 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.62 23.57 12.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.475 ' CD2' HG22 ' A' ' 480' ' ' VAL . 88.8 mt -131.69 153.09 50.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 519' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 520' ' ' LEU . 2.7 pp0? -145.39 127.94 16.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' LEU . . . . . 0.442 ' O ' ' NE2' ' A' ' 519' ' ' GLN . 13.1 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 11.1 t -98.09 173.1 7.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.0 m -59.98 132.12 52.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -173.84 -178.16 43.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 3.8 m -102.05 -51.9 3.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.836 0.351 . . . . 0.0 110.847 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 2.6 m -69.07 125.87 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 463' ' ' PHE . . . -117.97 163.51 12.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.79 81.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 110.836 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 461' ' ' GLY . 44.4 m-85 -123.4 74.95 52.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.626 0.727 . . . . 0.0 110.82 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -5.19 15.6 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.737 2.291 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -112.8 104.82 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -105.31 87.19 2.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -95.63 101.36 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.54 104.12 16.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -131.93 132.87 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.86 -40.63 76.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -47.17 109.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -50.21 110.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 492' ' ' ILE . 26.6 mttm -114.45 159.55 20.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.1 146.54 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 89.0 -17.57 50.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -92.19 152.32 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.413 ' O ' HD23 ' A' ' 520' ' ' LEU . 43.9 t-80 -92.98 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.74 151.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 489' ' ' THR . 30.2 tttm -114.69 159.73 20.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 518' ' ' LEU . 41.8 t -106.23 111.06 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ILE . . . . . 0.665 HG21 ' OE1' ' A' ' 519' ' ' GLN . 28.5 pt -92.99 -30.39 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.0 -179.32 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.35 -167.04 23.37 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.41 4.23 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -129.19 25.61 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.51 112.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.39 24.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.494 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.53 153.03 25.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 479' ' ' LYS . 32.6 p -137.5 164.06 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . 177.78 -173.93 46.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.5 162.51 12.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 473' ' ' LYS . 56.2 mt -93.46 114.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.3 m -104.88 -28.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -146.44 142.37 28.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.54 142.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.71 159.47 41.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.58 -18.63 65.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.85 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.905 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.4 p90 -135.2 179.71 6.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.94 129.1 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.5 mm -94.56 118.81 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.62 137.02 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -82.87 121.5 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 4.9 t -78.46 151.91 32.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.79 -12.79 17.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.6 mt -90.7 -54.94 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 23.6 p -85.39 -11.91 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.4 mtm 58.28 37.87 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -132.53 -178.01 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 510' ' ' GLU . 31.9 mp0 -102.28 117.9 35.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.24 135.26 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 499' ' ' PHE . 66.5 tttt -107.91 111.7 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 513' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 514' ' ' LEU . 21.2 t -142.72 161.22 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 499' ' ' PHE . 72.8 mt -82.41 151.48 65.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -5.17 15.53 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -86.75 -12.98 46.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -115.63 9.13 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.468 ' CD2' HG22 ' A' ' 480' ' ' VAL . 87.2 mt -115.13 167.98 10.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.665 ' OE1' HG21 ' A' ' 481' ' ' ILE . 13.4 pt20 -158.45 130.03 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 477' ' ' HIS . 14.6 mt -59.83 163.9 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 32.4 t -106.9 -45.55 4.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 27.2 t -70.49 -47.49 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.42 ' C ' ' OE1' ' A' ' 523' ' ' GLU . 1.3 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 16.3 t -87.29 101.72 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.376 . . . . 0.0 110.873 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 84.7 p -127.53 129.86 48.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 69.15 -160.8 52.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.8 t -91.99 119.35 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 461' ' ' GLY . 89.0 p -101.41 124.89 47.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 460' ' ' SER . . . 35.55 -153.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.59 164.63 13.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -55.45 144.31 53.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.654 0.74 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -17.3 37.84 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.736 2.291 . . . . 0.0 112.314 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -76.98 76.76 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -135.22 121.48 20.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -126.75 113.01 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 468' ' ' LEU . 2.6 mp -118.21 124.89 49.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.478 HH12 HD13 ' A' ' 520' ' ' LEU . 1.4 ppt_? -130.63 144.01 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 -36.02 2.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.87 179.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.445 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 8.7 m-30 -94.79 120.38 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.29 159.16 29.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -60.34 121.15 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 116.5 -11.43 16.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' A' ' 520' ' ' LEU . 9.8 m-20 -98.83 150.85 21.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 520' ' ' LEU . 10.0 t-80 -85.1 131.5 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.85 154.45 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.42 157.62 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.69 125.44 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -108.54 -31.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.18 170.92 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.12 -153.8 17.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -89.94 -22.1 22.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 511' ' ' LEU . 86.1 m-85 -105.32 39.41 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 123.98 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 97.6 22.19 17.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 489' ' ' THR . 9.6 t70 -118.66 170.93 8.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.471 ' N ' ' OD1' ' A' ' 488' ' ' ASP . 40.8 p -149.34 157.12 43.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.73 -179.76 48.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.26 154.01 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.51 110.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.78 -34.6 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -143.37 120.76 11.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.5 117.21 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -103.96 161.42 13.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.97 -28.2 69.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -88.43 -66.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -123.36 179.62 4.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.422 ' C ' HD13 ' A' ' 501' ' ' ILE . 48.8 t -125.69 129.81 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.139 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 501' ' ' ILE . 3.0 mm -97.95 111.14 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -111.66 137.25 49.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -81.7 138.7 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 18.1 t -91.43 147.31 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.18 -18.72 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.26 -54.32 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 42.8 p -81.74 -13.94 57.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.0 mtm 52.8 47.54 24.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -138.76 171.87 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -99.8 109.88 22.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 485' ' ' PHE . 24.2 mt -98.74 132.74 43.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.542 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 2.4 ttpm? -97.74 117.85 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.75 140.65 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 499' ' ' PHE . 48.7 mt -64.55 152.1 90.27 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 2.78 3.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -98.98 -4.36 32.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 518' ' ' LEU . 59.7 m-20 -121.78 17.93 11.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 517' ' ' ASP . 41.4 mt -123.31 163.13 21.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -153.61 127.12 8.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.478 HD13 HH12 ' A' ' 469' ' ' ARG . 9.9 mt -61.59 161.67 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 521' ' ' CYS . . . . . 0.413 ' CB ' ' ND1' ' A' ' 477' ' ' HIS . 6.7 t -100.08 -32.57 10.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 13.8 t -82.5 -59.36 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 91.5 p -73.47 175.03 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 79.2 p -72.77 143.73 47.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -163.09 -128.65 0.96 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.7 p -105.08 112.41 25.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.895 0.378 . . . . 0.0 110.812 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 9.1 t -50.43 166.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 462' ' ' GLU . . . 64.83 166.53 1.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 461' ' ' GLY . 8.5 tt0 -35.17 143.1 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -73.48 144.43 83.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -54.16 107.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -111.01 104.52 13.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -96.01 38.48 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.56 138.26 36.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -105.4 38.01 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.407 ' CG ' HD12 ' A' ' 520' ' ' LEU . 13.6 ttmm -86.22 40.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -74.0 136.65 43.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -87.45 98.7 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -109.81 146.46 34.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.4 ttp -42.26 133.66 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 106.91 -41.16 2.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.439 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.45 159.97 32.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -98.99 144.11 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.548 HG23 HD13 ' A' ' 502' ' ' LEU . 26.5 m -139.39 146.8 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.48 ' HB2' HG22 ' A' ' 489' ' ' THR . 19.8 tttp -117.56 152.65 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 485' ' ' PHE . 3.2 t -95.14 131.81 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ILE . . . . . 0.54 HG21 ' HG3' ' A' ' 519' ' ' GLN . 21.6 pt -116.82 -19.55 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.27 -176.92 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 90.94 -166.31 31.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.426 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -80.46 -6.04 57.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.409 ' O ' HG11 ' A' ' 480' ' ' VAL . 24.6 m-85 -122.96 44.05 2.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -71.89 112.3 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.32 7.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.05 168.45 9.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 479' ' ' LYS . 33.4 p -151.55 151.14 31.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -174.54 178.42 46.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.64 158.71 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 36.1 mt -86.07 115.98 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.22 -24.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -150.41 133.75 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.898 HG13 HG22 ' A' ' 500' ' ' VAL . 7.3 t -124.78 130.8 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -125.52 155.97 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.96 -16.67 32.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -97.81 -61.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -138.61 164.97 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.898 HG22 HG13 ' A' ' 495' ' ' VAL . 60.1 t -113.25 123.97 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.1 mm -89.65 117.9 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -114.12 143.33 44.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -83.85 131.6 34.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.5 t -101.3 141.7 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.74 -24.76 19.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.89 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 30.6 mt -71.27 -52.86 16.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 62.8 p -91.29 -17.65 25.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 9.5 mtt 63.96 40.61 7.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -143.7 171.87 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -92.49 126.71 37.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 58.2 mt -111.2 133.46 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 0.8 OUTLIER -99.73 114.66 27.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.58 146.03 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' ' 499' ' ' PHE . 84.4 mt -65.62 151.31 94.86 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -1.96 9.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.382 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -91.45 -14.31 30.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.91 2.42 19.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.66 153.66 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.54 ' HG3' HG21 ' A' ' 481' ' ' ILE . 4.5 mm-40 -141.65 131.3 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.4 mt -63.57 156.97 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 33.2 t -116.77 -33.21 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 69.9 m -69.82 -52.05 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.862 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 30.4 t -147.92 145.11 28.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.896 0.379 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.6 m -91.2 -46.78 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.836 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -173.82 152.15 14.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.0 p -123.35 -37.54 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.842 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 3.6 m -168.4 134.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 128.72 127.85 3.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.442 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -44.1 -61.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -107.13 144.1 28.45 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 157.75 59.35 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.694 2.262 . . . . 0.0 112.333 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -102.66 118.31 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.088 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -99.75 156.13 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -82.68 138.67 34.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.55 120.58 14.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -119.68 170.15 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -113.43 36.07 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -92.38 133.87 35.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.63 ' HB3' HD11 ' A' ' 492' ' ' ILE . 0.3 OUTLIER -97.75 104.78 16.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -118.76 170.14 9.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.0 ttp -53.85 140.16 31.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 91.77 -23.1 27.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -85.91 149.1 25.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.491 ' O ' HD23 ' A' ' 520' ' ' LEU . 23.5 t-80 -98.03 131.79 44.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 22.3 m -125.56 170.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.64 ' HG3' HG22 ' A' ' 489' ' ' THR . 50.6 tttt -134.79 144.82 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 488' ' ' ASP . 18.3 t -90.57 122.15 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.0 pt -106.31 -23.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -140.71 178.39 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.63 -152.14 20.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -88.35 -25.36 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -103.75 40.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.42 111.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.34 -9.18 26.6 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 480' ' ' VAL . 36.6 m-20 -93.3 145.03 24.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 479' ' ' LYS . 3.7 p -130.4 159.85 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.24 174.81 47.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.12 166.41 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 472' ' ' PHE . 22.9 mt -99.97 107.76 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.81 -27.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -154.67 148.76 25.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.835 HG13 HG22 ' A' ' 500' ' ' VAL . 65.4 t -129.94 144.84 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.63 142.36 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -47.63 -22.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -93.43 -59.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.455 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 171.36 14.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.835 HG22 HG13 ' A' ' 495' ' ' VAL . 53.9 t -114.73 128.79 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.77 107.28 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -106.17 136.88 45.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -85.54 132.37 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -87.41 152.49 22.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -101.15 -18.5 16.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.69 -53.95 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 72.1 p -82.01 -12.64 58.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.082 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.4 mtp 54.33 28.19 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -122.1 174.28 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.22 121.23 32.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.22 137.72 44.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.455 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.8 tmtt? -116.62 124.08 48.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 17.8 t -151.99 150.94 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.7 mt -67.85 152.52 96.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.583 0.706 . . . . 0.0 110.951 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.08 11.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -86.45 -21.74 26.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -108.2 20.31 18.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 480' ' ' VAL . 67.3 mt -126.29 156.57 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -153.85 127.83 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 477' ' ' HIS . 9.5 mt -54.68 160.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.83 -36.06 7.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 43.2 m -66.43 -55.08 17.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 40.7 m -83.85 90.39 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.2 m -55.49 166.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 121.31 -100.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.4 t -148.3 156.18 42.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 13.0 t -116.82 99.28 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -144.44 -162.67 9.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -138.34 109.38 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -109.14 145.08 31.02 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 162.4 42.2 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.709 2.273 . . . . 0.0 112.317 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -106.93 94.14 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.47 -60.09 4.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -93.67 133.17 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.41 95.45 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -76.78 87.71 3.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -110.19 27.45 9.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -88.7 153.77 20.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.542 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 1.5 m-30 -93.1 130.14 38.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -134.99 153.42 52.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 ttt -52.06 127.48 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 111.38 -10.89 28.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 491' ' ' LEU . 2.2 m-20 -102.21 164.27 11.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -103.44 137.9 40.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.537 HG12 HD23 ' A' ' 520' ' ' LEU . 32.3 m -139.58 168.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.15 147.15 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 518' ' ' LEU . 60.1 t -91.1 104.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.4 pt -86.68 -27.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -137.8 171.99 13.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 106.85 -162.14 13.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -89.95 -0.03 57.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -120.36 15.35 12.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -39.67 121.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.68 53.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.5 m-20 -110.24 131.49 55.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.3 p -123.81 163.18 21.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 178.91 -174.7 46.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 476' ' ' ASP . 13.2 mt -97.98 158.76 15.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 60.7 mt -89.73 114.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.5 -33.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -140.32 140.21 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 500' ' ' VAL . 36.5 t -129.63 124.93 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.0 155.81 30.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -59.77 -17.26 33.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.36 -61.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.622 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -134.91 168.0 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.908 HG22 HG13 ' A' ' 495' ' ' VAL . 77.7 t -117.16 123.94 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.49 117.36 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -112.42 139.42 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -82.12 126.23 31.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 47.2 t -86.53 153.8 21.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -105.32 -28.98 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.55 -50.15 19.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.0 p -93.94 -13.55 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 79.1 mtp 59.49 30.27 19.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -123.46 158.98 30.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -84.26 112.29 20.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 26.2 mt -93.25 140.35 29.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 28.3 tttt -109.55 123.06 48.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 514' ' ' LEU . 19.2 t -154.34 157.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.9 mt -73.65 152.12 89.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.64 8.84 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -89.91 -30.66 17.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.29 6.69 45.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.572 HD21 HG22 ' A' ' 480' ' ' VAL . 78.7 mt -112.53 156.08 23.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -143.1 129.31 19.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.542 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 11.6 mt -59.3 153.16 19.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.83 -17.8 30.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 40.7 t -101.9 -66.26 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.843 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.2 t -113.86 122.73 47.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 75.1 m -60.5 160.36 9.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 134.52 104.72 0.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.3 t -42.58 -58.58 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 0.0 110.91 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 1.7 t -118.33 125.9 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -120.61 -163.6 12.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.59 146.96 45.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -100.35 143.98 27.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -22.86 31.67 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.226 . . . . 0.0 112.39 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.49 117.39 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -137.85 105.06 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -57.1 104.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.9 91.72 8.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -107.83 143.93 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -71.93 98.47 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -155.63 154.6 31.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 -86.31 107.94 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.678 ' O ' HD12 ' A' ' 492' ' ' ILE . 2.0 mmmm -120.16 156.41 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 492' ' ' ILE . 1.1 tmt? -56.62 126.05 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.78 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -72.09 158.21 36.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -98.13 130.9 44.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.545 ' CG1' HD11 ' A' ' 492' ' ' ILE . 22.6 m -126.34 161.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 489' ' ' THR . 45.8 tttp -129.63 148.18 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 518' ' ' LEU . 40.8 t -92.13 116.76 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.46 -21.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.93 179.12 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.69 -149.46 19.23 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -89.92 -28.89 18.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -103.09 41.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -56.83 108.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.2 -17.3 19.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.0 t70 -75.15 141.77 43.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 479' ' ' LYS . 69.6 p -128.78 151.17 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.47 39.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.21 158.78 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 473' ' ' LYS . 45.7 mt -88.72 111.34 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 14.0 m -100.4 -28.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.06 142.43 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.81 HG13 HG22 ' A' ' 500' ' ' VAL . 5.0 t -127.8 146.88 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -139.79 140.83 36.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.15 -22.33 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -90.03 -62.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -136.98 169.92 16.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.81 HG22 HG13 ' A' ' 495' ' ' VAL . 39.6 t -115.91 127.62 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.3 mm -95.23 121.68 46.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -118.74 138.04 52.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -82.39 126.3 32.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 8.1 t -81.23 151.96 27.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -96.62 -18.87 19.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.83 -53.07 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 54.3 p -81.56 -0.8 43.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.444 ' C ' ' O ' ' A' ' 507' ' ' THR . 20.8 mtp 35.14 50.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 507' ' ' THR . 29.7 m-70 -145.67 170.23 16.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.1 118.43 28.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.69 137.17 42.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 25.8 tttt -111.63 114.98 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.75 141.69 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 499' ' ' PHE . 90.7 mt -60.28 152.13 64.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 1.86 4.04 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.33 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -93.71 -10.8 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.41 21.35 13.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.3 mt -128.79 166.98 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 138.47 13.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.3 mt -72.11 156.24 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.75 -39.91 5.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 39.5 m -70.83 -53.9 13.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 4.4 m -162.58 151.83 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 18.2 m -62.82 99.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 178.56 95.15 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.1 m -88.5 99.08 12.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 85.2 p -88.83 110.19 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 88.6 132.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.482 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -96.57 145.25 25.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -99.39 143.97 27.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.675 0.75 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 465' ' ' ALA . 53.8 Cg_endo -69.75 120.36 7.16 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 464' ' ' PRO . . . -35.08 -58.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.112 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.98 136.06 51.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.91 133.82 51.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.24 135.83 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -132.79 162.74 30.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -33.58 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -53.98 133.85 43.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -73.84 114.53 12.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -118.73 155.84 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 492' ' ' ILE . 0.3 OUTLIER -56.74 136.75 55.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 475' ' ' GLY . . . . . 0.432 ' N ' ' SD ' ' A' ' 474' ' ' MET . . . 101.01 -11.13 58.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.556 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.7 154.38 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -97.21 133.26 42.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 518' ' ' LEU . 4.3 m -128.61 159.0 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 489' ' ' THR . 69.3 tttt -125.52 141.84 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 488' ' ' ASP . 15.4 t -82.92 128.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.6 pt -111.92 -23.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.62 172.37 12.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.26 -152.31 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -88.89 -26.58 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.813 0.339 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -102.94 38.17 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.37 106.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.33 -18.22 11.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.847 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.1 t70 -77.39 146.1 36.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 479' ' ' LYS . 65.5 p -134.07 153.2 51.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.31 -178.08 41.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -99.69 154.91 17.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 474' ' ' MET . 72.2 mt -86.57 122.43 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.4 m -112.72 -34.63 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -143.37 121.99 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.39 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -124.97 153.35 42.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.13 -28.22 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -84.63 -61.35 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.558 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -138.87 174.31 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.35 136.47 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 9.9 mm -105.78 108.88 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -107.85 141.94 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -84.35 124.22 31.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 511' ' ' LEU . 12.2 t -76.14 154.81 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.97 -26.24 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.53 -57.89 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 508' ' ' MET . 77.1 p -79.99 3.76 19.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 507' ' ' THR . 45.7 mtt 35.08 49.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -139.71 177.75 7.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.99 121.82 38.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 504' ' ' SER . 27.5 mt -103.95 141.02 36.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.2 tmtt? -118.24 121.28 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 13.0 t -154.56 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 499' ' ' PHE . 69.0 mt -62.63 150.25 86.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -1.14 7.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.289 . . . . 0.0 112.356 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.35 -10.67 45.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 518' ' ' LEU . 3.1 m-20 -116.1 11.88 15.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 517' ' ' ASP . 22.4 mt -120.07 158.21 27.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -148.95 140.53 23.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.85 150.46 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 35.0 t -89.18 -45.52 9.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 14.5 m -71.81 -66.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 80.6 p -47.67 150.83 0.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.809 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.2 m -145.16 124.98 13.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -150.84 72.77 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.6 m -97.45 140.62 31.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 10.1 t -104.29 -48.38 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.43 -161.99 13.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -76.61 -46.07 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 110.84 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -101.43 145.04 29.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -22.87 31.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.356 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.21 147.94 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.85 167.32 21.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.65 87.76 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 39.6 mt -120.06 169.96 9.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 469' ' ' ARG . 0.3 OUTLIER -80.31 99.7 8.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.27 69.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.501 ' O ' HD11 ' A' ' 520' ' ' LEU . 98.8 m-85 -109.63 141.06 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.7 m-30 -93.68 104.67 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -121.09 154.01 36.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 27.8 ttp -49.89 133.77 21.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.52 -38.76 3.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.02 154.2 38.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -97.19 143.91 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 502' ' ' LEU . 25.1 m -139.08 177.65 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.715 ' HG3' HG22 ' A' ' 489' ' ' THR . 19.0 ttpt -142.88 156.6 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.425 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 40.3 t -99.59 109.2 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ILE . . . . . 0.581 HG23 ' HG2' ' A' ' 519' ' ' GLN . 34.3 pt -89.56 -23.94 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.56 170.96 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.24 -156.45 17.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -85.06 -27.15 26.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -99.13 28.34 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.74 119.78 5.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 98.01 16.66 32.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -117.06 138.74 51.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.715 HG22 ' HG3' ' A' ' 479' ' ' LYS . 12.8 p -118.65 157.72 26.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.6 171.74 44.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.61 164.88 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.409 HD11 ' CG1' ' A' ' 478' ' ' VAL . 60.8 mt -95.9 108.51 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.02 -37.47 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -140.68 153.3 45.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 500' ' ' VAL . 12.1 t -139.95 127.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 498' ' ' ASN . 2.4 mp0 -122.92 140.55 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -44.16 -23.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 496' ' ' GLU . 5.4 m-80 -88.67 -68.9 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.634 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.8 OUTLIER -130.74 171.26 13.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 495' ' ' VAL . 22.0 t -116.24 137.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.0 mm -104.61 106.29 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.1 pt? -103.49 136.35 43.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -80.7 129.35 34.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.9 t -84.99 148.61 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -98.08 -14.01 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.87 -51.38 4.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 67.4 p -83.16 -4.34 58.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 4.7 mtt 45.87 34.86 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.05 176.42 8.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -94.73 117.53 30.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.86 135.14 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.519 ' HE3' ' CG ' ' A' ' 499' ' ' PHE . 3.0 tmtt? -107.74 131.03 54.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.7 t -156.89 149.57 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 499' ' ' PHE . 52.0 mt -68.7 152.0 96.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 1.37 4.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.679 2.253 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' ARG . . . . . 0.429 ' HE ' HD12 ' A' ' 514' ' ' LEU . 10.7 ptt180 -92.25 -27.67 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' ASP . . . . . 0.533 ' O ' HD23 ' A' ' 518' ' ' LEU . 23.8 m-20 -106.76 40.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 517' ' ' ASP . 57.1 mt -143.29 162.99 34.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.581 ' HG2' HG23 ' A' ' 481' ' ' ILE . 1.2 pt20 -152.12 137.71 17.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 471' ' ' TYR . 12.0 mt -62.31 158.66 16.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.63 -27.79 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 51.7 m -120.78 47.77 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 20.2 m -111.04 -46.51 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 69.1 m -71.8 135.53 46.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 459' ' ' SER . . . 86.11 -153.17 26.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.454 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 458' ' ' GLY . 23.7 m -36.63 106.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 5.3 t -161.39 106.84 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.41 -154.47 20.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.66 157.28 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -95.92 145.07 28.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.648 2.232 . . . . 0.0 112.331 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -110.1 36.36 3.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -81.67 91.34 6.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.8 100.52 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.5 mt -132.46 158.49 41.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -122.37 77.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -106.69 82.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.93 133.77 46.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.6 m-85 -77.36 99.43 5.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.706 ' O ' HD12 ' A' ' 492' ' ' ILE . 9.2 ptmm? -112.7 159.84 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.6 ttt -59.84 126.18 26.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.03 -37.49 3.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -75.29 160.09 30.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -100.0 130.47 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 492' ' ' ILE . 26.9 m -122.56 153.0 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.97 138.3 54.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 488' ' ' ASP . 10.6 t -91.4 121.79 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.152 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 44.9 pt -106.15 -23.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.24 172.4 12.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 103.09 -156.81 18.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.497 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -83.23 -20.04 35.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -112.87 43.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -61.29 138.84 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.78 -16.06 22.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.552 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -85.39 149.18 25.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 4.8 p -140.97 159.15 42.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -172.51 -169.72 35.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.99 160.17 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 473' ' ' LYS . 24.0 mt -91.67 112.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.114 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.35 -31.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -153.4 131.81 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.769 HG22 HG13 ' A' ' 500' ' ' VAL . 41.2 t -118.24 151.66 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.7 157.57 46.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.61 -17.31 46.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.95 -66.48 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.514 ' CG ' ' HD3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -127.42 174.79 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.769 HG13 HG22 ' A' ' 495' ' ' VAL . 26.1 t -119.85 127.57 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 108.57 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -109.97 141.65 42.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -86.5 135.28 33.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.7 t -91.71 142.9 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.45 -5.4 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 44.5 mt -90.81 -73.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.2 p -82.35 7.57 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.8 mmm 44.13 30.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -111.63 159.24 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -82.78 117.67 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.38 153.7 19.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.514 ' HD3' ' CG ' ' A' ' 499' ' ' PHE . 6.1 tmmm? -123.77 124.52 42.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.0 143.65 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.123 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.3 mt -69.57 156.01 92.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -0.34 6.79 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.713 2.276 . . . . 0.0 112.319 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -97.25 -15.52 20.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -115.8 34.51 4.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.9 mt -134.26 157.52 46.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -145.44 129.17 17.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 520' ' ' LEU . 11.1 mt -68.95 153.78 43.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.75 -50.4 1.96 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 6.9 t -107.49 45.33 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 80.7 p -83.52 -37.38 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.4 m 46.13 45.73 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -172.17 -55.9 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.536 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 83.4 p -92.34 128.04 38.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 110.825 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 1.5 t -163.9 158.05 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 111.15 -178.78 19.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.2 161.0 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -127.34 144.58 51.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.678 0.752 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.96 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.299 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -93.07 81.04 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.06 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.69 134.09 40.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -104.08 58.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 30.6 mt -100.11 56.38 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -108.84 146.82 33.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.524 ' O ' ' CE1' ' A' ' 472' ' ' PHE . 0.1 OUTLIER -105.98 -20.66 13.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -54.52 128.07 30.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 470' ' ' LYS . 1.3 m-30 -85.29 113.84 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 492' ' ' ILE . 0.7 OUTLIER -112.83 -178.17 3.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.4 ttt -74.18 156.73 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 76.53 -9.63 21.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' ASP . . . . . 0.424 ' C ' HD23 ' A' ' 491' ' ' LEU . 86.5 m-20 -93.51 148.39 22.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -95.8 113.51 25.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.829 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 492' ' ' ILE . 10.8 m -106.36 161.39 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -121.78 141.55 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 19.4 t -89.49 116.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ILE . . . . . 0.634 HG21 ' OE1' ' A' ' 519' ' ' GLN . 24.6 pt -100.55 -30.37 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 481' ' ' ILE . . . -139.96 171.0 14.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.56 -157.17 15.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.533 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -87.92 -9.89 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.759 ' CE1' HD22 ' A' ' 511' ' ' LEU . 52.3 m-85 -119.23 38.74 3.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -60.19 137.73 58.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.31 -20.22 27.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.61 160.19 21.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -143.57 165.43 27.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.82 -178.83 48.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 476' ' ' ASP . 10.2 mt -99.37 160.98 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 473' ' ' LYS . 6.1 mt -94.51 105.01 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.89 -28.11 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -153.34 141.98 20.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.874 HG22 HG13 ' A' ' 500' ' ' VAL . 60.5 t -126.23 139.24 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -126.46 146.53 50.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -49.11 -29.08 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -85.31 -60.25 2.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -136.49 178.06 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.874 HG13 HG22 ' A' ' 495' ' ' VAL . 39.8 t -119.79 132.52 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.1 mm -97.09 110.94 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -112.72 137.55 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -84.25 135.62 34.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -91.36 142.3 27.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.66 -10.5 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.12 -48.49 4.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 9.0 p -92.96 -3.57 54.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 44.6 mmm 42.55 34.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -123.29 164.43 18.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -85.28 104.03 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.759 HD22 ' CE1' ' A' ' 485' ' ' PHE . 88.2 mt -87.91 143.26 27.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -114.89 113.37 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.29 139.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 499' ' ' PHE . 83.8 mt -61.89 153.69 71.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.584 0.707 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 2.1 3.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.631 2.221 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -97.46 -4.65 37.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -118.27 1.27 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 472' ' ' PHE . 20.1 mt -113.98 152.84 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.634 ' OE1' HG21 ' A' ' 481' ' ' ILE . 9.4 pt20 -143.97 132.28 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.38 153.46 18.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.9 t -92.41 103.57 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 16.6 m 57.2 53.0 8.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 523' ' ' GLU . 1.1 pm0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 37.8 m -110.96 -60.07 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.0 t -67.53 96.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.824 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 80.07 -137.6 18.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.477 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 3.2 t -119.42 163.7 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.896 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 27.1 m -78.91 -62.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -151.34 153.38 24.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.501 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -56.31 -49.53 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -101.99 144.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 158.78 55.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -80.11 99.6 7.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -92.89 -59.76 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -120.48 131.04 54.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.0 168.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -84.78 82.76 8.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.19 102.43 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 471' ' ' TYR . 11.4 p90 -143.19 141.88 31.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.8 m-30 -79.13 121.02 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -136.34 153.53 51.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 19.4 ttp -51.26 125.58 14.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.52 -29.61 7.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -84.77 158.92 20.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -102.69 131.77 49.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.426 HG12 HD23 ' A' ' 520' ' ' LEU . 14.8 m -123.45 159.39 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -125.04 136.5 53.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.719 HG22 ' CD2' ' A' ' 518' ' ' LEU . 29.9 t -86.24 114.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 33.2 pt -97.97 -24.72 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.45 -179.42 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.93 -160.59 21.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -86.13 -7.76 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.542 ' CE2' HD22 ' A' ' 511' ' ' LEU . 69.3 m-85 -119.15 35.83 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -57.66 138.6 55.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 84.02 -13.92 46.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -87.98 151.58 22.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 24.3 p -139.6 162.27 35.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.82 178.39 48.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.42 161.26 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -90.26 117.91 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -107.61 -31.65 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -149.18 137.79 21.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 500' ' ' VAL . 1.8 t -122.53 138.34 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.677 ' OE2' HD11 ' A' ' 501' ' ' ILE . 11.8 mt-10 -126.42 148.82 49.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -54.63 -21.09 9.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' ASN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 499' ' ' PHE . 4.2 t-20 -94.14 -53.7 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.701 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -142.36 172.0 13.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 495' ' ' VAL . 18.6 t -116.75 125.34 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ILE . . . . . 0.677 HD11 ' OE2' ' A' ' 496' ' ' GLU . 9.1 mm -90.85 119.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.54 140.53 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -85.58 132.03 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 13.4 t -85.95 154.82 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.92 -26.29 14.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.1 mt -86.85 -54.25 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 38.7 p -80.16 -7.23 58.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.7 mtm 45.55 36.94 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 507' ' ' THR . 17.9 m-70 -135.67 163.58 29.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.21 125.73 32.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.542 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -109.92 133.99 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 49.6 tttt -101.68 111.65 23.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.79 143.41 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 499' ' ' PHE . 96.0 mt -63.6 153.22 83.95 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.643 0.735 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -0.89 7.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -91.18 -11.2 39.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -112.21 1.94 16.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 480' ' ' VAL . 44.0 mt -116.45 159.58 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -151.96 133.79 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 478' ' ' VAL . 15.6 mt -59.53 160.55 6.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.5 t -105.97 94.17 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 11.6 m 61.04 50.8 4.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t 59.44 40.98 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.858 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 18.1 t -135.76 164.22 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -58.91 146.27 42.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 32.3 m -113.87 121.09 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 3.5 m -61.24 130.87 48.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 67.99 158.07 1.06 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -127.96 -55.64 1.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.46 145.96 85.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.638 0.732 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 94.22 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.633 2.222 . . . . 0.0 112.408 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -103.46 179.03 4.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.061 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -133.56 153.51 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.03 140.71 50.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.5 40.75 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.45 83.24 3.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -137.03 116.33 12.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 -60.01 102.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.51 ' O ' HD12 ' A' ' 492' ' ' ILE . 97.2 mttt -121.0 149.33 42.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 13.7 ttp -42.47 140.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 491' ' ' LEU . . . 96.05 -49.52 1.74 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.78 152.05 37.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.46 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.5 t-80 -94.7 130.09 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.45 HG23 HD13 ' A' ' 502' ' ' LEU . 3.6 m -124.54 158.14 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.37 148.45 50.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.07 121.6 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -103.8 -23.64 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.39 -177.89 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.04 -152.5 19.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -89.9 -5.52 56.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.41 ' CE2' HD22 ' A' ' 511' ' ' LEU . 32.1 m-85 -128.08 37.82 4.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.96 136.78 57.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.84 17.01 71.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.4 172.87 6.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 72.1 p -151.44 160.6 43.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 177.33 177.27 46.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 475' ' ' GLY . 11.0 mt -102.58 154.44 19.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 473' ' ' LYS . 39.7 mt -82.93 119.68 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.24 -26.34 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -160.56 120.83 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 500' ' ' VAL . 11.5 t -109.57 146.42 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -132.31 150.96 52.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.52 -27.03 23.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -85.35 -59.64 2.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.576 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -139.55 174.13 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.873 HG22 HG13 ' A' ' 495' ' ' VAL . 36.6 t -113.82 134.33 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ILE . . . . . 0.417 HD13 ' C ' ' A' ' 500' ' ' VAL . 4.7 mm -103.79 111.42 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.5 pt? -114.51 138.99 49.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -79.74 132.08 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -90.02 152.06 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.21 -20.89 17.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.08 -49.44 6.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 508' ' ' MET . 76.9 p -89.3 2.72 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 507' ' ' THR . 14.0 mtp 36.3 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.94 171.74 12.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.56 117.22 28.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -101.03 127.33 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.501 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 18.3 ttpt -101.55 117.07 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.7 t -139.65 157.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.18 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.4 mt -77.42 153.88 81.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.615 0.721 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 0.86 5.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.257 . . . . 0.0 112.338 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -95.15 -12.41 26.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.75 13.04 16.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.55 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 92.9 mt -115.56 162.35 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.401 ' HG2' ' C ' ' A' ' 518' ' ' LEU . 12.9 mm-40 -152.07 137.74 17.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 520' ' ' LEU . 12.9 mt -76.04 155.25 35.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 13.4 t -116.13 -27.91 6.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 2.3 m -124.62 40.54 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.922 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.3 t -91.77 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 m -97.04 175.86 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 60.58 147.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.4 m -111.62 -58.51 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 20.8 p -84.04 135.7 34.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -177.9 152.52 11.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -92.07 104.12 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.868 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -121.61 77.8 37.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.637 0.732 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 100.77 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -102.41 89.28 3.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -60.42 150.94 29.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.37 157.94 16.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.26 163.79 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.945 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' A' ' 469' ' ' ARG . 11.7 ttm105 -137.79 140.59 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 469' ' ' ARG . 11.3 mptt -38.03 103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -154.26 136.49 14.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.3 m-30 -62.16 98.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 474' ' ' MET . 44.2 pttt -123.48 141.17 52.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 473' ' ' LYS . 13.6 ttt -34.61 128.92 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 107.04 -49.58 0.86 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' ASP . . . . . 0.451 ' HB2' HD12 ' A' ' 492' ' ' ILE . 0.9 OUTLIER -62.79 154.03 31.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.555 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.9 t-160 -94.93 137.49 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 520' ' ' LEU . 19.8 m -133.02 156.29 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.159 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 480' ' ' VAL . 21.8 tttt -128.37 148.39 50.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.714 HG22 ' CD2' ' A' ' 518' ' ' LEU . 36.1 t -95.27 111.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.8 pt -94.53 -25.09 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.71 178.21 7.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.96 -154.48 19.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -86.33 -28.62 23.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 511' ' ' LEU . 6.0 m-85 -100.55 34.5 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.05 137.27 46.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.9 -21.15 24.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.34 158.29 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 27.8 p -145.34 159.82 42.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.62 178.8 43.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.3 mt -97.08 155.17 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.465 HD11 HG13 ' A' ' 478' ' ' VAL . 24.5 mt -81.82 111.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 503' ' ' PHE . 4.4 m -101.01 -25.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -155.83 150.22 25.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 500' ' ' VAL . 2.4 t -131.9 137.8 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.87 140.59 49.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.66 -29.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -83.7 -64.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.648 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -137.47 173.61 11.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 495' ' ' VAL . 26.2 t -114.41 140.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.8 mm -105.01 118.95 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -116.79 137.37 52.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' PHE . . . . . 0.429 ' HB2' HG11 ' A' ' 493' ' ' VAL . 54.6 t80 -84.25 129.69 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.6 t -85.53 152.81 22.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.41 -21.41 17.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 68.0 mt -90.49 -52.89 4.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 22.8 p -82.41 -9.0 59.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.6 mtt 46.24 41.09 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -136.25 167.97 20.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.96 113.88 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.848 HD22 ' CE2' ' A' ' 485' ' ' PHE . 85.7 mt -96.99 131.85 43.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 9.3 tttm -105.37 108.34 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 513' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 514' ' ' LEU . 39.8 t -133.76 154.08 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 499' ' ' PHE . 78.3 mt -71.82 155.26 92.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.33 15.93 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.232 . . . . 0.0 112.378 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.95 -26.99 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.57 18.33 16.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.714 ' CD2' HG22 ' A' ' 480' ' ' VAL . 48.8 mt -132.8 155.23 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -140.42 138.57 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 478' ' ' VAL . 9.3 mt -59.06 159.95 6.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 521' ' ' CYS . . . . . 0.413 ' CB ' ' ND1' ' A' ' 477' ' ' HIS . 3.8 m -134.23 -42.41 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 21.9 t -119.58 56.84 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 22.8 t -47.67 -46.49 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.828 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 458' ' ' GLY . 16.3 m 40.35 41.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 457' ' ' SER . . . -34.49 127.91 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.6 m -146.14 175.69 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 15.0 m -120.45 173.38 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.34 -134.24 7.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.459 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -73.42 144.02 46.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.95 144.0 45.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.71 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.47 16.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -115.21 140.99 48.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -100.68 -36.48 9.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.12 123.05 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.4 mt -54.26 168.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -109.84 142.41 41.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.18 51.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -114.17 138.62 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.0 m-30 -61.63 109.15 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -120.64 144.57 48.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 9.0 mtm -45.86 143.09 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.79 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.31 160.58 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -104.66 133.01 50.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 492' ' ' ILE . 27.6 m -126.05 159.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.459 ' HG3' HG22 ' A' ' 489' ' ' THR . 51.4 tttt -120.23 149.94 41.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.452 HG22 ' CD2' ' A' ' 518' ' ' LEU . 25.5 t -95.12 123.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.128 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ILE . . . . . 0.5 HG21 ' OE1' ' A' ' 519' ' ' GLN . 15.6 pt -103.54 -26.57 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.75 -175.65 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.74 -153.9 20.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -89.15 -3.89 58.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.36 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.65 33.47 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -56.95 108.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.13 -13.17 16.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 480' ' ' VAL . 1.0 OUTLIER -91.52 157.48 17.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.459 HG22 ' HG3' ' A' ' 479' ' ' LYS . 30.6 p -138.03 164.44 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.12 175.53 47.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 mt -92.2 165.58 13.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 478' ' ' VAL . 46.8 mt -97.67 113.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 9.5 m -103.37 -33.4 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -148.62 148.55 30.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.533 HG22 HG13 ' A' ' 500' ' ' VAL . 15.9 t -133.46 140.93 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -129.52 145.9 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -48.46 -33.4 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.94 -60.48 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.707 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -137.86 -179.0 5.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 495' ' ' VAL . 6.1 t -118.62 144.25 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.68 110.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -110.07 137.18 48.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -82.75 131.11 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 146.51 26.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -98.5 -22.43 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 66.6 mt -81.64 -59.57 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 56.4 p -84.04 -2.23 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 42.6 mtt 48.23 36.82 7.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.27 172.22 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -92.19 123.38 35.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 13.8 mt -104.5 135.24 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.6 tttt -113.4 112.18 23.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 514' ' ' LEU . 2.8 t -141.63 162.2 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 499' ' ' PHE . 97.0 mt -75.34 152.15 85.74 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.611 0.72 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -2.0 9.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -89.07 -28.4 20.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.9 15.05 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.452 ' CD2' HG22 ' A' ' 480' ' ' VAL . 50.8 mt -125.33 169.07 12.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.5 ' OE1' HG21 ' A' ' 481' ' ' ILE . 17.2 pt20 -163.52 134.23 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.85 155.5 16.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.8 t -105.06 -41.9 5.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 11.6 t -130.15 92.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 24.9 m -141.59 150.94 42.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 56.7 p -45.87 166.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.87 -57.22 0.48 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.4 t -60.64 131.61 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 6.4 p 45.36 42.11 7.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -115.17 -39.09 0.97 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.83 -42.12 41.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.901 0.382 . . . . 0.0 110.89 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.31 80.74 1.18 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.655 0.741 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 110.69 2.6 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.382 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -79.53 126.18 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.46 80.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.7 89.52 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.567 HD12 ' H ' ' A' ' 468' ' ' LEU . 5.3 mp -65.3 146.57 54.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -100.9 157.68 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -78.62 83.16 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -133.57 145.09 49.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -72.16 98.64 2.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 474' ' ' MET . 58.9 mttm -117.63 137.82 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.418 ' C ' ' O ' ' A' ' 473' ' ' LYS . 28.4 ttm -36.81 133.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.95 -45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 492' ' ' ILE . 39.5 m-20 -67.31 155.45 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.473 ' HA ' HD23 ' A' ' 491' ' ' LEU . 9.4 t-80 -94.78 124.97 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.622 HG13 HD11 ' A' ' 492' ' ' ILE . 4.7 m -117.27 162.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.617 ' HG3' HG22 ' A' ' 489' ' ' THR . 61.8 tttt -135.0 149.33 50.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 488' ' ' ASP . 6.3 t -93.02 124.81 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 519' ' ' GLN . 35.4 pt -103.29 -27.35 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.89 -177.16 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.94 -151.31 19.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -88.4 -24.08 23.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 39.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.28 119.67 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 103.08 -13.39 55.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -88.62 155.07 19.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.868 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.617 HG22 ' HG3' ' A' ' 479' ' ' LYS . 33.0 p -135.98 170.95 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 176.12 174.89 43.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.6 mt -96.7 151.71 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.3 . . . . 0.0 110.976 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.622 HD11 HG13 ' A' ' 478' ' ' VAL . 25.2 mt -80.77 106.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 m -97.45 -33.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -147.63 146.73 29.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 500' ' ' VAL . 1.2 t -131.08 151.5 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -145.94 145.89 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -49.23 -30.43 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -82.27 -65.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.663 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -133.87 171.25 14.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 495' ' ' VAL . 9.4 t -113.98 134.38 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 20.5 mm -100.26 132.12 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.5 pt? -133.94 146.27 50.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -91.6 129.76 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 511' ' ' LEU . 1.3 t -91.83 127.91 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.58 -18.31 61.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.4 -61.36 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 18.3 p -82.74 -5.03 58.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 36.7 mtm 47.3 39.93 9.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -136.14 170.85 15.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -87.54 114.99 24.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 504' ' ' SER . 38.1 mt -95.84 142.79 27.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.42 ' NZ ' ' CZ ' ' A' ' 499' ' ' PHE . 5.8 tttp -112.58 118.31 34.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' VAL . . . . . 0.432 ' HB ' HD21 ' A' ' 518' ' ' LEU . 11.5 t -148.12 143.11 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 499' ' ' PHE . 79.6 mt -66.77 155.1 90.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -1.18 8.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 22.0 ptt85 -93.22 -7.46 45.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.14 5.16 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.432 HD21 ' HB ' ' A' ' 513' ' ' VAL . 46.0 mt -112.75 159.41 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' A' ' 481' ' ' ILE . 15.5 pt20 -152.88 131.02 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.51 HD13 ' HG3' ' A' ' 523' ' ' GLU . 9.1 mt -58.16 166.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.58 114.79 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 8.0 t 71.94 53.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.51 ' HG3' HD13 ' A' ' 520' ' ' LEU . 63.7 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.6 t -90.52 163.1 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 69.0 m -137.62 150.04 47.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 112.94 145.26 9.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 79.3 p -151.13 166.73 29.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 54.9 p -79.81 146.88 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 128.13 116.27 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -66.49 147.1 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -127.69 80.69 71.56 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 160.62 49.04 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.364 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -114.37 -44.4 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.87 142.41 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.35 157.39 20.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.78 179.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.42 123.43 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -111.18 82.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -140.16 126.02 19.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 4.8 m-85 -59.3 100.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 492' ' ' ILE . 6.6 mmmt -115.98 148.31 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -45.16 137.67 4.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 97.95 -39.41 2.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.42 156.52 38.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.478 ' HA ' HD23 ' A' ' 491' ' ' LEU . 34.8 t-80 -97.68 129.85 44.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 502' ' ' LEU . 30.0 m -119.44 158.86 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -126.65 152.14 47.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 50.5 t -100.38 117.29 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.85 -23.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -141.86 -179.65 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.82 -159.05 21.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -81.63 -21.02 38.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.489 ' CE2' HD22 ' A' ' 511' ' ' LEU . 26.8 m-85 -111.64 40.21 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.8 108.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.96 -24.53 8.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.75 155.14 41.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 61.0 p -143.43 148.39 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -165.25 -173.83 34.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.451 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.4 mt -102.06 159.47 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 473' ' ' LYS . 54.8 mt -87.06 124.97 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.93 -35.1 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -151.4 117.14 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 500' ' ' VAL . 1.7 p -113.59 131.44 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.15 -20.83 66.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -95.62 -65.57 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.566 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -124.2 173.16 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 495' ' ' VAL . 26.3 t -117.49 137.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 8.6 mm -106.73 120.5 58.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.0 pt? -119.03 140.19 50.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 508' ' ' MET . 83.4 t80 -78.95 129.55 34.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 24.0 t -83.33 138.43 33.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.44 2.31 55.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.01 -67.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 508' ' ' MET . 16.2 p -108.58 29.11 7.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 503' ' ' PHE . 0.4 OUTLIER 34.52 49.61 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -116.55 159.0 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -94.24 116.26 28.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 485' ' ' PHE . 83.1 mt -99.29 138.76 35.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.566 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 6.5 tmtt? -114.9 110.32 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.45 145.1 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.534 HD23 ' HB3' ' A' ' 499' ' ' PHE . 91.2 mt -62.25 152.9 77.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.34 30.57 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -19.48 53.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -112.32 21.18 16.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 25.8 mt -120.78 162.19 20.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -149.9 142.09 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.5 mt -75.91 155.96 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 34.5 t -128.5 -42.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 523' ' ' GLU . 68.7 m -61.87 -45.85 91.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.482 ' CD ' ' C ' ' A' ' 523' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 93.3 p -52.11 141.68 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 39.0 m -90.15 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -85.08 94.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.462 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 75.6 m -91.11 -49.87 6.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 110.86 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -114.06 82.21 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 165.07 -149.21 15.5 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.4 134.4 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.06 80.48 1.07 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 111.68 2.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.24 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -99.05 177.23 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -38.84 106.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 467' ' ' GLU . 3.5 mp0 -57.93 134.36 56.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 9.0 mt -102.41 90.43 3.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 -86.25 50.9 2.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -113.95 84.29 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.795 ' O ' HD11 ' A' ' 520' ' ' LEU . 0.3 OUTLIER -118.24 155.83 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 -108.23 99.75 9.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -120.46 138.73 53.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.55 ' HA ' HG22 ' A' ' 492' ' ' ILE . 2.6 ttp -38.33 132.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 109.35 -34.74 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' ASP . . . . . 0.529 ' HB2' HD12 ' A' ' 492' ' ' ILE . 10.3 m-20 -79.92 163.16 24.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 110.843 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' HIS . . . . . 0.423 ' HA ' HD23 ' A' ' 491' ' ' LEU . 45.6 t60 -100.36 121.92 42.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.764 HG13 HD11 ' A' ' 492' ' ' ILE . 14.4 m -114.71 148.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -124.11 143.32 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 488' ' ' ASP . 24.7 t -93.88 124.05 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.9 pt -107.13 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 517' ' ' ASP . . . -140.29 -176.94 4.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.58 -159.39 25.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.17 -10.55 54.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.55 32.08 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -56.39 125.11 20.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.03 64.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.3 t70 -99.82 129.96 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 67.1 p -124.78 146.63 49.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -168.7 -170.26 33.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.7 mt -104.49 158.95 16.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.764 HD11 HG13 ' A' ' 478' ' ' VAL . 45.3 mt -89.29 121.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.37 -35.55 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -144.27 121.44 11.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 500' ' ' VAL . 3.0 t -112.12 126.96 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.47 157.15 21.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.78 -36.82 77.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.63 -59.15 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.716 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.7 OUTLIER -136.56 176.7 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 495' ' ' VAL . 14.9 t -115.01 140.03 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.6 mm -109.0 109.68 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.679 HD13 HG23 ' A' ' 478' ' ' VAL . 2.4 pt? -109.26 137.16 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 503' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 504' ' ' SER . 65.1 t80 -79.69 132.37 36.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 504' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 503' ' ' PHE . 1.4 t -84.9 149.0 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.76 -31.6 10.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.7 -44.63 18.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 2.7 p -90.34 -10.01 45.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 29.1 mtt 51.96 36.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -137.08 159.88 40.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -80.84 128.9 34.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 30.6 mt -116.47 135.06 54.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.4 tmtt? -103.63 129.12 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.0 t -149.47 161.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 499' ' ' PHE . 95.1 mt -81.07 154.02 72.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.607 0.717 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 2.28 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -95.57 -25.64 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.816 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' ASP . . . . . 0.812 ' OD1' ' HB3' ' A' ' 482' ' ' ALA . 31.7 m-20 -105.0 22.69 14.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 72.1 mt -121.78 150.79 41.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -141.95 126.42 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.795 HD11 ' O ' ' A' ' 471' ' ' TYR . 12.6 mt -62.27 151.8 35.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.0 t -120.27 106.26 11.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 9.5 t 70.17 31.24 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.916 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 45.6 t -99.1 -45.85 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.813 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.3 m -94.08 148.56 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -167.02 -62.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.0 t -58.18 133.21 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 50.6 m -43.11 155.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 165.48 132.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -65.37 103.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 0.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -81.88 144.04 51.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.31 6.28 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -114.57 -46.24 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.07 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -39.56 114.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.6 149.36 39.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.69 163.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -81.56 177.89 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -109.8 50.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -127.56 127.78 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 1.6 m-85 -52.71 98.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 474' ' ' MET . 41.4 mttp -120.9 139.67 52.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 473' ' ' LYS . 18.1 ttt -34.65 132.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 102.33 -40.7 2.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' ASP . . . . . 0.626 ' HB2' HD12 ' A' ' 492' ' ' ILE . 7.8 m-20 -70.83 157.28 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -101.94 136.76 41.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.887 HG12 HD23 ' A' ' 520' ' ' LEU . 3.8 m -139.03 159.42 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 489' ' ' THR . 3.1 ttpm? -123.19 159.36 28.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 488' ' ' ASP . 48.0 t -104.39 121.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 20.3 pt -101.73 -23.43 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.79 171.29 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.29 -166.03 15.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -76.52 -7.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 511' ' ' LEU . 12.9 m-85 -124.7 42.19 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -55.54 135.03 51.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 72.78 10.63 77.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 480' ' ' VAL . 19.9 t0 -95.99 125.03 40.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 479' ' ' LYS . 18.9 p -109.79 155.55 21.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.23 174.62 47.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.76 153.08 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 476' ' ' ASP . 14.5 mt -83.41 118.84 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.5 m -111.23 -31.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -146.16 141.02 27.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.85 HG13 HG22 ' A' ' 500' ' ' VAL . 15.9 t -129.39 128.67 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -124.75 148.45 48.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -52.22 -24.62 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -87.75 -61.73 1.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -140.09 169.11 18.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 495' ' ' VAL . 62.6 t -114.24 134.77 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.28 119.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -115.63 139.54 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.74 125.77 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 6.1 t -86.01 153.1 22.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.25 -32.37 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.24 -56.08 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 81.7 p -80.73 -8.41 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.4 mtt 49.56 31.07 3.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -130.02 172.4 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.6 124.24 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 485' ' ' PHE . 29.3 mt -104.1 133.7 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 16.5 tttm -103.0 114.96 29.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 23.0 t -140.15 151.81 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.4 mt -72.04 155.16 92.13 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.609 0.719 . . . . 0.0 110.86 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.24 4.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.334 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -34.05 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 22.34 7.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.484 ' CD2' HG22 ' A' ' 480' ' ' VAL . 23.9 mt -122.64 149.27 44.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -138.48 135.51 35.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 478' ' ' VAL . 9.8 mt -69.07 159.72 32.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.38 -33.94 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 19.4 t -157.67 113.78 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 41.2 t -90.26 -49.27 6.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.355 . . . . 0.0 110.829 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.1 t -63.57 -56.67 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 40.58 59.01 2.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.4 m -59.77 -51.8 68.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.901 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 30.3 m -155.49 164.42 38.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 156.7 66.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.71 146.35 24.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 463' ' ' PHE . 0.1 OUTLIER -134.09 65.38 69.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.697 0.76 . . . . 0.0 110.895 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 96.11 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.363 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -88.77 114.86 25.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -81.43 -45.26 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -86.89 158.3 19.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 469' ' ' ARG . 26.9 mt -133.81 110.77 10.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 468' ' ' LEU . 0.0 OUTLIER -36.89 139.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -99.32 88.0 3.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.68 ' O ' HD11 ' A' ' 520' ' ' LEU . 18.8 m-85 -93.5 159.82 15.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 -115.8 98.84 6.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -111.79 153.75 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.9 ttt -52.41 138.25 27.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 99.8 -26.72 23.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.83 147.99 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -92.54 144.32 25.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 520' ' ' LEU . 34.0 m -140.67 166.61 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.87 ' HD3' HG22 ' A' ' 489' ' ' THR . 6.9 tptm -130.72 131.58 44.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.471 HG22 ' CD2' ' A' ' 518' ' ' LEU . 24.8 t -80.88 108.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 -26.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 517' ' ' ASP . . . -130.68 176.36 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.64 -164.06 25.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -84.68 -19.21 33.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 511' ' ' LEU . 31.2 m-85 -105.97 41.28 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.31 133.92 46.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.05 55.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.03 137.99 53.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.87 HG22 ' HD3' ' A' ' 479' ' ' LYS . 7.1 p -117.73 152.19 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.19 176.84 47.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.56 165.54 12.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 71.5 mt -94.31 113.31 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.57 -33.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -142.14 150.06 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.773 HG13 HG22 ' A' ' 500' ' ' VAL . 11.4 t -138.5 128.87 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -126.35 143.61 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -48.89 -22.42 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.02 -57.87 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.548 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -142.7 169.75 17.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.773 HG22 HG13 ' A' ' 495' ' ' VAL . 50.1 t -116.36 133.43 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.9 mm -100.04 117.5 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.1 pt? -114.95 138.25 51.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.3 125.57 32.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 20.8 t -83.57 130.86 35.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.14 -11.7 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 92.9 mt -98.0 -57.24 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 508' ' ' MET . 73.3 p -84.05 2.02 41.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 507' ' ' THR . 35.6 mmm 36.64 49.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -140.86 166.36 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -91.98 115.18 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 485' ' ' PHE . 60.1 mt -99.95 137.55 38.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.548 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.7 tttt -109.08 110.43 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 5.6 t -136.4 150.76 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.7 mt -70.86 154.54 94.21 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.586 0.707 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -2.24 9.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -95.4 -9.73 31.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 482' ' ' ALA . 4.0 m-20 -121.29 38.39 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.527 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 71.2 mt -143.5 155.5 44.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -140.27 132.34 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 471' ' ' TYR . 12.2 mt -63.9 148.05 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 521' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 522' ' ' SER . 1.4 p -74.53 -44.32 51.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 522' ' ' SER . . . . . 0.49 ' N ' ' SG ' ' A' ' 521' ' ' CYS . 38.8 m -134.39 86.5 2.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 55.1 p -138.66 153.57 48.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.2 t -166.17 142.47 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -125.04 -84.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.486 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 11.1 t -62.54 142.3 58.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 4.1 m -148.38 154.74 40.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 141.04 -175.1 22.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -105.88 92.37 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 0.0 110.864 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.05 150.76 63.97 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -25.13 28.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.46 139.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -70.78 134.24 47.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -80.31 137.45 36.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 468' ' ' LEU . 4.6 mp -104.26 96.96 6.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 471' ' ' TYR . 53.1 mtt-85 -99.75 131.91 45.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.58 90.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 469' ' ' ARG . 22.0 m-85 -134.78 137.22 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.1 m-30 -69.36 100.9 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 492' ' ' ILE . 57.1 mttm -121.61 155.15 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -52.52 134.86 34.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 98.38 -25.81 26.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.71 148.22 25.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -88.21 142.08 28.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' A' ' 492' ' ' ILE . 10.9 m -136.94 157.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 1.9 ttmp? -121.91 147.8 45.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.479 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 48.1 t -97.88 99.13 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 22.4 pt -87.56 -18.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -134.94 170.98 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.74 -158.04 20.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -89.98 -16.96 28.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.84 39.26 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.54 109.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.89 -13.86 14.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.63 137.86 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -118.29 165.77 13.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.166 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.63 176.71 48.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.48 156.08 16.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 473' ' ' LYS . 59.8 mt -86.23 114.1 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.46 -33.89 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -142.61 144.04 32.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 500' ' ' VAL . 21.3 t -130.15 120.63 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.28 149.86 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.79 -30.75 46.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -80.6 -59.37 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -141.15 173.53 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 495' ' ' VAL . 44.9 t -116.17 134.09 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 mm -99.66 121.83 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -119.75 137.91 53.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -82.48 124.79 30.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 3.0 t -82.0 154.97 25.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -101.78 -9.34 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 35.9 mt -99.19 -55.19 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 508' ' ' MET . 81.1 p -84.87 4.05 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 507' ' ' THR . 3.4 mtt 35.1 54.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -149.3 177.85 9.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -98.53 115.84 29.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 18.2 mt -104.55 139.89 38.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' LYS . . . . . 0.532 ' CG ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -108.12 118.11 35.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.35 146.72 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 499' ' ' PHE . 80.7 mt -68.4 153.24 95.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -1.61 8.78 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.54 -11.13 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.62 23.57 12.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.475 ' CD2' HG22 ' A' ' 480' ' ' VAL . 88.8 mt -131.69 153.09 50.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 520' ' ' LEU . 2.7 pp0? -145.39 127.94 16.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' LEU . . . . . 0.442 ' O ' ' NE2' ' A' ' 519' ' ' GLN . 13.1 mt -62.87 154.85 28.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 46.6 t -113.28 -30.03 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 22.8 m -117.91 45.3 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 492' ' ' ILE . 26.6 mttm -114.45 159.55 20.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.1 146.54 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 89.0 -17.57 50.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -92.19 152.32 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.413 ' O ' HD23 ' A' ' 520' ' ' LEU . 43.9 t-80 -92.98 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.74 151.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 489' ' ' THR . 30.2 tttm -114.69 159.73 20.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 518' ' ' LEU . 41.8 t -106.23 111.06 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . 0.665 HG21 ' OE1' ' A' ' 519' ' ' GLN . 28.5 pt -92.99 -30.39 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.0 -179.32 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.35 -167.04 23.37 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.41 4.23 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -129.19 25.61 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.51 112.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.39 24.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.494 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.53 153.03 25.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 479' ' ' LYS . 32.6 p -137.5 164.06 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . 177.78 -173.93 46.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.5 162.51 12.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 473' ' ' LYS . 56.2 mt -93.46 114.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.3 m -104.88 -28.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -146.44 142.37 28.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.54 142.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.71 159.47 41.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.58 -18.63 65.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.85 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.905 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.4 p90 -135.2 179.71 6.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.94 129.1 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.5 mm -94.56 118.81 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.62 137.02 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -82.87 121.5 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 4.9 t -78.46 151.91 32.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.79 -12.79 17.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.6 mt -90.7 -54.94 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 23.6 p -85.39 -11.91 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.4 mtm 58.28 37.87 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -132.53 -178.01 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . 0.411 ' N ' ' OE1' ' A' ' 510' ' ' GLU . 31.9 mp0 -102.28 117.9 35.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.24 135.26 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 499' ' ' PHE . 66.5 tttt -107.91 111.7 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 514' ' ' LEU . 21.2 t -142.72 161.22 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 499' ' ' PHE . 72.8 mt -82.41 151.48 65.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -5.17 15.53 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -86.75 -12.98 46.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -115.63 9.13 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.468 ' CD2' HG22 ' A' ' 480' ' ' VAL . 87.2 mt -115.13 167.98 10.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.665 ' OE1' HG21 ' A' ' 481' ' ' ILE . 13.4 pt20 -158.45 130.03 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 477' ' ' HIS . 14.6 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.445 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 8.7 m-30 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.29 159.16 29.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -60.34 121.15 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 116.5 -11.43 16.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' A' ' 520' ' ' LEU . 9.8 m-20 -98.83 150.85 21.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 520' ' ' LEU . 10.0 t-80 -85.1 131.5 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.85 154.45 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.42 157.62 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.69 125.44 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -108.54 -31.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.18 170.92 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.12 -153.8 17.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -89.94 -22.1 22.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 511' ' ' LEU . 86.1 m-85 -105.32 39.41 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 123.98 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 97.6 22.19 17.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 489' ' ' THR . 9.6 t70 -118.66 170.93 8.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.471 ' N ' ' OD1' ' A' ' 488' ' ' ASP . 40.8 p -149.34 157.12 43.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.73 -179.76 48.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.26 154.01 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.51 110.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.78 -34.6 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -143.37 120.76 11.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.5 117.21 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -103.96 161.42 13.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.97 -28.2 69.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -88.43 -66.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -123.36 179.62 4.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.422 ' C ' HD13 ' A' ' 501' ' ' ILE . 48.8 t -125.69 129.81 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.139 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 501' ' ' ILE . 3.0 mm -97.95 111.14 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -111.66 137.25 49.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -81.7 138.7 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 18.1 t -91.43 147.31 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.18 -18.72 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.26 -54.32 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 42.8 p -81.74 -13.94 57.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.0 mtm 52.8 47.54 24.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -138.76 171.87 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -99.8 109.88 22.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 485' ' ' PHE . 24.2 mt -98.74 132.74 43.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.542 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 2.4 ttpm? -97.74 117.85 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.75 140.65 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 499' ' ' PHE . 48.7 mt -64.55 152.1 90.27 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 2.78 3.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -98.98 -4.36 32.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 518' ' ' LEU . 59.7 m-20 -121.78 17.93 11.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 517' ' ' ASP . 41.4 mt -123.31 163.13 21.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -153.61 127.12 8.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 477' ' ' HIS . 9.9 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.925 0.393 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -109.81 146.46 34.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.4 ttp -42.26 133.66 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 106.91 -41.16 2.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.439 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.45 159.97 32.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -98.99 144.11 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.548 HG23 HD13 ' A' ' 502' ' ' LEU . 26.5 m -139.39 146.8 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.48 ' HB2' HG22 ' A' ' 489' ' ' THR . 19.8 tttp -117.56 152.65 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 485' ' ' PHE . 3.2 t -95.14 131.81 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . 0.54 HG21 ' HG3' ' A' ' 519' ' ' GLN . 21.6 pt -116.82 -19.55 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.27 -176.92 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 90.94 -166.31 31.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.426 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -80.46 -6.04 57.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.409 ' O ' HG11 ' A' ' 480' ' ' VAL . 24.6 m-85 -122.96 44.05 2.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -71.89 112.3 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.32 7.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.05 168.45 9.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 479' ' ' LYS . 33.4 p -151.55 151.14 31.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -174.54 178.42 46.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.64 158.71 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 36.1 mt -86.07 115.98 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.22 -24.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -150.41 133.75 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.898 HG13 HG22 ' A' ' 500' ' ' VAL . 7.3 t -124.78 130.8 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -125.52 155.97 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.96 -16.67 32.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -97.81 -61.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -138.61 164.97 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.898 HG22 HG13 ' A' ' 495' ' ' VAL . 60.1 t -113.25 123.97 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.1 mm -89.65 117.9 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -114.12 143.33 44.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -83.85 131.6 34.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.5 t -101.3 141.7 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.74 -24.76 19.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.89 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 30.6 mt -71.27 -52.86 16.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 62.8 p -91.29 -17.65 25.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 9.5 mtt 63.96 40.61 7.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -143.7 171.87 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -92.49 126.71 37.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 58.2 mt -111.2 133.46 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 0.8 OUTLIER -99.73 114.66 27.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.58 146.03 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' ' 499' ' ' PHE . 84.4 mt -65.62 151.31 94.86 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -1.96 9.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.382 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -91.45 -14.31 30.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.91 2.42 19.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.66 153.66 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.54 ' HG3' HG21 ' A' ' 481' ' ' ILE . 4.5 mm-40 -141.65 131.3 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.63 ' HB3' HD11 ' A' ' 492' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -118.76 170.14 9.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.0 ttp -53.85 140.16 31.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 91.77 -23.1 27.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -85.91 149.1 25.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.491 ' O ' HD23 ' A' ' 520' ' ' LEU . 23.5 t-80 -98.03 131.79 44.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 22.3 m -125.56 170.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.64 ' HG3' HG22 ' A' ' 489' ' ' THR . 50.6 tttt -134.79 144.82 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 488' ' ' ASP . 18.3 t -90.57 122.15 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.0 pt -106.31 -23.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -140.71 178.39 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.63 -152.14 20.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -88.35 -25.36 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -103.75 40.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.42 111.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.34 -9.18 26.6 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 480' ' ' VAL . 36.6 m-20 -93.3 145.03 24.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 479' ' ' LYS . 3.7 p -130.4 159.85 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.24 174.81 47.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.12 166.41 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 472' ' ' PHE . 22.9 mt -99.97 107.76 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.81 -27.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -154.67 148.76 25.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.835 HG13 HG22 ' A' ' 500' ' ' VAL . 65.4 t -129.94 144.84 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.63 142.36 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -47.63 -22.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -93.43 -59.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.455 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 171.36 14.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.835 HG22 HG13 ' A' ' 495' ' ' VAL . 53.9 t -114.73 128.79 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.77 107.28 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -106.17 136.88 45.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -85.54 132.37 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -87.41 152.49 22.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -101.15 -18.5 16.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.69 -53.95 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 72.1 p -82.01 -12.64 58.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.082 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.4 mtp 54.33 28.19 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -122.1 174.28 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.22 121.23 32.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.22 137.72 44.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.455 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.8 tmtt? -116.62 124.08 48.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 17.8 t -151.99 150.94 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.7 mt -67.85 152.52 96.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.583 0.706 . . . . 0.0 110.951 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.08 11.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -86.45 -21.74 26.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -108.2 20.31 18.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 480' ' ' VAL . 67.3 mt -126.29 156.57 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -153.85 127.83 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 477' ' ' HIS . 9.5 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.542 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 1.5 m-30 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -134.99 153.42 52.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 ttt -52.06 127.48 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 111.38 -10.89 28.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 491' ' ' LEU . 2.2 m-20 -102.21 164.27 11.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -103.44 137.9 40.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.537 HG12 HD23 ' A' ' 520' ' ' LEU . 32.3 m -139.58 168.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.15 147.15 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 518' ' ' LEU . 60.1 t -91.1 104.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.4 pt -86.68 -27.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -137.8 171.99 13.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 106.85 -162.14 13.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -89.95 -0.03 57.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -120.36 15.35 12.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -39.67 121.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.68 53.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.5 m-20 -110.24 131.49 55.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.3 p -123.81 163.18 21.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 178.91 -174.7 46.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 476' ' ' ASP . 13.2 mt -97.98 158.76 15.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 60.7 mt -89.73 114.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.5 -33.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -140.32 140.21 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 500' ' ' VAL . 36.5 t -129.63 124.93 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.0 155.81 30.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -59.77 -17.26 33.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.36 -61.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.622 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -134.91 168.0 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.908 HG22 HG13 ' A' ' 495' ' ' VAL . 77.7 t -117.16 123.94 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.49 117.36 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -112.42 139.42 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -82.12 126.23 31.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 47.2 t -86.53 153.8 21.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -105.32 -28.98 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.55 -50.15 19.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.0 p -93.94 -13.55 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 79.1 mtp 59.49 30.27 19.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -123.46 158.98 30.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -84.26 112.29 20.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 26.2 mt -93.25 140.35 29.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 28.3 tttt -109.55 123.06 48.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 514' ' ' LEU . 19.2 t -154.34 157.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.9 mt -73.65 152.12 89.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.64 8.84 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -89.91 -30.66 17.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.29 6.69 45.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.572 HD21 HG22 ' A' ' 480' ' ' VAL . 78.7 mt -112.53 156.08 23.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -143.1 129.31 19.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.542 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 11.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.912 0.387 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.678 ' O ' HD12 ' A' ' 492' ' ' ILE . 2.0 mmmm -120.16 156.41 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 492' ' ' ILE . 1.1 tmt? -56.62 126.05 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.78 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -72.09 158.21 36.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -98.13 130.9 44.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.545 ' CG1' HD11 ' A' ' 492' ' ' ILE . 22.6 m -126.34 161.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 489' ' ' THR . 45.8 tttp -129.63 148.18 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 518' ' ' LEU . 40.8 t -92.13 116.76 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.46 -21.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.93 179.12 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.69 -149.46 19.23 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -89.92 -28.89 18.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -103.09 41.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -56.83 108.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.2 -17.3 19.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.0 t70 -75.15 141.77 43.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 479' ' ' LYS . 69.6 p -128.78 151.17 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.47 39.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.21 158.78 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 473' ' ' LYS . 45.7 mt -88.72 111.34 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 14.0 m -100.4 -28.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.06 142.43 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.81 HG13 HG22 ' A' ' 500' ' ' VAL . 5.0 t -127.8 146.88 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -139.79 140.83 36.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.15 -22.33 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -90.03 -62.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -136.98 169.92 16.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.81 HG22 HG13 ' A' ' 495' ' ' VAL . 39.6 t -115.91 127.62 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.3 mm -95.23 121.68 46.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -118.74 138.04 52.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -82.39 126.3 32.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 8.1 t -81.23 151.96 27.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -96.62 -18.87 19.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.83 -53.07 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 54.3 p -81.56 -0.8 43.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.444 ' C ' ' O ' ' A' ' 507' ' ' THR . 20.8 mtp 35.14 50.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 507' ' ' THR . 29.7 m-70 -145.67 170.23 16.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.1 118.43 28.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.69 137.17 42.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 25.8 tttt -111.63 114.98 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.75 141.69 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 499' ' ' PHE . 90.7 mt -60.28 152.13 64.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 1.86 4.04 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.33 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -93.71 -10.8 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.41 21.35 13.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.3 mt -128.79 166.98 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 138.47 13.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.926 0.393 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -118.73 155.84 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 492' ' ' ILE . 0.3 OUTLIER -56.74 136.75 55.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . 0.432 ' N ' ' SD ' ' A' ' 474' ' ' MET . . . 101.01 -11.13 58.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.556 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.7 154.38 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -97.21 133.26 42.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 518' ' ' LEU . 4.3 m -128.61 159.0 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 489' ' ' THR . 69.3 tttt -125.52 141.84 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 488' ' ' ASP . 15.4 t -82.92 128.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.6 pt -111.92 -23.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.62 172.37 12.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.26 -152.31 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -88.89 -26.58 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.813 0.339 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -102.94 38.17 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.37 106.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.33 -18.22 11.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.847 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.1 t70 -77.39 146.1 36.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 479' ' ' LYS . 65.5 p -134.07 153.2 51.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.31 -178.08 41.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -99.69 154.91 17.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 474' ' ' MET . 72.2 mt -86.57 122.43 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.4 m -112.72 -34.63 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -143.37 121.99 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.39 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -124.97 153.35 42.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.13 -28.22 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -84.63 -61.35 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.558 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -138.87 174.31 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.35 136.47 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 9.9 mm -105.78 108.88 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -107.85 141.94 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -84.35 124.22 31.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 511' ' ' LEU . 12.2 t -76.14 154.81 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.97 -26.24 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.53 -57.89 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 508' ' ' MET . 77.1 p -79.99 3.76 19.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 507' ' ' THR . 45.7 mtt 35.08 49.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -139.71 177.75 7.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.99 121.82 38.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 504' ' ' SER . 27.5 mt -103.95 141.02 36.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.2 tmtt? -118.24 121.28 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 13.0 t -154.56 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 499' ' ' PHE . 69.0 mt -62.63 150.25 86.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -1.14 7.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.289 . . . . 0.0 112.356 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.35 -10.67 45.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 518' ' ' LEU . 3.1 m-20 -116.1 11.88 15.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 517' ' ' ASP . 22.4 mt -120.07 158.21 27.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -148.95 140.53 23.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.7 m-30 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -121.09 154.01 36.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 27.8 ttp -49.89 133.77 21.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.52 -38.76 3.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.02 154.2 38.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -97.19 143.91 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 502' ' ' LEU . 25.1 m -139.08 177.65 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.715 ' HG3' HG22 ' A' ' 489' ' ' THR . 19.0 ttpt -142.88 156.6 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.425 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 40.3 t -99.59 109.2 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . 0.581 HG23 ' HG2' ' A' ' 519' ' ' GLN . 34.3 pt -89.56 -23.94 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.56 170.96 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.24 -156.45 17.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -85.06 -27.15 26.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -99.13 28.34 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.74 119.78 5.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 98.01 16.66 32.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -117.06 138.74 51.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.715 HG22 ' HG3' ' A' ' 479' ' ' LYS . 12.8 p -118.65 157.72 26.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.6 171.74 44.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.61 164.88 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.409 HD11 ' CG1' ' A' ' 478' ' ' VAL . 60.8 mt -95.9 108.51 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.02 -37.47 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -140.68 153.3 45.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 500' ' ' VAL . 12.1 t -139.95 127.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 498' ' ' ASN . 2.4 mp0 -122.92 140.55 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -44.16 -23.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 496' ' ' GLU . 5.4 m-80 -88.67 -68.9 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.634 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.8 OUTLIER -130.74 171.26 13.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 495' ' ' VAL . 22.0 t -116.24 137.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.0 mm -104.61 106.29 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.1 pt? -103.49 136.35 43.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -80.7 129.35 34.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.9 t -84.99 148.61 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -98.08 -14.01 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.87 -51.38 4.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 67.4 p -83.16 -4.34 58.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 4.7 mtt 45.87 34.86 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.05 176.42 8.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -94.73 117.53 30.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.86 135.14 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.519 ' HE3' ' CG ' ' A' ' 499' ' ' PHE . 3.0 tmtt? -107.74 131.03 54.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.7 t -156.89 149.57 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 499' ' ' PHE . 52.0 mt -68.7 152.0 96.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 1.37 4.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.679 2.253 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . 0.429 ' HE ' HD12 ' A' ' 514' ' ' LEU . 10.7 ptt180 -92.25 -27.67 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . 0.533 ' O ' HD23 ' A' ' 518' ' ' LEU . 23.8 m-20 -106.76 40.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 517' ' ' ASP . 57.1 mt -143.29 162.99 34.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.581 ' HG2' HG23 ' A' ' 481' ' ' ILE . 1.2 pt20 -152.12 137.71 17.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.6 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.934 0.397 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.706 ' O ' HD12 ' A' ' 492' ' ' ILE . 9.2 ptmm? -112.7 159.84 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.6 ttt -59.84 126.18 26.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.03 -37.49 3.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -75.29 160.09 30.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -100.0 130.47 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 492' ' ' ILE . 26.9 m -122.56 153.0 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.97 138.3 54.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 488' ' ' ASP . 10.6 t -91.4 121.79 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.152 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 44.9 pt -106.15 -23.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.24 172.4 12.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 103.09 -156.81 18.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.497 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -83.23 -20.04 35.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -112.87 43.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -61.29 138.84 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.78 -16.06 22.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.552 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -85.39 149.18 25.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 4.8 p -140.97 159.15 42.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -172.51 -169.72 35.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.99 160.17 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 473' ' ' LYS . 24.0 mt -91.67 112.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.114 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.35 -31.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -153.4 131.81 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.769 HG22 HG13 ' A' ' 500' ' ' VAL . 41.2 t -118.24 151.66 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.7 157.57 46.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.61 -17.31 46.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.95 -66.48 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.514 ' CG ' ' HD3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -127.42 174.79 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.769 HG13 HG22 ' A' ' 495' ' ' VAL . 26.1 t -119.85 127.57 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 108.57 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -109.97 141.65 42.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -86.5 135.28 33.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.7 t -91.71 142.9 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.45 -5.4 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 44.5 mt -90.81 -73.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.2 p -82.35 7.57 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.8 mmm 44.13 30.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -111.63 159.24 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -82.78 117.67 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.38 153.7 19.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.514 ' HD3' ' CG ' ' A' ' 499' ' ' PHE . 6.1 tmmm? -123.77 124.52 42.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.0 143.65 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.123 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.3 mt -69.57 156.01 92.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -0.34 6.79 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.713 2.276 . . . . 0.0 112.319 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -97.25 -15.52 20.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -115.8 34.51 4.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.9 mt -134.26 157.52 46.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -145.44 129.17 17.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 520' ' ' LEU . 11.1 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.3 m-30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.906 0.384 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 492' ' ' ILE . 0.7 OUTLIER -112.83 -178.17 3.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.4 ttt -74.18 156.73 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 76.53 -9.63 21.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . 0.424 ' C ' HD23 ' A' ' 491' ' ' LEU . 86.5 m-20 -93.51 148.39 22.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -95.8 113.51 25.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.829 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 492' ' ' ILE . 10.8 m -106.36 161.39 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -121.78 141.55 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 19.4 t -89.49 116.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . 0.634 HG21 ' OE1' ' A' ' 519' ' ' GLN . 24.6 pt -100.55 -30.37 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 481' ' ' ILE . . . -139.96 171.0 14.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.56 -157.17 15.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.533 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -87.92 -9.89 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.759 ' CE1' HD22 ' A' ' 511' ' ' LEU . 52.3 m-85 -119.23 38.74 3.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -60.19 137.73 58.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.31 -20.22 27.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.61 160.19 21.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -143.57 165.43 27.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.82 -178.83 48.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 476' ' ' ASP . 10.2 mt -99.37 160.98 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 473' ' ' LYS . 6.1 mt -94.51 105.01 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.89 -28.11 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -153.34 141.98 20.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.874 HG22 HG13 ' A' ' 500' ' ' VAL . 60.5 t -126.23 139.24 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -126.46 146.53 50.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -49.11 -29.08 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -85.31 -60.25 2.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -136.49 178.06 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.874 HG13 HG22 ' A' ' 495' ' ' VAL . 39.8 t -119.79 132.52 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.1 mm -97.09 110.94 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -112.72 137.55 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -84.25 135.62 34.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -91.36 142.3 27.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.66 -10.5 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.12 -48.49 4.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 9.0 p -92.96 -3.57 54.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 44.6 mmm 42.55 34.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -123.29 164.43 18.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -85.28 104.03 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.759 HD22 ' CE1' ' A' ' 485' ' ' PHE . 88.2 mt -87.91 143.26 27.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -114.89 113.37 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.29 139.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 499' ' ' PHE . 83.8 mt -61.89 153.69 71.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.584 0.707 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 2.1 3.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.631 2.221 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -97.46 -4.65 37.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -118.27 1.27 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 472' ' ' PHE . 20.1 mt -113.98 152.84 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.634 ' OE1' HG21 ' A' ' 481' ' ' ILE . 9.4 pt20 -143.97 132.28 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.8 m-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.932 0.396 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -136.34 153.53 51.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 19.4 ttp -51.26 125.58 14.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.52 -29.61 7.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -84.77 158.92 20.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -102.69 131.77 49.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.426 HG12 HD23 ' A' ' 520' ' ' LEU . 14.8 m -123.45 159.39 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -125.04 136.5 53.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.719 HG22 ' CD2' ' A' ' 518' ' ' LEU . 29.9 t -86.24 114.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 33.2 pt -97.97 -24.72 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.45 -179.42 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.93 -160.59 21.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -86.13 -7.76 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.542 ' CE2' HD22 ' A' ' 511' ' ' LEU . 69.3 m-85 -119.15 35.83 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -57.66 138.6 55.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 84.02 -13.92 46.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -87.98 151.58 22.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 24.3 p -139.6 162.27 35.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.82 178.39 48.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.42 161.26 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -90.26 117.91 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -107.61 -31.65 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -149.18 137.79 21.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 500' ' ' VAL . 1.8 t -122.53 138.34 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.677 ' OE2' HD11 ' A' ' 501' ' ' ILE . 11.8 mt-10 -126.42 148.82 49.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -54.63 -21.09 9.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 499' ' ' PHE . 4.2 t-20 -94.14 -53.7 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.701 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -142.36 172.0 13.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 495' ' ' VAL . 18.6 t -116.75 125.34 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . 0.677 HD11 ' OE2' ' A' ' 496' ' ' GLU . 9.1 mm -90.85 119.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.54 140.53 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -85.58 132.03 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 13.4 t -85.95 154.82 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.92 -26.29 14.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.1 mt -86.85 -54.25 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 38.7 p -80.16 -7.23 58.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.7 mtm 45.55 36.94 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 507' ' ' THR . 17.9 m-70 -135.67 163.58 29.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.21 125.73 32.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.542 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -109.92 133.99 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 49.6 tttt -101.68 111.65 23.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.79 143.41 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 499' ' ' PHE . 96.0 mt -63.6 153.22 83.95 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.643 0.735 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -0.89 7.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -91.18 -11.2 39.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -112.21 1.94 16.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 480' ' ' VAL . 44.0 mt -116.45 159.58 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -151.96 133.79 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 478' ' ' VAL . 15.6 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.51 ' O ' HD12 ' A' ' 492' ' ' ILE . 97.2 mttt -121.0 149.33 42.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 13.7 ttp -42.47 140.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 491' ' ' LEU . . . 96.05 -49.52 1.74 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.78 152.05 37.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.46 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.5 t-80 -94.7 130.09 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.45 HG23 HD13 ' A' ' 502' ' ' LEU . 3.6 m -124.54 158.14 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.37 148.45 50.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.07 121.6 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -103.8 -23.64 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.39 -177.89 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.04 -152.5 19.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -89.9 -5.52 56.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.41 ' CE2' HD22 ' A' ' 511' ' ' LEU . 32.1 m-85 -128.08 37.82 4.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.96 136.78 57.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.84 17.01 71.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.4 172.87 6.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 72.1 p -151.44 160.6 43.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 177.33 177.27 46.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 475' ' ' GLY . 11.0 mt -102.58 154.44 19.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 473' ' ' LYS . 39.7 mt -82.93 119.68 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.24 -26.34 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -160.56 120.83 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 500' ' ' VAL . 11.5 t -109.57 146.42 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -132.31 150.96 52.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.52 -27.03 23.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -85.35 -59.64 2.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.576 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -139.55 174.13 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.873 HG22 HG13 ' A' ' 495' ' ' VAL . 36.6 t -113.82 134.33 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . 0.417 HD13 ' C ' ' A' ' 500' ' ' VAL . 4.7 mm -103.79 111.42 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 502' ' ' LEU . 2.5 pt? -114.51 138.99 49.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -79.74 132.08 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -90.02 152.06 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.21 -20.89 17.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.08 -49.44 6.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 508' ' ' MET . 76.9 p -89.3 2.72 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 507' ' ' THR . 14.0 mtp 36.3 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.94 171.74 12.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.56 117.22 28.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -101.03 127.33 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.501 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 18.3 ttpt -101.55 117.07 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.7 t -139.65 157.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.18 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.4 mt -77.42 153.88 81.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.615 0.721 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 0.86 5.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.257 . . . . 0.0 112.338 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -95.15 -12.41 26.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.75 13.04 16.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.55 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 92.9 mt -115.56 162.35 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.401 ' HG2' ' C ' ' A' ' 518' ' ' LEU . 12.9 mm-40 -152.07 137.74 17.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 520' ' ' LEU . 12.9 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.3 m-30 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 474' ' ' MET . 44.2 pttt -123.48 141.17 52.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 473' ' ' LYS . 13.6 ttt -34.61 128.92 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 107.04 -49.58 0.86 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . 0.451 ' HB2' HD12 ' A' ' 492' ' ' ILE . 0.9 OUTLIER -62.79 154.03 31.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.555 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.9 t-160 -94.93 137.49 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 520' ' ' LEU . 19.8 m -133.02 156.29 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.159 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 480' ' ' VAL . 21.8 tttt -128.37 148.39 50.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.714 HG22 ' CD2' ' A' ' 518' ' ' LEU . 36.1 t -95.27 111.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.8 pt -94.53 -25.09 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.71 178.21 7.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.96 -154.48 19.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -86.33 -28.62 23.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 511' ' ' LEU . 6.0 m-85 -100.55 34.5 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.05 137.27 46.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.9 -21.15 24.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.34 158.29 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 27.8 p -145.34 159.82 42.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.62 178.8 43.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.3 mt -97.08 155.17 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.465 HD11 HG13 ' A' ' 478' ' ' VAL . 24.5 mt -81.82 111.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 503' ' ' PHE . 4.4 m -101.01 -25.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -155.83 150.22 25.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 500' ' ' VAL . 2.4 t -131.9 137.8 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.87 140.59 49.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.66 -29.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -83.7 -64.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.648 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -137.47 173.61 11.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 495' ' ' VAL . 26.2 t -114.41 140.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.8 mm -105.01 118.95 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -116.79 137.37 52.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . 0.429 ' HB2' HG11 ' A' ' 493' ' ' VAL . 54.6 t80 -84.25 129.69 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.6 t -85.53 152.81 22.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.41 -21.41 17.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 68.0 mt -90.49 -52.89 4.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 22.8 p -82.41 -9.0 59.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.6 mtt 46.24 41.09 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -136.25 167.97 20.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.96 113.88 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.848 HD22 ' CE2' ' A' ' 485' ' ' PHE . 85.7 mt -96.99 131.85 43.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 9.3 tttm -105.37 108.34 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 514' ' ' LEU . 39.8 t -133.76 154.08 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 499' ' ' PHE . 78.3 mt -71.82 155.26 92.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.33 15.93 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.232 . . . . 0.0 112.378 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.95 -26.99 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.57 18.33 16.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.714 ' CD2' HG22 ' A' ' 480' ' ' VAL . 48.8 mt -132.8 155.23 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -140.42 138.57 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 478' ' ' VAL . 9.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.0 m-30 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.912 0.387 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -120.64 144.57 48.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 9.0 mtm -45.86 143.09 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.79 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.31 160.58 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -104.66 133.01 50.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 492' ' ' ILE . 27.6 m -126.05 159.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.459 ' HG3' HG22 ' A' ' 489' ' ' THR . 51.4 tttt -120.23 149.94 41.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.452 HG22 ' CD2' ' A' ' 518' ' ' LEU . 25.5 t -95.12 123.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.128 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . 0.5 HG21 ' OE1' ' A' ' 519' ' ' GLN . 15.6 pt -103.54 -26.57 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.75 -175.65 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.74 -153.9 20.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -89.15 -3.89 58.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.36 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.65 33.47 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -56.95 108.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.13 -13.17 16.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 480' ' ' VAL . 1.0 OUTLIER -91.52 157.48 17.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.459 HG22 ' HG3' ' A' ' 479' ' ' LYS . 30.6 p -138.03 164.44 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.12 175.53 47.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 mt -92.2 165.58 13.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 478' ' ' VAL . 46.8 mt -97.67 113.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 9.5 m -103.37 -33.4 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -148.62 148.55 30.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.533 HG22 HG13 ' A' ' 500' ' ' VAL . 15.9 t -133.46 140.93 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -129.52 145.9 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -48.46 -33.4 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.94 -60.48 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.707 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -137.86 -179.0 5.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 495' ' ' VAL . 6.1 t -118.62 144.25 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.68 110.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -110.07 137.18 48.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -82.75 131.11 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 146.51 26.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -98.5 -22.43 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 66.6 mt -81.64 -59.57 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 56.4 p -84.04 -2.23 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 42.6 mtt 48.23 36.82 7.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.27 172.22 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -92.19 123.38 35.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 13.8 mt -104.5 135.24 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.6 tttt -113.4 112.18 23.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 514' ' ' LEU . 2.8 t -141.63 162.2 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 499' ' ' PHE . 97.0 mt -75.34 152.15 85.74 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.611 0.72 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -2.0 9.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -89.07 -28.4 20.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.9 15.05 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.452 ' CD2' HG22 ' A' ' 480' ' ' VAL . 50.8 mt -125.33 169.07 12.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.5 ' OE1' HG21 ' A' ' 481' ' ' ILE . 17.2 pt20 -163.52 134.23 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.893 -179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.931 0.396 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 474' ' ' MET . 58.9 mttm -117.63 137.82 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.418 ' C ' ' O ' ' A' ' 473' ' ' LYS . 28.4 ttm -36.81 133.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.95 -45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 492' ' ' ILE . 39.5 m-20 -67.31 155.45 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.473 ' HA ' HD23 ' A' ' 491' ' ' LEU . 9.4 t-80 -94.78 124.97 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.622 HG13 HD11 ' A' ' 492' ' ' ILE . 4.7 m -117.27 162.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.617 ' HG3' HG22 ' A' ' 489' ' ' THR . 61.8 tttt -135.0 149.33 50.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 488' ' ' ASP . 6.3 t -93.02 124.81 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 519' ' ' GLN . 35.4 pt -103.29 -27.35 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.89 -177.16 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.94 -151.31 19.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -88.4 -24.08 23.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 39.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.28 119.67 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 103.08 -13.39 55.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -88.62 155.07 19.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.868 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.617 HG22 ' HG3' ' A' ' 479' ' ' LYS . 33.0 p -135.98 170.95 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 176.12 174.89 43.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.6 mt -96.7 151.71 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.3 . . . . 0.0 110.976 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.622 HD11 HG13 ' A' ' 478' ' ' VAL . 25.2 mt -80.77 106.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 m -97.45 -33.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -147.63 146.73 29.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 500' ' ' VAL . 1.2 t -131.08 151.5 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -145.94 145.89 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -49.23 -30.43 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -82.27 -65.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.663 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -133.87 171.25 14.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 495' ' ' VAL . 9.4 t -113.98 134.38 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 20.5 mm -100.26 132.12 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.5 pt? -133.94 146.27 50.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -91.6 129.76 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 511' ' ' LEU . 1.3 t -91.83 127.91 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.58 -18.31 61.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.4 -61.36 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 18.3 p -82.74 -5.03 58.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 36.7 mtm 47.3 39.93 9.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -136.14 170.85 15.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -87.54 114.99 24.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 504' ' ' SER . 38.1 mt -95.84 142.79 27.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.42 ' NZ ' ' CZ ' ' A' ' 499' ' ' PHE . 5.8 tttp -112.58 118.31 34.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . 0.432 ' HB ' HD21 ' A' ' 518' ' ' LEU . 11.5 t -148.12 143.11 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 499' ' ' PHE . 79.6 mt -66.77 155.1 90.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -1.18 8.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 22.0 ptt85 -93.22 -7.46 45.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.14 5.16 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.432 HD21 ' HB ' ' A' ' 513' ' ' VAL . 46.0 mt -112.75 159.41 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' A' ' 481' ' ' ILE . 15.5 pt20 -152.88 131.02 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.487 HD23 HG12 ' A' ' 478' ' ' VAL . 9.1 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 4.8 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.949 0.404 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 492' ' ' ILE . 6.6 mmmt -115.98 148.31 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -45.16 137.67 4.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 97.95 -39.41 2.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.42 156.52 38.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.478 ' HA ' HD23 ' A' ' 491' ' ' LEU . 34.8 t-80 -97.68 129.85 44.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 502' ' ' LEU . 30.0 m -119.44 158.86 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -126.65 152.14 47.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 50.5 t -100.38 117.29 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.85 -23.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -141.86 -179.65 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.82 -159.05 21.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -81.63 -21.02 38.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.489 ' CE2' HD22 ' A' ' 511' ' ' LEU . 26.8 m-85 -111.64 40.21 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.8 108.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.96 -24.53 8.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.75 155.14 41.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 61.0 p -143.43 148.39 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -165.25 -173.83 34.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.451 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.4 mt -102.06 159.47 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 473' ' ' LYS . 54.8 mt -87.06 124.97 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.93 -35.1 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -151.4 117.14 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 500' ' ' VAL . 1.7 p -113.59 131.44 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.15 -20.83 66.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -95.62 -65.57 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.566 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -124.2 173.16 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 495' ' ' VAL . 26.3 t -117.49 137.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 8.6 mm -106.73 120.5 58.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.0 pt? -119.03 140.19 50.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 508' ' ' MET . 83.4 t80 -78.95 129.55 34.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 24.0 t -83.33 138.43 33.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.44 2.31 55.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.01 -67.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 508' ' ' MET . 16.2 p -108.58 29.11 7.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 503' ' ' PHE . 0.4 OUTLIER 34.52 49.61 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -116.55 159.0 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -94.24 116.26 28.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 485' ' ' PHE . 83.1 mt -99.29 138.76 35.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.566 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 6.5 tmtt? -114.9 110.32 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.45 145.1 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.534 HD23 ' HB3' ' A' ' 499' ' ' PHE . 91.2 mt -62.25 152.9 77.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.34 30.57 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -19.48 53.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -112.32 21.18 16.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 25.8 mt -120.78 162.19 20.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -149.9 142.09 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.5 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.887 0.375 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -120.46 138.73 53.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.55 ' HA ' HG22 ' A' ' 492' ' ' ILE . 2.6 ttp -38.33 132.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 109.35 -34.74 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . 0.529 ' HB2' HD12 ' A' ' 492' ' ' ILE . 10.3 m-20 -79.92 163.16 24.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 110.843 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 9.7 t-80 -100.36 121.92 42.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.764 HG13 HD11 ' A' ' 492' ' ' ILE . 14.4 m -114.71 148.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -124.11 143.32 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 488' ' ' ASP . 24.7 t -93.88 124.05 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.9 pt -107.13 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 517' ' ' ASP . . . -140.29 -176.94 4.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.58 -159.39 25.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.17 -10.55 54.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.55 32.08 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -56.39 125.11 20.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.03 64.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.3 t70 -99.82 129.96 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 67.1 p -124.78 146.63 49.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -168.7 -170.26 33.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.7 mt -104.49 158.95 16.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.764 HD11 HG13 ' A' ' 478' ' ' VAL . 45.3 mt -89.29 121.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.37 -35.55 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -144.27 121.44 11.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 500' ' ' VAL . 3.0 t -112.12 126.96 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.47 157.15 21.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.78 -36.82 77.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.63 -59.15 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.716 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.7 OUTLIER -136.56 176.7 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 495' ' ' VAL . 14.9 t -115.01 140.03 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.6 mm -109.0 109.68 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.679 HD13 HG23 ' A' ' 478' ' ' VAL . 2.4 pt? -109.26 137.16 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 504' ' ' SER . 65.1 t80 -79.69 132.37 36.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 503' ' ' PHE . 1.4 t -84.9 149.0 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.76 -31.6 10.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.7 -44.63 18.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 2.7 p -90.34 -10.01 45.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 29.1 mtt 51.96 36.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -137.08 159.88 40.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -80.84 128.9 34.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 30.6 mt -116.47 135.06 54.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.4 tmtt? -103.63 129.12 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.0 t -149.47 161.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 499' ' ' PHE . 95.1 mt -81.07 154.02 72.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.607 0.717 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 2.28 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -95.57 -25.64 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.816 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . 0.812 ' OD1' ' HB3' ' A' ' 482' ' ' ALA . 31.7 m-20 -105.0 22.69 14.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 72.1 mt -121.78 150.79 41.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -141.95 126.42 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 520' ' ' LEU . 12.6 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 1.6 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.932 0.396 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 474' ' ' MET . 41.4 mttp -120.9 139.67 52.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 473' ' ' LYS . 18.1 ttt -34.65 132.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 102.33 -40.7 2.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . 0.626 ' HB2' HD12 ' A' ' 492' ' ' ILE . 7.8 m-20 -70.83 157.28 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -101.94 136.76 41.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.887 HG12 HD23 ' A' ' 520' ' ' LEU . 3.8 m -139.03 159.42 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 489' ' ' THR . 3.1 ttpm? -123.19 159.36 28.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 488' ' ' ASP . 48.0 t -104.39 121.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 20.3 pt -101.73 -23.43 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.79 171.29 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.29 -166.03 15.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -76.52 -7.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 511' ' ' LEU . 12.9 m-85 -124.7 42.19 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -55.54 135.03 51.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 72.78 10.63 77.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 480' ' ' VAL . 19.9 t0 -95.99 125.03 40.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 479' ' ' LYS . 18.9 p -109.79 155.55 21.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.23 174.62 47.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.76 153.08 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 476' ' ' ASP . 14.5 mt -83.41 118.84 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.5 m -111.23 -31.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -146.16 141.02 27.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.85 HG13 HG22 ' A' ' 500' ' ' VAL . 15.9 t -129.39 128.67 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -124.75 148.45 48.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -52.22 -24.62 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -87.75 -61.73 1.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -140.09 169.11 18.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 495' ' ' VAL . 62.6 t -114.24 134.77 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.28 119.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -115.63 139.54 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.74 125.77 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 6.1 t -86.01 153.1 22.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.25 -32.37 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.24 -56.08 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 81.7 p -80.73 -8.41 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.4 mtt 49.56 31.07 3.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -130.02 172.4 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.6 124.24 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 485' ' ' PHE . 29.3 mt -104.1 133.7 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 16.5 tttm -103.0 114.96 29.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 23.0 t -140.15 151.81 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.4 mt -72.04 155.16 92.13 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.609 0.719 . . . . 0.0 110.86 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.24 4.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.334 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -34.05 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 22.34 7.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.484 ' CD2' HG22 ' A' ' 480' ' ' VAL . 23.9 mt -122.64 149.27 44.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -138.48 135.51 35.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 478' ' ' VAL . 9.8 mt . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -111.79 153.75 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.9 ttt -52.41 138.25 27.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 99.8 -26.72 23.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.83 147.99 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 21.7 t-80 -92.54 144.32 25.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 520' ' ' LEU . 34.0 m -140.67 166.61 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.87 ' HD3' HG22 ' A' ' 489' ' ' THR . 6.9 tptm -130.72 131.58 44.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.471 HG22 ' CD2' ' A' ' 518' ' ' LEU . 24.8 t -80.88 108.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 -26.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 517' ' ' ASP . . . -130.68 176.36 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.64 -164.06 25.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -84.68 -19.21 33.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 511' ' ' LEU . 31.2 m-85 -105.97 41.28 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.31 133.92 46.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.05 55.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.03 137.99 53.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.87 HG22 ' HD3' ' A' ' 479' ' ' LYS . 7.1 p -117.73 152.19 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . 0.43 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -176.19 176.84 47.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.56 165.54 12.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 71.5 mt -94.31 113.31 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.57 -33.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -142.14 150.06 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.773 HG13 HG22 ' A' ' 500' ' ' VAL . 11.4 t -138.5 128.87 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -126.35 143.61 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -48.89 -22.42 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.02 -57.87 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.548 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -142.7 169.75 17.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.773 HG22 HG13 ' A' ' 495' ' ' VAL . 50.1 t -116.36 133.43 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.9 mm -100.04 117.5 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.1 pt? -114.95 138.25 51.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.3 125.57 32.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 20.8 t -83.57 130.86 35.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.14 -11.7 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 92.9 mt -98.0 -57.24 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 508' ' ' MET . 73.3 p -84.05 2.02 41.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 507' ' ' THR . 35.6 mmm 36.64 49.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -140.86 166.36 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -91.98 115.18 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 485' ' ' PHE . 60.1 mt -99.95 137.55 38.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.548 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.7 tttt -109.08 110.43 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 5.6 t -136.4 150.76 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.7 mt -70.86 154.54 94.21 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.586 0.707 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -2.24 9.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -95.4 -9.73 31.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 482' ' ' ALA . 4.0 m-20 -121.29 38.39 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.527 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 71.2 mt -143.5 155.5 44.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -140.27 132.34 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.598 HD23 HG12 ' A' ' 478' ' ' VAL . 12.2 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.1 m-30 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.901 0.381 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 492' ' ' ILE . 57.1 mttm -121.61 155.15 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -52.52 134.86 34.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 98.38 -25.81 26.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.71 148.22 25.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -88.21 142.08 28.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' A' ' 492' ' ' ILE . 10.9 m -136.94 157.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 1.9 ttmp? -121.91 147.8 45.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' VAL . . . . . 0.479 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 48.1 t -97.88 99.13 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 22.4 pt -87.56 -18.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -134.94 170.98 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.74 -158.04 20.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -89.98 -16.96 28.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.84 39.26 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.54 109.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.89 -13.86 14.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.63 137.86 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -118.29 165.77 13.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.166 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.63 176.71 48.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.48 156.08 16.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 473' ' ' LYS . 59.8 mt -86.23 114.1 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.46 -33.89 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -142.61 144.04 32.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 500' ' ' VAL . 21.3 t -130.15 120.63 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.28 149.86 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.79 -30.75 46.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -80.6 -59.37 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -141.15 173.53 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 495' ' ' VAL . 44.9 t -116.17 134.09 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 mm -99.66 121.83 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -119.75 137.91 53.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -82.48 124.79 30.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 3.0 t -82.0 154.97 25.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -101.78 -9.34 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 35.9 mt -99.19 -55.19 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 81.1 p -84.87 4.05 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 507' ' ' THR . 3.4 mtt 35.1 54.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 507' ' ' THR . 53.9 m-70 -149.3 177.85 9.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -98.53 115.84 29.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 18.2 mt -104.55 139.89 38.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' LYS . . . . . 0.532 ' CG ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -108.12 118.11 35.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.35 146.72 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 499' ' ' PHE . 80.7 mt -68.4 153.24 95.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -1.61 8.78 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.54 -11.13 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.62 23.57 12.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.475 ' CD2' HG22 ' A' ' 480' ' ' VAL . 88.8 mt -131.69 153.09 50.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 520' ' ' LEU . 2.7 pp0? -145.39 127.94 16.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' LEU . . . . . 0.442 ' O ' ' NE2' ' A' ' 519' ' ' GLN . 13.1 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 11.1 t -98.09 173.1 7.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.0 m -59.98 132.12 52.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -173.84 -178.16 43.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 3.8 m -102.05 -51.9 3.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.836 0.351 . . . . 0.0 110.847 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 2.6 m -69.07 125.87 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 463' ' ' PHE . . . -117.97 163.51 12.87 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.79 81.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 110.836 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 461' ' ' GLY . 44.4 m-85 -123.4 74.95 52.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.626 0.727 . . . . 0.0 110.82 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -5.19 15.6 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.737 2.291 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -112.8 104.82 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.094 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -105.31 87.19 2.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -95.63 101.36 13.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.54 104.12 16.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -131.93 132.87 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.86 -40.63 76.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -47.17 109.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.904 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -50.21 110.11 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.485 ' O ' HD12 ' A' ' 492' ' ' ILE . 26.6 mttm -114.45 159.55 20.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.4 ttt -59.1 146.54 38.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 89.0 -17.57 50.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -92.19 152.32 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.413 ' O ' HD23 ' A' ' 520' ' ' LEU . 43.9 t-80 -92.98 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.74 151.04 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 489' ' ' THR . 30.2 tttm -114.69 159.73 20.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 518' ' ' LEU . 41.8 t -106.23 111.06 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . 0.665 HG21 ' OE1' ' A' ' 519' ' ' GLN . 28.5 pt -92.99 -30.39 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.0 -179.32 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.131 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.35 -167.04 23.37 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -82.41 4.23 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 0.0 110.858 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -129.19 25.61 5.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.51 112.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.7 5.39 24.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.494 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.53 153.03 25.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 479' ' ' LYS . 32.6 p -137.5 164.06 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . 177.78 -173.93 46.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.9 mt -101.5 162.51 12.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 473' ' ' LYS . 56.2 mt -93.46 114.81 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.157 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.3 m -104.88 -28.51 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -146.44 142.37 28.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.54 142.82 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.71 159.47 41.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.58 -18.63 65.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.85 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.905 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.4 p90 -135.2 179.71 6.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 10.6 t -127.94 129.1 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.101 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.5 mm -94.56 118.81 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.62 137.02 52.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -82.87 121.5 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 4.9 t -78.46 151.91 32.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.79 -12.79 17.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.6 mt -90.7 -54.94 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.909 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 23.6 p -85.39 -11.91 53.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.4 mtm 58.28 37.87 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.864 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -132.53 -178.01 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . 0.411 ' N ' ' OE1' ' A' ' 510' ' ' GLU . 31.9 mp0 -102.28 117.9 35.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 12.9 mt -97.24 135.26 39.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 499' ' ' PHE . 66.5 tttt -107.91 111.7 23.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 514' ' ' LEU . 21.2 t -142.72 161.22 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.905 HD23 ' HB3' ' A' ' 499' ' ' PHE . 72.8 mt -82.41 151.48 65.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 0.0 110.939 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -5.17 15.53 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.338 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -86.75 -12.98 46.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -115.63 9.13 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.468 ' CD2' HG22 ' A' ' 480' ' ' VAL . 87.2 mt -115.13 167.98 10.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.665 ' OE1' HG21 ' A' ' 481' ' ' ILE . 13.4 pt20 -158.45 130.03 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 477' ' ' HIS . 14.6 mt -59.83 163.9 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 32.4 t -106.9 -45.55 4.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 27.2 t -70.49 -47.49 60.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.42 ' OE1' ' C ' ' A' ' 523' ' ' GLU . 1.3 tm-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 16.3 t -87.29 101.72 13.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.891 0.376 . . . . 0.0 110.873 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 84.7 p -127.53 129.86 48.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 69.15 -160.8 52.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.8 t -91.99 119.35 31.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.953 0.406 . . . . 0.0 110.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 461' ' ' GLY . 89.0 p -101.41 124.89 47.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 460' ' ' SER . . . 35.55 -153.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.59 164.63 13.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.889 0.376 . . . . 0.0 110.894 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -55.45 144.31 53.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.654 0.74 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -17.3 37.84 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.736 2.291 . . . . 0.0 112.314 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -76.98 76.76 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.14 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -135.22 121.48 20.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -126.75 113.01 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 468' ' ' LEU . 2.6 mp -118.21 124.89 49.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.478 HH12 HD13 ' A' ' 520' ' ' LEU . 1.4 ppt_? -130.63 144.01 51.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.45 -36.02 2.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.87 179.66 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.445 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 8.7 m-30 -94.79 120.38 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.29 159.16 29.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -60.34 121.15 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 116.5 -11.43 16.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.471 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . 0.437 ' HB3' HD21 ' A' ' 520' ' ' LEU . 9.8 m-20 -98.83 150.85 21.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.452 ' O ' HD23 ' A' ' 520' ' ' LEU . 10.0 t-80 -85.1 131.5 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.85 154.45 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -124.42 157.62 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 6.1 t -98.69 125.44 52.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.148 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 49.1 pt -108.54 -31.03 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -138.18 170.92 15.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.12 -153.8 17.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 70.8 ttt-85 -89.94 -22.1 22.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.477 ' CE1' HD22 ' A' ' 511' ' ' LEU . 86.1 m-85 -105.32 39.41 1.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.66 123.98 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.904 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 97.6 22.19 17.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 489' ' ' THR . 9.6 t70 -118.66 170.93 8.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.471 ' N ' ' OD1' ' A' ' 488' ' ' ASP . 40.8 p -149.34 157.12 43.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.73 -179.76 48.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -104.26 154.01 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.51 110.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -100.78 -34.6 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.126 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -143.37 120.76 11.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.5 117.21 54.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -103.96 161.42 13.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -63.97 -28.2 69.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -88.43 -66.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.773 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -123.36 179.62 4.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.422 ' C ' HD13 ' A' ' 501' ' ' ILE . 48.8 t -125.69 129.81 72.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.139 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 501' ' ' ILE . 3.0 mm -97.95 111.14 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -111.66 137.25 49.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -81.7 138.7 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 18.1 t -91.43 147.31 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.81 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.18 -18.72 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 61.7 mt -95.26 -54.32 3.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 42.8 p -81.74 -13.94 57.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.0 mtm 52.8 47.54 24.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -138.76 171.87 13.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -99.8 109.88 22.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 485' ' ' PHE . 24.2 mt -98.74 132.74 43.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.542 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 2.4 ttpm? -97.74 117.85 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.75 140.65 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 499' ' ' PHE . 48.7 mt -64.55 152.1 90.27 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 2.78 3.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -98.98 -4.36 32.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 518' ' ' LEU . 59.7 m-20 -121.78 17.93 11.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 517' ' ' ASP . 41.4 mt -123.31 163.13 21.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -153.61 127.12 8.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.478 HD13 HH12 ' A' ' 469' ' ' ARG . 9.9 mt -61.59 161.67 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . 0.413 ' CB ' ' ND1' ' A' ' 477' ' ' HIS . 6.7 t -100.08 -32.57 10.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 13.8 t -82.5 -59.36 2.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.828 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 91.5 p -73.47 175.03 7.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 0.0 110.876 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 79.2 p -72.77 143.73 47.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -163.09 -128.65 0.96 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.7 p -105.08 112.41 25.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.895 0.378 . . . . 0.0 110.812 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 9.1 t -50.43 166.04 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 462' ' ' GLU . . . 64.83 166.53 1.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 461' ' ' GLY . 8.5 tt0 -35.17 143.1 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.924 0.392 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -73.48 144.43 83.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.607 0.718 . . . . 0.0 110.879 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -10.05 27.65 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.378 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -54.16 107.68 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -111.01 104.52 13.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -96.01 38.48 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 mp -98.56 138.26 36.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.962 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -105.4 38.01 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.407 ' CG ' HD12 ' A' ' 520' ' ' LEU . 13.6 ttmm -86.22 40.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -74.0 136.65 43.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -87.45 98.7 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -109.81 146.46 34.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 1.4 ttp -42.26 133.66 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 106.91 -41.16 2.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.439 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -73.45 159.97 32.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -98.99 144.11 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.548 HG23 HD13 ' A' ' 502' ' ' LEU . 26.5 m -139.39 146.8 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.119 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.48 ' HB2' HG22 ' A' ' 489' ' ' THR . 19.8 tttp -117.56 152.65 34.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 485' ' ' PHE . 3.2 t -95.14 131.81 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . 0.54 HG21 ' HG3' ' A' ' 519' ' ' GLN . 21.6 pt -116.82 -19.55 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.13 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.27 -176.92 5.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 90.94 -166.31 31.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.426 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -80.46 -6.04 57.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.82 0.343 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.409 ' O ' HG11 ' A' ' 480' ' ' VAL . 24.6 m-85 -122.96 44.05 2.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -71.89 112.3 7.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.51 17.32 7.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -113.05 168.45 9.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 479' ' ' LYS . 33.4 p -151.55 151.14 31.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.183 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -174.54 178.42 46.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.64 158.71 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 36.1 mt -86.07 115.98 28.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.22 -24.65 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 7.8 ttt-85 -150.41 133.75 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.898 HG13 HG22 ' A' ' 500' ' ' VAL . 7.3 t -124.78 130.8 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -125.52 155.97 39.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.96 -16.67 32.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -97.81 -61.35 1.4 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.565 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -138.61 164.97 28.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.898 HG22 HG13 ' A' ' 495' ' ' VAL . 60.1 t -113.25 123.97 69.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.1 mm -89.65 117.9 33.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -114.12 143.33 44.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -83.85 131.6 34.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.5 t -101.3 141.7 33.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.74 -24.76 19.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.89 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 30.6 mt -71.27 -52.86 16.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 62.8 p -91.29 -17.65 25.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 9.5 mtt 63.96 40.61 7.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -143.7 171.87 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -92.49 126.71 37.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 58.2 mt -111.2 133.46 53.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 0.8 OUTLIER -99.73 114.66 27.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.58 146.03 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' ' 499' ' ' PHE . 84.4 mt -65.62 151.31 94.86 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -1.96 9.37 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.662 2.241 . . . . 0.0 112.382 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -91.45 -14.31 30.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.91 2.42 19.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 39.8 mt -106.66 153.66 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.54 ' HG3' HG21 ' A' ' 481' ' ' ILE . 4.5 mm-40 -141.65 131.3 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.4 mt -63.57 156.97 24.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 33.2 t -116.77 -33.21 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 69.9 m -69.82 -52.05 28.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.862 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 30.4 t -147.92 145.11 28.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.896 0.379 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.6 m -91.2 -46.78 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.836 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -173.82 152.15 14.57 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.0 p -123.35 -37.54 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 110.842 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 3.6 m -168.4 134.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 128.72 127.85 3.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.442 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -44.1 -61.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -107.13 144.1 28.45 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 157.75 59.35 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.694 2.262 . . . . 0.0 112.333 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -102.66 118.31 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.088 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -99.75 156.13 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -82.68 138.67 34.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 51.7 mt -67.55 120.58 14.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -119.68 170.15 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -113.43 36.07 3.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -92.38 133.87 35.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.63 ' HB3' HD11 ' A' ' 492' ' ' ILE . 0.3 OUTLIER -97.75 104.78 16.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -118.76 170.14 9.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.0 ttp -53.85 140.16 31.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 91.77 -23.1 27.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -85.91 149.1 25.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.83 0.348 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.491 ' O ' HD23 ' A' ' 520' ' ' LEU . 23.5 t-80 -98.03 131.79 44.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . . . . . . . . . 22.3 m -125.56 170.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.64 ' HG3' HG22 ' A' ' 489' ' ' THR . 50.6 tttt -134.79 144.82 47.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 488' ' ' ASP . 18.3 t -90.57 122.15 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.0 pt -106.31 -23.3 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -140.71 178.39 7.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.088 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.63 -152.14 20.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -88.35 -25.36 22.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -103.75 40.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.42 111.02 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 112.34 -9.18 26.6 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.584 ' O ' HG23 ' A' ' 480' ' ' VAL . 36.6 m-20 -93.3 145.03 24.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 479' ' ' LYS . 3.7 p -130.4 159.85 35.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.24 174.81 47.2 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.9 mt -90.12 166.41 13.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.817 0.341 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 472' ' ' PHE . 22.9 mt -99.97 107.76 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.174 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.81 -27.73 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -154.67 148.76 25.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.835 HG13 HG22 ' A' ' 500' ' ' VAL . 65.4 t -129.94 144.84 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.13 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.63 142.36 49.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -47.63 -22.08 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -93.43 -59.21 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.455 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -137.86 171.36 14.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.835 HG22 HG13 ' A' ' 495' ' ' VAL . 53.9 t -114.73 128.79 71.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 12.3 mm -91.77 107.28 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -106.17 136.88 45.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -85.54 132.37 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.3 t -87.41 152.49 22.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -101.15 -18.5 16.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.69 -53.95 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 72.1 p -82.01 -12.64 58.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.082 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 38.4 mtp 54.33 28.19 9.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -122.1 174.28 7.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.22 121.23 32.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 11.7 mt -107.22 137.72 44.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.455 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.8 tmtt? -116.62 124.08 48.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 17.8 t -151.99 150.94 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.7 mt -67.85 152.52 96.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.583 0.706 . . . . 0.0 110.951 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.08 11.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 0.0 112.34 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -86.45 -21.74 26.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -108.2 20.31 18.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.422 ' CD2' HG22 ' A' ' 480' ' ' VAL . 67.3 mt -126.29 156.57 40.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -153.85 127.83 8.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 477' ' ' HIS . 9.5 mt -54.68 160.02 1.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.6 t -103.83 -36.06 7.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 43.2 m -66.43 -55.08 17.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 40.7 m -83.85 90.39 7.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.2 m -55.49 166.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 121.31 -100.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.4 t -148.3 156.18 42.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 13.0 t -116.82 99.28 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -144.44 -162.67 9.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.451 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -138.34 109.38 6.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -109.14 145.08 31.02 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.656 0.741 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 162.4 42.2 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.709 2.273 . . . . 0.0 112.317 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -106.93 94.14 4.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.47 -60.09 4.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -93.67 133.17 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.41 95.45 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -76.78 87.71 3.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -110.19 27.45 9.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -88.7 153.77 20.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.542 ' CD1' ' HG ' ' A' ' 520' ' ' LEU . 1.5 m-30 -93.1 130.14 38.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -134.99 153.42 52.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.6 ttt -52.06 127.48 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 111.38 -10.89 28.55 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.461 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . 0.412 ' O ' HD23 ' A' ' 491' ' ' LEU . 2.2 m-20 -102.21 164.27 11.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -103.44 137.9 40.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.537 HG12 HD23 ' A' ' 520' ' ' LEU . 32.3 m -139.58 168.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.15 147.15 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.572 HG22 HD21 ' A' ' 518' ' ' LEU . 60.1 t -91.1 104.97 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 21.4 pt -86.68 -27.22 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -137.8 171.99 13.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 106.85 -162.14 13.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -89.95 -0.03 57.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -120.36 15.35 12.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -39.67 121.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 100.17 6.68 53.41 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.5 m-20 -110.24 131.49 55.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.373 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 1.3 p -123.81 163.18 21.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.14 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 178.91 -174.7 46.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 476' ' ' ASP . 13.2 mt -97.98 158.76 15.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 60.7 mt -89.73 114.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.5 -33.43 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -140.32 140.21 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.908 HG13 HG22 ' A' ' 500' ' ' VAL . 36.5 t -129.63 124.93 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.0 155.81 30.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -59.77 -17.26 33.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.36 -61.52 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.622 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -134.91 168.0 19.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.908 HG22 HG13 ' A' ' 495' ' ' VAL . 77.7 t -117.16 123.94 72.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.49 117.36 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -112.42 139.42 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -82.12 126.23 31.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 47.2 t -86.53 153.8 21.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.861 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -105.32 -28.98 10.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.55 -50.15 19.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.0 p -93.94 -13.55 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 79.1 mtp 59.49 30.27 19.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -123.46 158.98 30.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -84.26 112.29 20.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 26.2 mt -93.25 140.35 29.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 28.3 tttt -109.55 123.06 48.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 514' ' ' LEU . 19.2 t -154.34 157.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.137 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.9 mt -73.65 152.12 89.34 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.579 0.704 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.64 8.84 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -89.91 -30.66 17.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.29 6.69 45.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.572 HD21 HG22 ' A' ' 480' ' ' VAL . 78.7 mt -112.53 156.08 23.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -143.1 129.31 19.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.542 ' HG ' ' CD1' ' A' ' 472' ' ' PHE . 11.6 mt -59.3 153.16 19.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 7.5 t -87.83 -17.8 30.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 40.7 t -101.9 -66.26 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.843 -179.895 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.2 t -113.86 122.73 47.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 75.1 m -60.5 160.36 9.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 134.52 104.72 0.83 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.3 t -42.58 -58.58 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.379 . . . . 0.0 110.91 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 1.7 t -118.33 125.9 51.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.851 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -120.61 -163.6 12.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.511 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -120.59 146.96 45.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -100.35 143.98 27.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.879 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -22.86 31.67 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.638 2.226 . . . . 0.0 112.39 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.49 117.39 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.105 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -137.85 105.06 5.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -57.1 104.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.9 91.72 8.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.92 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -107.83 143.93 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -71.93 98.47 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -155.63 154.6 31.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 -86.31 107.94 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.678 ' O ' HD12 ' A' ' 492' ' ' ILE . 2.0 mmmm -120.16 156.41 31.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.418 ' HA ' HG22 ' A' ' 492' ' ' ILE . 1.1 tmt? -56.62 126.05 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.824 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.78 2.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -72.09 158.21 36.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -98.13 130.9 44.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.841 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.545 ' CG1' HD11 ' A' ' 492' ' ' ILE . 22.6 m -126.34 161.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 489' ' ' THR . 45.8 tttp -129.63 148.18 51.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 518' ' ' LEU . 40.8 t -92.13 116.76 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.46 -21.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.93 179.12 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 97.69 -149.46 19.23 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -89.92 -28.89 18.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.826 0.346 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -103.09 41.68 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -56.83 108.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 114.2 -17.3 19.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.0 t70 -75.15 141.77 43.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.88 0.372 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.511 HG22 ' HG3' ' A' ' 479' ' ' LYS . 69.6 p -128.78 151.17 49.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.143 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.47 39.92 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.45 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 12.3 mt -101.21 158.78 15.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 473' ' ' LYS . 45.7 mt -88.72 111.34 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 14.0 m -100.4 -28.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.06 142.43 21.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.81 HG13 HG22 ' A' ' 500' ' ' VAL . 5.0 t -127.8 146.88 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.106 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -139.79 140.83 36.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.15 -22.33 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -90.03 -62.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.601 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -136.98 169.92 16.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.81 HG22 HG13 ' A' ' 495' ' ' VAL . 39.6 t -115.91 127.62 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.3 mm -95.23 121.68 46.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -118.74 138.04 52.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -82.39 126.3 32.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 8.1 t -81.23 151.96 27.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -96.62 -18.87 19.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 45.3 mt -96.83 -53.07 3.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . 0.466 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 54.3 p -81.56 -0.8 43.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.444 ' C ' ' O ' ' A' ' 507' ' ' THR . 20.8 mtp 35.14 50.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . 0.466 ' CD2' ' O ' ' A' ' 507' ' ' THR . 29.7 m-70 -145.67 170.23 16.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.1 118.43 28.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 74.7 mt -103.69 137.17 42.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.56 ' HE3' ' CD2' ' A' ' 499' ' ' PHE . 25.8 tttt -111.63 114.98 28.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.75 141.69 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 499' ' ' PHE . 90.7 mt -60.28 152.13 64.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.629 0.728 . . . . 0.0 110.925 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 1.86 4.04 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.696 2.264 . . . . 0.0 112.33 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -93.71 -10.8 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -116.41 21.35 13.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.3 mt -128.79 166.98 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 138.47 13.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 14.3 mt -72.11 156.24 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 52.8 t -106.75 -39.91 5.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 39.5 m -70.83 -53.9 13.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 4.4 m -162.58 151.83 15.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.88 0.371 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 18.2 m -62.82 99.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 178.56 95.15 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.473 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.1 m -88.5 99.08 12.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.865 0.364 . . . . 0.0 110.868 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 85.2 p -88.83 110.19 20.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.833 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 88.6 132.18 4.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.482 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -96.57 145.25 25.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.916 0.389 . . . . 0.0 110.894 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -99.39 143.97 27.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.675 0.75 . . . . 0.0 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 465' ' ' ALA . 53.8 Cg_endo -69.75 120.36 7.16 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.691 2.261 . . . . 0.0 112.313 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 464' ' ' PRO . . . -35.08 -58.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.112 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.98 136.06 51.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -107.91 133.82 51.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.24 135.83 31.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -132.79 162.74 30.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.4 -33.58 14.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -53.98 133.85 43.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.982 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 12.5 m-30 -73.84 114.53 12.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -118.73 155.84 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.449 ' HA ' HG22 ' A' ' 492' ' ' ILE . 0.3 OUTLIER -56.74 136.75 55.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . 0.432 ' N ' ' SD ' ' A' ' 474' ' ' MET . . . 101.01 -11.13 58.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.556 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -99.7 154.38 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -97.21 133.26 42.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 518' ' ' LEU . 4.3 m -128.61 159.0 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.487 ' HA ' HG22 ' A' ' 489' ' ' THR . 69.3 tttt -125.52 141.84 51.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 488' ' ' ASP . 15.4 t -82.92 128.22 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.6 pt -111.92 -23.9 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.62 172.37 12.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.107 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 101.26 -152.31 18.88 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -88.89 -26.58 21.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.813 0.339 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -102.94 38.17 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.37 106.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.33 -18.22 11.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.847 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.1 t70 -77.39 146.1 36.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.938 0.399 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 479' ' ' LYS . 65.5 p -134.07 153.2 51.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.31 -178.08 41.53 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.494 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.2 mt -99.69 154.91 17.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.945 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 474' ' ' MET . 72.2 mt -86.57 122.43 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.143 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.4 m -112.72 -34.63 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -143.37 121.99 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.39 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -124.97 153.35 42.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -59.13 -28.22 66.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -84.63 -61.35 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.558 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -138.87 174.31 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.35 136.47 54.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 9.9 mm -105.78 108.88 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -107.85 141.94 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -84.35 124.22 31.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 511' ' ' LEU . 12.2 t -76.14 154.81 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.819 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.97 -26.24 13.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 62.4 mt -87.53 -57.89 2.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 508' ' ' MET . 77.1 p -79.99 3.76 19.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.134 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.442 ' C ' ' O ' ' A' ' 507' ' ' THR . 45.7 mtt 35.08 49.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -139.71 177.75 7.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.826 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.99 121.82 38.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 504' ' ' SER . 27.5 mt -103.95 141.02 36.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.2 tmtt? -118.24 121.28 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 13.0 t -154.56 145.78 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 499' ' ' PHE . 69.0 mt -62.63 150.25 86.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.614 0.721 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -1.14 7.9 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.289 . . . . 0.0 112.356 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -89.35 -10.67 45.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 518' ' ' LEU . 3.1 m-20 -116.1 11.88 15.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 517' ' ' ASP . 22.4 mt -120.07 158.21 27.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -148.95 140.53 23.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.85 150.46 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 35.0 t -89.18 -45.52 9.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 14.5 m -71.81 -66.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.894 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 80.6 p -47.67 150.83 0.94 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 0.0 110.809 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 4.2 m -145.16 124.98 13.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -150.84 72.77 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.6 m -97.45 140.62 31.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 10.1 t -104.29 -48.38 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.899 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.43 -161.99 13.49 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.457 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -76.61 -46.07 27.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.89 0.376 . . . . 0.0 110.84 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -101.43 145.04 29.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 -22.87 31.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.356 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.21 147.94 49.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -73.85 167.32 21.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -131.65 87.76 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 39.6 mt -120.06 169.96 9.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.417 ' HD3' ' N ' ' A' ' 469' ' ' ARG . 0.3 OUTLIER -80.31 99.7 8.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.27 69.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.501 ' O ' HD11 ' A' ' 520' ' ' LEU . 98.8 m-85 -109.63 141.06 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.7 m-30 -93.68 104.67 16.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -121.09 154.01 36.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 27.8 ttp -49.89 133.77 21.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.52 -38.76 3.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.02 154.2 38.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.841 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -97.19 143.91 27.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 502' ' ' LEU . 25.1 m -139.08 177.65 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.141 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.715 ' HG3' HG22 ' A' ' 489' ' ' THR . 19.0 ttpt -142.88 156.6 44.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.425 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 40.3 t -99.59 109.2 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.17 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . 0.581 HG23 ' HG2' ' A' ' 519' ' ' GLN . 34.3 pt -89.56 -23.94 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.56 170.96 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.24 -156.45 17.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -85.06 -27.15 26.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -99.13 28.34 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.872 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.74 119.78 5.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 98.01 16.66 32.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -117.06 138.74 51.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.85 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.715 HG22 ' HG3' ' A' ' 479' ' ' LYS . 12.8 p -118.65 157.72 26.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.6 171.74 44.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.61 164.88 14.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.807 0.337 . . . . 0.0 110.863 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.409 HD11 ' CG1' ' A' ' 478' ' ' VAL . 60.8 mt -95.9 108.51 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.02 -37.47 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -140.68 153.3 45.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.839 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 500' ' ' VAL . 12.1 t -139.95 127.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.401 ' C ' ' N ' ' A' ' 498' ' ' ASN . 2.4 mp0 -122.92 140.55 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -44.16 -23.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 496' ' ' GLU . 5.4 m-80 -88.67 -68.9 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.634 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.8 OUTLIER -130.74 171.26 13.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 495' ' ' VAL . 22.0 t -116.24 137.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.0 mm -104.61 106.29 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.582 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.1 pt? -103.49 136.35 43.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -80.7 129.35 34.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.9 t -84.99 148.61 26.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.837 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -98.08 -14.01 20.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.87 -51.38 4.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 67.4 p -83.16 -4.34 58.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 4.7 mtt 45.87 34.86 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -133.05 176.42 8.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -94.73 117.53 30.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.892 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.86 135.14 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.519 ' HE3' ' CG ' ' A' ' 499' ' ' PHE . 3.0 tmtt? -107.74 131.03 54.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.7 t -156.89 149.57 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 499' ' ' PHE . 52.0 mt -68.7 152.0 96.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 1.37 4.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.679 2.253 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . 0.429 ' HE ' HD12 ' A' ' 514' ' ' LEU . 10.7 ptt180 -92.25 -27.67 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . 0.533 ' O ' HD23 ' A' ' 518' ' ' LEU . 23.8 m-20 -106.76 40.31 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 517' ' ' ASP . 57.1 mt -143.29 162.99 34.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.581 ' HG2' HG23 ' A' ' 481' ' ' ILE . 1.2 pt20 -152.12 137.71 17.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.501 HD11 ' O ' ' A' ' 471' ' ' TYR . 12.0 mt -62.31 158.66 16.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.63 -27.79 3.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 51.7 m -120.78 47.77 1.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 20.2 m -111.04 -46.51 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 69.1 m -71.8 135.53 46.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.84 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 459' ' ' SER . . . 86.11 -153.17 26.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.454 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 458' ' ' GLY . 23.7 m -36.63 106.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 5.3 t -161.39 106.84 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.41 -154.47 20.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.488 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -136.66 157.28 47.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -95.92 145.07 28.92 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.667 0.746 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 138.07 36.82 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.648 2.232 . . . . 0.0 112.331 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -110.1 36.36 3.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.087 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -81.67 91.34 6.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.8 100.52 12.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.5 mt -132.46 158.49 41.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -122.37 77.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -106.69 82.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -130.93 133.77 46.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.6 m-85 -77.36 99.43 5.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.706 ' O ' HD12 ' A' ' 492' ' ' ILE . 9.2 ptmm? -112.7 159.84 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 3.6 ttt -59.84 126.18 26.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.03 -37.49 3.61 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -75.29 160.09 30.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -100.0 130.47 46.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.498 HG13 HD11 ' A' ' 492' ' ' ILE . 26.9 m -122.56 153.0 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -120.97 138.3 54.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 488' ' ' ASP . 10.6 t -91.4 121.79 42.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.152 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 44.9 pt -106.15 -23.09 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.24 172.4 12.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.1 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 103.09 -156.81 18.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.497 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 56.2 mmt-85 -83.23 -20.04 35.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -112.87 43.14 1.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -61.29 138.84 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.78 -16.06 22.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.552 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -85.39 149.18 25.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.922 0.391 . . . . 0.0 110.886 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 4.8 p -140.97 159.15 42.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -172.51 -169.72 35.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.99 160.17 14.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 0.0 110.906 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.706 HD12 ' O ' ' A' ' 473' ' ' LYS . 24.0 mt -91.67 112.34 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.114 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.35 -31.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -153.4 131.81 12.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.769 HG22 HG13 ' A' ' 500' ' ' VAL . 41.2 t -118.24 151.66 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.7 157.57 46.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.61 -17.31 46.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.95 -66.48 0.9 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.514 ' CG ' ' HD3' ' A' ' 512' ' ' LYS . 1.0 OUTLIER -127.42 174.79 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.769 HG13 HG22 ' A' ' 495' ' ' VAL . 26.1 t -119.85 127.57 75.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 108.57 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.575 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.2 pt? -109.97 141.65 42.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -86.5 135.28 33.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.7 t -91.71 142.9 27.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.858 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -91.45 -5.4 54.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 44.5 mt -90.81 -73.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 82.2 p -82.35 7.57 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 22.8 mmm 44.13 30.91 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -111.63 159.24 18.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -82.78 117.67 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 10.1 mt -102.38 153.7 19.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.514 ' HD3' ' CG ' ' A' ' 499' ' ' PHE . 6.1 tmmm? -123.77 124.52 42.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 6.3 t -144.0 143.65 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.123 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 499' ' ' PHE . 64.3 mt -69.57 156.01 92.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.959 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -0.34 6.79 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.713 2.276 . . . . 0.0 112.319 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -97.25 -15.52 20.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -115.8 34.51 4.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.585 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 87.9 mt -134.26 157.52 46.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -145.44 129.17 17.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 520' ' ' LEU . 11.1 mt -68.95 153.78 43.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.75 -50.4 1.96 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 6.9 t -107.49 45.33 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 80.7 p -83.52 -37.38 23.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 3.4 m 46.13 45.73 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -172.17 -55.9 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.536 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 83.4 p -92.34 128.04 38.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.897 0.379 . . . . 0.0 110.825 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 1.5 t -163.9 158.05 19.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 111.15 -178.78 19.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.2 161.0 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -127.34 144.58 51.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.678 0.752 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 112.96 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.299 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -93.07 81.04 4.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.06 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.69 134.09 40.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -104.08 58.25 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 30.6 mt -100.11 56.38 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -108.84 146.82 33.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.524 ' O ' ' CE1' ' A' ' 472' ' ' PHE . 0.1 OUTLIER -105.98 -20.66 13.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.879 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -54.52 128.07 30.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 470' ' ' LYS . 1.3 m-30 -85.29 113.84 21.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.558 ' O ' HD12 ' A' ' 492' ' ' ILE . 0.7 OUTLIER -112.83 -178.17 3.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 10.4 ttt -74.18 156.73 37.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 76.53 -9.63 21.05 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . 0.424 ' C ' HD23 ' A' ' 491' ' ' LEU . 86.5 m-20 -93.51 148.39 22.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -95.8 113.51 25.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.829 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 492' ' ' ILE . 10.8 m -106.36 161.39 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -121.78 141.55 51.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 19.4 t -89.49 116.4 30.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . 0.634 HG21 ' OE1' ' A' ' 519' ' ' GLN . 24.6 pt -100.55 -30.37 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.158 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 481' ' ' ILE . . . -139.96 171.0 14.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.092 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 107.56 -157.17 15.59 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.533 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -87.92 -9.89 52.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.875 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.759 ' CE1' HD22 ' A' ' 511' ' ' LEU . 52.3 m-85 -119.23 38.74 3.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -60.19 137.73 58.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.31 -20.22 27.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.61 160.19 21.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.399 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 69.6 p -143.57 165.43 27.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -179.82 -178.83 48.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 476' ' ' ASP . 10.2 mt -99.37 160.98 13.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.9 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 473' ' ' LYS . 6.1 mt -94.51 105.01 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.069 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.7 m -90.89 -28.11 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.149 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -153.34 141.98 20.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.874 HG22 HG13 ' A' ' 500' ' ' VAL . 60.5 t -126.23 139.24 52.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.165 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -126.46 146.53 50.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.859 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -49.11 -29.08 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -85.31 -60.25 2.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -136.49 178.06 7.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.874 HG13 HG22 ' A' ' 495' ' ' VAL . 39.8 t -119.79 132.52 69.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 10.1 mm -97.09 110.94 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -112.72 137.55 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -84.25 135.62 34.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -91.36 142.3 27.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -88.66 -10.5 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 53.7 mt -99.12 -48.49 4.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 9.0 p -92.96 -3.57 54.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.138 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 44.6 mmm 42.55 34.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -123.29 164.43 18.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -85.28 104.03 14.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.759 HD22 ' CE1' ' A' ' 485' ' ' PHE . 88.2 mt -87.91 143.26 27.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -114.89 113.37 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.29 139.1 29.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 499' ' ' PHE . 83.8 mt -61.89 153.69 71.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.584 0.707 . . . . 0.0 110.933 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 2.1 3.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.631 2.221 . . . . 0.0 112.334 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -97.46 -4.65 37.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -118.27 1.27 11.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 472' ' ' PHE . 20.1 mt -113.98 152.84 30.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.634 ' OE1' HG21 ' A' ' 481' ' ' ILE . 9.4 pt20 -143.97 132.28 21.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.38 153.46 18.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.9 t -92.41 103.57 15.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 16.6 m 57.2 53.0 8.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.404 ' N ' ' OE1' ' A' ' 523' ' ' GLU . 1.1 pm0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 37.8 m -110.96 -60.07 1.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 12.0 t -67.53 96.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.824 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 80.07 -137.6 18.76 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.477 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 3.2 t -119.42 163.7 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.896 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 27.1 m -78.91 -62.72 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -151.34 153.38 24.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.501 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -56.31 -49.53 74.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -101.99 144.04 27.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.642 0.734 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 158.78 55.73 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.636 2.224 . . . . 0.0 112.358 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -80.11 99.6 7.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -92.89 -59.76 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.957 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -120.48 131.04 54.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.913 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.0 168.33 0.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -84.78 82.76 8.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.19 102.43 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 471' ' ' TYR . 11.4 p90 -143.19 141.88 31.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.8 m-30 -79.13 121.02 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -136.34 153.53 51.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 19.4 ttp -51.26 125.58 14.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 113.52 -29.61 7.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -84.77 158.92 20.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -102.69 131.77 49.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.426 HG12 HD23 ' A' ' 520' ' ' LEU . 14.8 m -123.45 159.39 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.135 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -125.04 136.5 53.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.719 HG22 ' CD2' ' A' ' 518' ' ' LEU . 29.9 t -86.24 114.68 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 33.2 pt -97.97 -24.72 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.45 -179.42 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.93 -160.59 21.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.467 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -86.13 -7.76 58.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.542 ' CE2' HD22 ' A' ' 511' ' ' LEU . 69.3 m-85 -119.15 35.83 4.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -57.66 138.6 55.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 84.02 -13.92 46.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -87.98 151.58 22.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 24.3 p -139.6 162.27 35.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.164 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -176.82 178.39 48.06 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 10.9 mt -96.42 161.26 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . . . . . . . . . 66.5 mt -90.26 117.91 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.1 m -107.61 -31.65 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -149.18 137.79 21.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 500' ' ' VAL . 1.8 t -122.53 138.34 52.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.113 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.677 ' OE2' HD11 ' A' ' 501' ' ' ILE . 11.8 mt-10 -126.42 148.82 49.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -54.63 -21.09 9.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . 0.407 ' HB3' ' CD2' ' A' ' 499' ' ' PHE . 4.2 t-20 -94.14 -53.7 3.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.701 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.2 p90 -142.36 172.0 13.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.684 HG13 HG13 ' A' ' 495' ' ' VAL . 18.6 t -116.75 125.34 73.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.079 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . 0.677 HD11 ' OE2' ' A' ' 496' ' ' GLU . 9.1 mm -90.85 119.13 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -116.54 140.53 49.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -85.58 132.03 34.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 13.4 t -85.95 154.82 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.92 -26.29 14.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.1 mt -86.85 -54.25 4.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . 0.43 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 38.7 p -80.16 -7.23 58.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.7 mtm 45.55 36.94 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 507' ' ' THR . 17.9 m-70 -135.67 163.58 29.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.21 125.73 32.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.542 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -109.92 133.99 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 49.6 tttt -101.68 111.65 23.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.79 143.41 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 499' ' ' PHE . 96.0 mt -63.6 153.22 83.95 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.643 0.735 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -0.89 7.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.705 2.27 . . . . 0.0 112.327 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -91.18 -11.2 39.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -112.21 1.94 16.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 480' ' ' VAL . 44.0 mt -116.45 159.58 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -151.96 133.79 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 478' ' ' VAL . 15.6 mt -59.53 160.55 6.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.5 t -105.97 94.17 5.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 11.6 m 61.04 50.8 4.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t 59.44 40.98 20.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.861 0.362 . . . . 0.0 110.858 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 18.1 t -135.76 164.22 28.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -58.91 146.27 42.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 32.3 m -113.87 121.09 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 3.5 m -61.24 130.87 48.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.859 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 67.99 158.07 1.06 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -127.96 -55.64 1.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -60.46 145.96 85.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.638 0.732 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 94.22 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.633 2.222 . . . . 0.0 112.408 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -103.46 179.03 4.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.061 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -133.56 153.51 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.888 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -71.03 140.71 50.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 24.5 mt -122.5 40.75 3.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -109.49 166.11 11.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -96.45 83.24 3.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -137.03 116.33 12.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 10.4 m-85 -60.01 102.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.51 ' O ' HD12 ' A' ' 492' ' ' ILE . 97.2 mttt -121.0 149.33 42.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 13.7 ttp -42.47 140.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 491' ' ' LEU . . . 96.05 -49.52 1.74 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.78 152.05 37.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.34 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.46 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.5 t-80 -94.7 130.09 41.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.45 HG23 HD13 ' A' ' 502' ' ' LEU . 3.6 m -124.54 158.14 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.37 148.45 50.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 10.1 t -98.07 121.6 48.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 34.9 pt -103.8 -23.64 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.126 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.39 -177.89 5.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.057 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.04 -152.5 19.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -89.9 -5.52 56.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.41 ' CE2' HD22 ' A' ' 511' ' ' LEU . 32.1 m-85 -128.08 37.82 4.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -57.96 136.78 57.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 81.84 17.01 71.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.5 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.4 172.87 6.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.933 0.397 . . . . 0.0 110.896 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 72.1 p -151.44 160.6 43.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 177.33 177.27 46.09 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.454 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 475' ' ' GLY . 11.0 mt -102.58 154.44 19.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 473' ' ' LYS . 39.7 mt -82.93 119.68 32.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.24 -26.34 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -160.56 120.83 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.873 HG13 HG22 ' A' ' 500' ' ' VAL . 11.5 t -109.57 146.42 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -132.31 150.96 52.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.52 -27.03 23.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -85.35 -59.64 2.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.576 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -139.55 174.13 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.873 HG22 HG13 ' A' ' 495' ' ' VAL . 36.6 t -113.82 134.33 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . 0.417 HD13 ' C ' ' A' ' 500' ' ' VAL . 4.7 mm -103.79 111.42 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 502' ' ' LEU . 2.5 pt? -114.51 138.99 49.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -79.74 132.08 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.1 t -90.02 152.06 21.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -97.21 -20.89 17.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.83 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 78.5 mt -90.08 -49.44 6.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 508' ' ' MET . 76.9 p -89.3 2.72 53.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 507' ' ' THR . 14.0 mtp 36.3 35.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.94 171.74 12.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -89.56 117.22 28.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' A' ' 485' ' ' PHE . 42.9 mt -101.03 127.33 47.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.501 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 18.3 ttpt -101.55 117.07 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.7 t -139.65 157.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.18 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.4 mt -77.42 153.88 81.69 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.615 0.721 . . . . 0.0 110.896 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 0.86 5.01 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.685 2.257 . . . . 0.0 112.338 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -95.15 -12.41 26.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.75 13.04 16.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.55 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 92.9 mt -115.56 162.35 17.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.401 ' HG2' ' C ' ' A' ' 518' ' ' LEU . 12.9 mm-40 -152.07 137.74 17.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 520' ' ' LEU . 12.9 mt -76.04 155.25 35.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 13.4 t -116.13 -27.91 6.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 2.3 m -124.62 40.54 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.922 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.3 t -91.77 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 34.1 m -97.04 175.86 6.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 60.58 147.0 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.4 m -111.62 -58.51 2.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.873 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 20.8 p -84.04 135.7 34.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -177.9 152.52 11.85 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -92.07 104.12 16.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 110.868 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -121.61 77.8 37.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.637 0.732 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 100.77 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -102.41 89.28 3.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -60.42 150.94 29.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -102.37 157.94 16.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.26 163.79 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.945 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.423 ' HB2' ' NH1' ' A' ' 469' ' ' ARG . 11.7 ttm105 -137.79 140.59 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 469' ' ' ARG . 11.3 mptt -38.03 103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -154.26 136.49 14.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.3 m-30 -62.16 98.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 474' ' ' MET . 44.2 pttt -123.48 141.17 52.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 473' ' ' LYS . 13.6 ttt -34.61 128.92 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.909 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 107.04 -49.58 0.86 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . 0.451 ' HB2' HD12 ' A' ' 492' ' ' ILE . 0.9 OUTLIER -62.79 154.03 31.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.798 0.332 . . . . 0.0 110.874 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.555 ' HA ' HD23 ' A' ' 491' ' ' LEU . 11.9 t-160 -94.93 137.49 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.471 HG12 HD23 ' A' ' 520' ' ' LEU . 19.8 m -133.02 156.29 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.159 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 480' ' ' VAL . 21.8 tttt -128.37 148.39 50.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.714 HG22 ' CD2' ' A' ' 518' ' ' LEU . 36.1 t -95.27 111.3 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 42.8 pt -94.53 -25.09 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -142.71 178.21 7.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.96 -154.48 19.56 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -86.33 -28.62 23.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.818 0.342 . . . . 0.0 110.863 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 511' ' ' LEU . 6.0 m-85 -100.55 34.5 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -55.05 137.27 46.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 87.9 -21.15 24.82 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.525 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.34 158.29 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 27.8 p -145.34 159.82 42.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -171.62 178.8 43.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.3 mt -97.08 155.17 16.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.465 HD11 HG13 ' A' ' 478' ' ' VAL . 24.5 mt -81.82 111.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.429 HG11 ' HB2' ' A' ' 503' ' ' PHE . 4.4 m -101.01 -25.78 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -155.83 150.22 25.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.601 HG13 HG22 ' A' ' 500' ' ' VAL . 2.4 t -131.9 137.8 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.87 140.59 49.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -44.66 -29.08 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -83.7 -64.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.648 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -137.47 173.61 11.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.601 HG22 HG13 ' A' ' 495' ' ' VAL . 26.2 t -114.41 140.66 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 11.8 mm -105.01 118.95 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -116.79 137.37 52.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . 0.429 ' HB2' HG11 ' A' ' 493' ' ' VAL . 54.6 t80 -84.25 129.69 34.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 1.6 t -85.53 152.81 22.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.41 -21.41 17.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 68.0 mt -90.49 -52.89 4.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 22.8 p -82.41 -9.0 59.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.143 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 10.6 mtt 46.24 41.09 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -136.25 167.97 20.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -86.96 113.88 23.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.848 HD22 ' CE2' ' A' ' 485' ' ' PHE . 85.7 mt -96.99 131.85 43.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.41 ' HG3' ' CD1' ' A' ' 499' ' ' PHE . 9.3 tttm -105.37 108.34 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 514' ' ' LEU . 39.8 t -133.76 154.08 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.648 HD23 ' HB3' ' A' ' 499' ' ' PHE . 78.3 mt -71.82 155.26 92.36 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.608 0.718 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.33 15.93 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.649 2.232 . . . . 0.0 112.378 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.95 -26.99 19.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.57 18.33 16.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.714 ' CD2' HG22 ' A' ' 480' ' ' VAL . 48.8 mt -132.8 155.23 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -140.42 138.57 34.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.471 HD23 HG12 ' A' ' 478' ' ' VAL . 9.3 mt -59.06 159.95 6.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . 0.413 ' CB ' ' ND1' ' A' ' 477' ' ' HIS . 3.8 m -134.23 -42.41 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 21.9 t -119.58 56.84 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.905 -179.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 22.8 t -47.67 -46.49 29.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.828 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 458' ' ' GLY . 16.3 m 40.35 41.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 457' ' ' SER . . . -34.49 127.91 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 28.6 m -146.14 175.69 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 110.845 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 15.0 m -120.45 173.38 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.34 -134.24 7.87 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.459 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -73.42 144.02 46.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -124.95 144.0 45.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.71 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 170.47 16.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.673 2.248 . . . . 0.0 112.349 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -115.21 140.99 48.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.133 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -100.68 -36.48 9.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.12 123.05 5.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.4 mt -54.26 168.01 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -109.84 142.41 41.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.18 51.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -114.17 138.62 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 2.0 m-30 -61.63 109.15 1.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -120.64 144.57 48.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 9.0 mtm -45.86 143.09 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.79 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.503 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.31 160.58 25.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -104.66 133.01 50.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.466 HG13 HD11 ' A' ' 492' ' ' ILE . 27.6 m -126.05 159.04 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.459 ' HG3' HG22 ' A' ' 489' ' ' THR . 51.4 tttt -120.23 149.94 41.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.452 HG22 ' CD2' ' A' ' 518' ' ' LEU . 25.5 t -95.12 123.73 47.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.128 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . 0.5 HG21 ' OE1' ' A' ' 519' ' ' GLN . 15.6 pt -103.54 -26.57 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -144.75 -175.65 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.74 -153.9 20.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.493 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -89.15 -3.89 58.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.36 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -126.65 33.47 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -56.95 108.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.13 -13.17 16.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.483 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 480' ' ' VAL . 1.0 OUTLIER -91.52 157.48 17.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.866 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.459 HG22 ' HG3' ' A' ' 479' ' ' LYS . 30.6 p -138.03 164.44 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -178.12 175.53 47.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.3 mt -92.2 165.58 13.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 0.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 478' ' ' VAL . 46.8 mt -97.67 113.57 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 9.5 m -103.37 -33.4 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -148.62 148.55 30.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.533 HG22 HG13 ' A' ' 500' ' ' VAL . 15.9 t -133.46 140.93 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -129.52 145.9 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -48.46 -33.4 9.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.94 -60.48 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.707 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -137.86 -179.0 5.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 495' ' ' VAL . 6.1 t -118.62 144.25 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.68 110.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.4 pt? -110.07 137.18 48.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -82.75 131.11 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 146.51 26.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.831 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -98.5 -22.43 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 66.6 mt -81.64 -59.57 2.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 56.4 p -84.04 -2.23 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.151 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 42.6 mtt 48.23 36.82 7.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.27 172.22 11.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -92.19 123.38 35.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 13.8 mt -104.5 135.24 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.561 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.6 tttt -113.4 112.18 23.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 514' ' ' LEU . 2.8 t -141.63 162.2 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.174 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 499' ' ' PHE . 97.0 mt -75.34 152.15 85.74 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.611 0.72 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -2.0 9.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.698 2.265 . . . . 0.0 112.362 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -89.07 -28.4 20.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.9 15.05 23.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.452 ' CD2' HG22 ' A' ' 480' ' ' VAL . 50.8 mt -125.33 169.07 12.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.5 ' OE1' HG21 ' A' ' 481' ' ' ILE . 17.2 pt20 -163.52 134.23 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.85 155.5 16.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.8 t -105.06 -41.9 5.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 11.6 t -130.15 92.45 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 24.9 m -141.59 150.94 42.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.886 0.374 . . . . 0.0 110.86 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 56.7 p -45.87 166.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 114.87 -57.22 0.48 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.4 t -60.64 131.61 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 6.4 p 45.36 42.11 7.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . -115.17 -39.09 0.97 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -76.83 -42.12 41.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.901 0.382 . . . . 0.0 110.89 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.31 80.74 1.18 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.655 0.741 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 110.69 2.6 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.382 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -79.53 126.18 30.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.46 80.18 1.54 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -87.7 89.52 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.567 ' H ' HD12 ' A' ' 468' ' ' LEU . 5.3 mp -65.3 146.57 54.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -100.9 157.68 16.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -78.62 83.16 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -133.57 145.09 49.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -72.16 98.64 2.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 474' ' ' MET . 58.9 mttm -117.63 137.82 52.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.418 ' C ' ' O ' ' A' ' 473' ' ' LYS . 28.4 ttm -36.81 133.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 104.95 -45.41 1.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . 0.403 ' HB2' HD12 ' A' ' 492' ' ' ILE . 39.5 m-20 -67.31 155.45 38.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.473 ' HA ' HD23 ' A' ' 491' ' ' LEU . 9.4 t-80 -94.78 124.97 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.622 HG13 HD11 ' A' ' 492' ' ' ILE . 4.7 m -117.27 162.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.617 ' HG3' HG22 ' A' ' 489' ' ' THR . 61.8 tttt -135.0 149.33 50.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 488' ' ' ASP . 6.3 t -93.02 124.81 45.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.14 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . 0.602 HG23 ' HG2' ' A' ' 519' ' ' GLN . 35.4 pt -103.29 -27.35 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -143.89 -177.16 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 95.94 -151.31 19.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -88.4 -24.08 23.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -105.45 39.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.28 119.67 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 103.08 -13.39 55.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.462 ' O ' HG23 ' A' ' 480' ' ' VAL . 0.9 OUTLIER -88.62 155.07 19.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.868 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.617 HG22 ' HG3' ' A' ' 479' ' ' LYS . 33.0 p -135.98 170.95 15.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.189 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . 176.12 174.89 43.03 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.6 mt -96.7 151.71 19.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.729 0.3 . . . . 0.0 110.976 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.622 HD11 HG13 ' A' ' 478' ' ' VAL . 25.2 mt -80.77 106.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 m -97.45 -33.21 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.121 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -147.63 146.73 29.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 500' ' ' VAL . 1.2 t -131.08 151.5 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -145.94 145.89 30.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -49.23 -30.43 7.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -82.27 -65.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.663 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.9 OUTLIER -133.87 171.25 14.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.898 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.942 HG13 HG13 ' A' ' 495' ' ' VAL . 9.4 t -113.98 134.38 57.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 20.5 mm -100.26 132.12 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 502' ' ' LEU . 2.5 pt? -133.94 146.27 50.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -91.6 129.76 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 511' ' ' LEU . 1.3 t -91.83 127.91 37.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.58 -18.31 61.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 41.2 mt -82.4 -61.36 1.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 18.3 p -82.74 -5.03 58.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 36.7 mtm 47.3 39.93 9.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -136.14 170.85 15.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -87.54 114.99 24.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 504' ' ' SER . 38.1 mt -95.84 142.79 27.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.42 ' NZ ' ' CZ ' ' A' ' 499' ' ' PHE . 5.8 tttp -112.58 118.31 34.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.921 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . 0.432 ' HB ' HD21 ' A' ' 518' ' ' LEU . 11.5 t -148.12 143.11 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 499' ' ' PHE . 79.6 mt -66.77 155.1 90.37 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.728 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -1.18 8.06 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.245 . . . . 0.0 112.31 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 22.0 ptt85 -93.22 -7.46 45.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.14 5.16 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.832 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.432 HD21 ' HB ' ' A' ' 513' ' ' VAL . 46.0 mt -112.75 159.41 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.602 ' HG2' HG23 ' A' ' 481' ' ' ILE . 15.5 pt20 -152.88 131.02 11.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.51 HD13 ' HG3' ' A' ' 523' ' ' GLU . 9.1 mt -58.16 166.36 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.58 114.79 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 8.0 t 71.94 53.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.824 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.51 ' HG3' HD13 ' A' ' 520' ' ' LEU . 63.7 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.6 t -90.52 163.1 14.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 69.0 m -137.62 150.04 47.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 112.94 145.26 9.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 79.3 p -151.13 166.73 29.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.859 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 54.9 p -79.81 146.88 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.838 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 128.13 116.27 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -66.49 147.1 53.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -127.69 80.69 71.56 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 160.62 49.04 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.662 2.241 . . . . 0.0 112.364 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -114.37 -44.4 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.87 142.41 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.35 157.39 20.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 67.2 mt -52.78 179.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.42 123.43 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.5 pttm -111.18 82.14 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -140.16 126.02 19.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 4.8 m-85 -59.3 100.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 492' ' ' ILE . 6.6 mmmt -115.98 148.31 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.919 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -45.16 137.67 4.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 97.95 -39.41 2.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.42 156.52 38.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.478 ' HA ' HD23 ' A' ' 491' ' ' LEU . 34.8 t-80 -97.68 129.85 44.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 502' ' ' LEU . 30.0 m -119.44 158.86 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.158 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -126.65 152.14 47.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 50.5 t -100.38 117.29 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.85 -23.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -141.86 -179.65 6.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.138 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 96.82 -159.05 21.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -81.63 -21.02 38.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.489 ' CE2' HD22 ' A' ' 511' ' ' LEU . 26.8 m-85 -111.64 40.21 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.8 108.52 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 118.96 -24.53 8.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.75 155.14 41.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 61.0 p -143.43 148.39 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -165.25 -173.83 34.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.451 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.4 mt -102.06 159.47 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 473' ' ' LYS . 54.8 mt -87.06 124.97 40.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.207 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.93 -35.1 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.3 ttm-85 -151.4 117.14 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 500' ' ' VAL . 1.7 p -113.59 131.44 65.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -108.87 167.79 9.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -66.15 -20.83 66.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -95.62 -65.57 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.566 ' CD2' ' HE2' ' A' ' 512' ' ' LYS . 0.9 OUTLIER -124.2 173.16 8.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.706 HG22 HG23 ' A' ' 495' ' ' VAL . 26.3 t -117.49 137.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 8.6 mm -106.73 120.5 58.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.198 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.0 pt? -119.03 140.19 50.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 508' ' ' MET . 83.4 t80 -78.95 129.55 34.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 24.0 t -83.33 138.43 33.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -90.44 2.31 55.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.9 mt -93.01 -67.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 508' ' ' MET . 16.2 p -108.58 29.11 7.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 503' ' ' PHE . 0.4 OUTLIER 34.52 49.61 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -116.55 159.0 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -94.24 116.26 28.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 485' ' ' PHE . 83.1 mt -99.29 138.76 35.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.566 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 6.5 tmtt? -114.9 110.32 19.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 8.0 t -138.45 145.1 28.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.148 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.534 HD23 ' HB3' ' A' ' 499' ' ' PHE . 91.2 mt -62.25 152.9 77.53 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 0.0 110.954 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -11.34 30.57 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.18 -19.48 53.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -112.32 21.18 16.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 25.8 mt -120.78 162.19 20.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -149.9 142.09 24.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 520' ' ' LEU . 10.5 mt -75.91 155.96 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 34.5 t -128.5 -42.92 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 523' ' ' GLU . 68.7 m -61.87 -45.85 91.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.482 ' C ' ' CD ' ' A' ' 523' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 93.3 p -52.11 141.68 17.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 39.0 m -90.15 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.827 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -85.08 94.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.462 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 75.6 m -91.11 -49.87 6.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 110.86 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -114.06 82.21 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.862 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 165.07 -149.21 15.5 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -40.4 134.4 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -108.06 80.48 1.07 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 111.68 2.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.24 . . . . 0.0 112.375 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -99.05 177.23 5.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -38.84 106.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 467' ' ' GLU . 3.5 mp0 -57.93 134.36 56.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 9.0 mt -102.41 90.43 3.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 42.7 mmt-85 -86.25 50.9 2.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -113.95 84.29 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.795 ' O ' HD11 ' A' ' 520' ' ' LEU . 0.3 OUTLIER -118.24 155.83 29.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.939 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 -108.23 99.75 9.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -120.46 138.73 53.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.55 ' HA ' HG22 ' A' ' 492' ' ' ILE . 2.6 ttp -38.33 132.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 109.35 -34.74 5.33 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . 0.529 ' HB2' HD12 ' A' ' 492' ' ' ILE . 10.3 m-20 -79.92 163.16 24.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.821 0.343 . . . . 0.0 110.843 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 9.7 t-80 -100.36 121.92 42.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.764 HG13 HD11 ' A' ' 492' ' ' ILE . 14.4 m -114.71 148.04 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.099 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -124.11 143.32 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 488' ' ' ASP . 24.7 t -93.88 124.05 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.138 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 40.9 pt -107.13 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.184 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 517' ' ' ASP . . . -140.29 -176.94 4.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 91.58 -159.39 25.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -86.17 -10.55 54.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.861 0.362 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.55 32.08 6.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -56.39 125.11 20.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.35 6.03 64.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.487 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 480' ' ' VAL . 3.3 t70 -99.82 129.96 45.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 67.1 p -124.78 146.63 49.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.18 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . 0.507 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -168.7 -170.26 33.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.518 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 477' ' ' HIS . 12.7 mt -104.49 158.95 16.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.764 0.316 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.764 HD11 HG13 ' A' ' 478' ' ' VAL . 45.3 mt -89.29 121.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.37 -35.55 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -144.27 121.44 11.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 500' ' ' VAL . 3.0 t -112.12 126.96 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.47 157.15 21.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.78 -36.82 77.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -76.63 -59.15 2.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.716 ' HB3' HD23 ' A' ' 514' ' ' LEU . 0.7 OUTLIER -136.56 176.7 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.631 HG13 HG13 ' A' ' 495' ' ' VAL . 14.9 t -115.01 140.03 38.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.107 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.6 mm -109.0 109.68 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.679 HD13 HG23 ' A' ' 478' ' ' VAL . 2.4 pt? -109.26 137.16 47.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . 0.424 ' CE2' ' O ' ' A' ' 504' ' ' SER . 65.1 t80 -79.69 132.37 36.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . 0.424 ' O ' ' CE2' ' A' ' 503' ' ' PHE . 1.4 t -84.9 149.0 25.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.76 -31.6 10.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 36.2 mt -80.7 -44.63 18.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 2.7 p -90.34 -10.01 45.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 29.1 mtt 51.96 36.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -137.08 159.88 40.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -80.84 128.9 34.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 30.6 mt -116.47 135.06 54.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.581 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 3.4 tmtt? -103.63 129.12 50.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . 0.532 HG12 ' N ' ' A' ' 514' ' ' LEU . 22.0 t -149.47 161.42 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 499' ' ' PHE . 95.1 mt -81.07 154.02 72.36 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.607 0.717 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 2.28 3.7 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.661 2.241 . . . . 0.0 112.353 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -95.57 -25.64 16.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.816 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . 0.812 ' OD1' ' HB3' ' A' ' 482' ' ' ALA . 31.7 m-20 -105.0 22.69 14.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 72.1 mt -121.78 150.79 41.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -141.95 126.42 17.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.795 HD11 ' O ' ' A' ' 471' ' ' TYR . 12.6 mt -62.27 151.8 35.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 12.0 t -120.27 106.26 11.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 9.5 t 70.17 31.24 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.916 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 45.6 t -99.1 -45.85 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.813 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 62.3 m -94.08 148.56 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -167.02 -62.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.0 t -58.18 133.21 55.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 50.6 m -43.11 155.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 165.48 132.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -65.37 103.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.85 0.357 . . . . 0.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -81.88 144.04 51.01 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.31 6.28 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.706 2.271 . . . . 0.0 112.35 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -114.57 -46.24 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.07 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -39.56 114.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -61.6 149.36 39.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.879 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 79.6 mt -53.69 163.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.927 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -81.56 177.89 8.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -109.8 50.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -127.56 127.78 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 1.6 m-85 -52.71 98.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 474' ' ' MET . 41.4 mttp -120.9 139.67 52.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . 0.423 ' C ' ' O ' ' A' ' 473' ' ' LYS . 18.1 ttt -34.65 132.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 102.33 -40.7 2.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.503 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . 0.626 ' HB2' HD12 ' A' ' 492' ' ' ILE . 7.8 m-20 -70.83 157.28 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.862 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -101.94 136.76 41.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.887 HG12 HD23 ' A' ' 520' ' ' LEU . 3.8 m -139.03 159.42 29.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 489' ' ' THR . 3.1 ttpm? -123.19 159.36 28.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 488' ' ' ASP . 48.0 t -104.39 121.84 56.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.142 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 20.3 pt -101.73 -23.43 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -145.79 171.29 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.131 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 104.29 -166.03 15.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.49 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -76.52 -7.69 55.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.872 0.368 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.584 ' CE2' HD22 ' A' ' 511' ' ' LEU . 12.9 m-85 -124.7 42.19 3.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -55.54 135.03 51.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 72.78 10.63 77.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.513 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . 0.736 ' O ' HG23 ' A' ' 480' ' ' VAL . 19.9 t0 -95.99 125.03 40.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.514 HG22 ' HG3' ' A' ' 479' ' ' LYS . 18.9 p -109.79 155.55 21.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.23 174.62 47.15 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.76 153.08 17.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 476' ' ' ASP . 14.5 mt -83.41 118.84 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.5 m -111.23 -31.41 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -146.16 141.02 27.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.85 HG13 HG22 ' A' ' 500' ' ' VAL . 15.9 t -129.39 128.67 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -124.75 148.45 48.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -52.22 -24.62 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -87.75 -61.73 1.65 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.59 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.0 OUTLIER -140.09 169.11 18.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.85 HG22 HG13 ' A' ' 495' ' ' VAL . 62.6 t -114.24 134.77 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.14 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 19.3 mm -102.28 119.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.6 pt? -115.63 139.54 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.74 125.77 30.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 6.1 t -86.01 153.1 22.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.25 -32.37 11.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.832 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 40.6 mt -77.24 -56.08 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . . . . . . . . . 81.7 p -80.73 -8.41 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . . . . . . . . . 27.4 mtt 49.56 31.07 3.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -130.02 172.4 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.6 124.24 34.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.584 HD22 ' CE2' ' A' ' 485' ' ' PHE . 29.3 mt -104.1 133.7 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 499' ' ' PHE . 16.5 tttm -103.0 114.96 29.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 23.0 t -140.15 151.81 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 499' ' ' PHE . 66.4 mt -72.04 155.16 92.13 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.609 0.719 . . . . 0.0 110.86 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.24 4.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.687 2.258 . . . . 0.0 112.334 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -34.05 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 22.34 7.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.484 ' CD2' HG22 ' A' ' 480' ' ' VAL . 23.9 mt -122.64 149.27 44.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -138.48 135.51 35.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 478' ' ' VAL . 9.8 mt -69.07 159.72 32.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.38 -33.94 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 19.4 t -157.67 113.78 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 41.2 t -90.26 -49.27 6.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.355 . . . . 0.0 110.829 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.1 t -63.57 -56.67 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 40.58 59.01 2.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 9.4 m -59.77 -51.8 68.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.888 0.375 . . . . 0.0 110.901 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 30.3 m -155.49 164.42 38.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 156.7 66.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.486 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.71 146.35 24.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 0.0 110.882 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 463' ' ' PHE . 0.1 OUTLIER -134.09 65.38 69.16 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.697 0.76 . . . . 0.0 110.895 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 96.11 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.363 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -88.77 114.86 25.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -81.43 -45.26 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -86.89 158.3 19.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 469' ' ' ARG . 26.9 mt -133.81 110.77 10.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 468' ' ' LEU . 0.0 OUTLIER -36.89 139.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -99.32 88.0 3.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.959 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.68 ' O ' HD11 ' A' ' 520' ' ' LEU . 18.8 m-85 -93.5 159.82 15.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.527 ' CE2' ' HB2' ' A' ' 518' ' ' LEU . 7.8 m-85 -115.8 98.84 6.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -111.79 153.75 26.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 4.9 ttt -52.41 138.25 27.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 99.8 -26.72 23.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.83 147.99 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.903 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 490' ' ' GLY . 21.7 t-80 -92.54 144.32 25.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 520' ' ' LEU . 34.0 m -140.67 166.61 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.87 ' HD3' HG22 ' A' ' 489' ' ' THR . 6.9 tptm -130.72 131.58 44.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.471 HG22 ' CD2' ' A' ' 518' ' ' LEU . 24.8 t -80.88 108.86 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 36.2 pt -95.02 -26.84 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 517' ' ' ASP . . . -130.68 176.36 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.117 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 94.64 -164.06 25.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -84.68 -19.21 33.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.793 ' CD2' HD22 ' A' ' 511' ' ' LEU . 31.2 m-85 -105.97 41.28 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.31 133.92 46.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 92.05 15.05 55.25 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.49 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.03 137.99 53.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.87 HG22 ' HD3' ' A' ' 479' ' ' LYS . 7.1 p -117.73 152.19 35.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . 0.43 ' O ' ' CD2' ' A' ' 477' ' ' HIS . . . -176.19 176.84 47.8 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.501 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.56 165.54 12.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 472' ' ' PHE . 71.5 mt -94.31 113.31 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.57 -33.18 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.143 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -142.14 150.06 40.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.773 HG13 HG22 ' A' ' 500' ' ' VAL . 11.4 t -138.5 128.87 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.109 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -126.35 143.61 51.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -48.89 -22.42 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.02 -57.87 2.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.548 ' CE2' ' HE3' ' A' ' 512' ' ' LYS . 1.1 p90 -142.7 169.75 17.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.773 HG22 HG13 ' A' ' 495' ' ' VAL . 50.1 t -116.36 133.43 62.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 7.9 mm -100.04 117.5 45.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 502' ' ' LEU . 2.1 pt? -114.95 138.25 51.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.3 125.57 32.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 20.8 t -83.57 130.86 35.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.14 -11.7 59.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.858 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 92.9 mt -98.0 -57.24 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 508' ' ' MET . 73.3 p -84.05 2.02 41.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 507' ' ' THR . 35.6 mmm 36.64 49.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -140.86 166.36 24.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -91.98 115.18 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.793 HD22 ' CD2' ' A' ' 485' ' ' PHE . 60.1 mt -99.95 137.55 38.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.548 ' HE3' ' CE2' ' A' ' 499' ' ' PHE . 29.7 tttt -109.08 110.43 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 5.6 t -136.4 150.76 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 499' ' ' PHE . 92.7 mt -70.86 154.54 94.21 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.586 0.707 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -2.24 9.8 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 0.0 112.38 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -95.4 -9.73 31.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 482' ' ' ALA . 4.0 m-20 -121.29 38.39 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.527 ' HB2' ' CE2' ' A' ' 472' ' ' PHE . 71.2 mt -143.5 155.5 44.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -140.27 132.34 27.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 471' ' ' TYR . 12.2 mt -63.9 148.05 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 522' ' ' SER . 1.4 p -74.53 -44.32 51.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . 0.49 ' N ' ' SG ' ' A' ' 521' ' ' CYS . 38.8 m -134.39 86.5 2.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 55.1 p -138.66 153.57 48.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.895 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 46.2 t -166.17 142.47 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -125.04 -84.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.486 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 11.1 t -62.54 142.3 58.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 4.1 m -148.38 154.74 40.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 141.04 -175.1 22.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -105.88 92.37 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.859 0.362 . . . . 0.0 110.864 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -124.05 150.76 63.97 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -25.13 28.95 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.694 2.263 . . . . 0.0 112.349 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -39.46 139.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -70.78 134.24 47.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -80.31 137.45 36.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 468' ' ' LEU . 4.6 mp -104.26 96.96 6.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 471' ' ' TYR . 53.1 mtt-85 -99.75 131.91 45.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.58 90.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.889 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 469' ' ' ARG . 22.0 m-85 -134.78 137.22 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 472' ' ' PHE . 1.1 m-30 -69.36 100.9 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.552 ' O ' HD12 ' A' ' 492' ' ' ILE . 57.1 mttm -121.61 155.15 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -52.52 134.86 34.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' GLY . . . . . . . . . . . . . . . 98.38 -25.81 26.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.491 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.71 148.22 25.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -88.21 142.08 28.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' A' ' 492' ' ' ILE . 10.9 m -136.94 157.15 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 480' ' ' VAL . 1.9 ttmp? -121.91 147.8 45.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.479 ' N ' ' HG2' ' A' ' 479' ' ' LYS . 48.1 t -97.88 99.13 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ILE . . . . . . . . . . . . . 22.4 pt -87.56 -18.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -134.94 170.98 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.74 -158.04 20.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -89.98 -16.96 28.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -106.84 39.26 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.54 109.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . 116.89 -13.86 14.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.63 137.86 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.887 0.375 . . . . 0.0 110.847 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 30.6 p -118.29 165.77 13.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.166 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . -177.63 176.71 48.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.48 156.08 16.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 473' ' ' LYS . 59.8 mt -86.23 114.1 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.46 -33.89 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -142.61 144.04 32.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 500' ' ' VAL . 21.3 t -130.15 120.63 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.28 149.86 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -53.79 -30.75 46.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -80.6 -59.37 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 514' ' ' LEU . 1.1 p90 -141.15 173.53 11.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 495' ' ' VAL . 44.9 t -116.17 134.09 60.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 6.7 mm -99.66 121.83 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.165 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 502' ' ' LEU . 2.3 pt? -119.75 137.91 53.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -82.48 124.79 30.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' SER . . . . . . . . . . . . . 3.0 t -82.0 154.97 25.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -101.78 -9.34 20.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' LEU . . . . . . . . . . . . . 35.9 mt -99.19 -55.19 2.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 509' ' ' HIS . 81.1 p -84.87 4.05 35.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 507' ' ' THR . 3.4 mtt 35.1 54.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 507' ' ' THR . 53.9 m-70 -149.3 177.85 9.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -98.53 115.84 29.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 18.2 mt -104.55 139.89 38.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' LYS . . . . . 0.532 ' CG ' ' CD1' ' A' ' 499' ' ' PHE . 0.1 OUTLIER -108.12 118.11 35.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.35 146.72 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 499' ' ' PHE . 80.7 mt -68.4 153.24 95.9 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 0.0 110.926 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -1.61 8.78 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -95.54 -11.13 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.62 23.57 12.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.475 ' CD2' HG22 ' A' ' 480' ' ' VAL . 88.8 mt -131.69 153.09 50.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 520' ' ' LEU . 2.7 pp0? -145.39 127.94 16.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' LEU . . . . . 0.442 ' O ' ' NE2' ' A' ' 519' ' ' GLN . 13.1 mt -62.87 154.85 28.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' CYS . . . . . . . . . . . . . 46.6 t -113.28 -30.03 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' SER . . . . . . . . . . . . . 22.8 m -117.91 45.3 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 stop_ save_